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DISSERTATION ABSTRACT 
 
Matthew David Hartle 
 
Doctor of Philosophy 
 
Department of Chemistry and Biochemistry 
 
December 2016 
 
Title: Binding of Hydrogen Sulfide to Biologically Relevant Scaffolds: Metal Systems 
and Non-Covalent Binding 
 
 
Hydrogen Sulfide (H2S) is an important biologically produced gasotransmitter 
along with carbon monoxide (CO) and nitric oxide (NO). Unlike CO and NO, the 
bioinorganic chemistry of H2S reactivity with biologically relevant metal centers remains 
underinvestigated. To address this gap, several model bio(in)organic complexes were 
used to understand the ligation and reaction chemistry of H2S, including phthalocyanine, 
protoporphyrin IX, tetraphenyl porphyrin, and a pyridine diimine zinc complex. In 
addition to being a reactive gasotransmitter, the hydrosulfide anion (HS–) has been found 
to be an important biological anion. 
Studies with readily available cobalt and zinc phthalocyanines in organic solution 
illustrated the importance of protonation state in the ligation and redox chemistry of H2S 
and highlighted the need for an organic-soluble source of HS–. To address this need, we 
developed a simple method to prepare tetrabutylammonium hydrosulfide (NBu4SH). 
Using NBu4SH, we expanded the knowledge of H2S reaction chemistry to encompass a 
significantly larger set of biologically relevant metals beyond iron using the 
protoporphyrin IX scaffold, revealing three principle reaction pathways: binding, no 
response, or reduction and binding. 
  v 
Iron in biology is of particular importance given its role in oxygen transport in 
hemoglobin. The swamp-dwelling bivalve L. Pectinata hemoglobin 1 (Hb1) transports 
H2S, via ligation to heme, to symbiotic bacteria. The stabilization of H2S in Hb1 is 
believed to be from one of the following: a protected pocket, hydrogen bonding with a 
proximal glutamate residue, or a complex combination of these or other factors. By using 
Collman's "Picket-Fence" porphyrin to isolate the protected pocket model, we determined 
that a protected pocket alone as insufficient to account for H2S stabilization on Hb1. This 
realization led to an examination of hydrogen bonding in the secondary coordination 
sphere of a zinc complex. 
Finally, we explored the role of HS– as a biologically relevant anion using a 
bis(ethynylaniline) supramolecular receptor. We determined that rather than covalently 
modifying the receptor molecule, HS– was bound in the pocket, similar to bacterial anion 
transport channel. 
This dissertation includes previously published co-authored material. 
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CHAPTER I  
A PRACTICAL GUIDE TO WORKING WITH H2S AT THE INTERFACE OF 
CHEMISTRY AND BIOLOGY 
Published as Hartle, M. D. and Pluth M. D. “A practical guide to working with 
H2S at the interface of chemistry and biology.” Chem. Soc. Rev. 2016 
DOI:10.1039/c6cs00212a. This is a co-authored literature review with M. D. Pluth. This 
chapter is a general introduction to the currently available tools for studying hydrogen 
sulfide at the interface of chemistry and biology. 
Preface 
Hydrogen sulfide (H2S) is the most recently accepted endogenously produced 
gasotransmitter and is now implicated in a variety of physiological functions. This 
chapter provides a background on H2S chemical biology and highlights  practical 
considerations, pitfalls, and best practices in the field. Practical handling and safety 
considerations for working with this reactive biomolecule and basic roles of H2S 
biogenesis and action are presented. Experimental methods for modulating H2S levels, 
including enzymatic knockout, RNA silencing, enzymatic inhibition, and use of small 
molecule H2S donors are also highlighted. Complementing H2S modulation techniques, 
we also highlight current strategies for H2S detection and quantification. 
Introduction 
Hydrogen sulfide (H2S) has emerged as an important biological signaling 
molecule that plays diverse roles in human health and physiology. Despite its long history 
as a toxic gas and environmental pollutant, H2S now joins nitric oxide (NO) and carbon 
monoxide (CO) as a gasotransmitter – a small, enzymatically generated, gaseous 
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molecule with a tightly regulated metabolism that impacts physiological functions.1-4 The 
innate chemical properties of H2S, including its redox activity, acidity, and high 
nucleophilicity, allow for reaction with different cellular targets as part of its signaling 
capacity. By comparison, disentangling this chemistry is in many ways more complicated 
to that of NO and CO.5 Misregulation of endogenous H2S is implicated in diverse 
physiological processes, including blood pressure regulation, immune response, and long 
term potentiation, as well as various diseases in the neuronal, gastrointestinal, circulatory, 
and endocrine systems.2 Aligned with our rapidly expanding understanding of biological 
H2S, new and impactful investigative tools for elucidating its genesis, translocation, and 
action have emerged and continue to be an active and fruitful research area. 
By contrast to biological studies focused on NO and CO, H2S-focused 
investigations are often faced with unique experimental challenges – some of which are 
due to the recent emergence of H2S chemical biology and others from the innate physical 
properties of H2S. For example, although CO, NO, and H2S are all gasses, common gas 
detection techniques, such as gas chromatography (GC) and chemiluminescence detectors 
provide robust methods for detection and quantification for CO and NO, respectively, 
whereas similar techniques have not been widely developed for H2S. The different 
protonation states of H2S, and its interaction with the redox-active biological sulfur pool, 
make analysis by GC or other common analytical methods challenging. Similarly, 
reaction-based imaging techniques, as well as synthetic donor scaffolds, are often more 
complicated than similar systems for NO or CO. Despite these challenges, recent studies 
have suggested the potential interplay between the biological chemistry of H2S and NO3,6 
as well as CO,4 thus highlighting the interconnectivity of these three gaseous molecules. 
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These interactions, as well as those with H2S and reactive sulfur, oxygen, and nitrogen 
species (RSONS) highlight the complexity of the biological landscape in which H2S is 
involved, and the synergistic relationship of H2S to other important and reactive small 
molecules in biology.  
In this chapter, we highlight key points regarding H2S chemical biology and 
provide a brief survey of accessible tools and methods for H2S research at the interface of 
chemistry and biology. Our goal is not to provide a comprehensive overview of all 
investigative tools for H2S research, but rather to highlight currently available classes of 
tools and to provide important considerations to help guide new researchers into the 
rapidly developing field of H2S chemical biology. 
Properties and Enzymatic Production of H2S 
H2S is a weak acid with a first pKa of 7.0, and a second pKa, corresponding to the 
deprotonation of hydrosulfide anion (HS–) of >14.1 Under physiological conditions, HS– 
constitutes about 80% of the speciation, neutral H2S about 20%, and dianionic S2– less 
than 1%.1 The HS– and H2S protonation states provide water-solubility and lipophilicity, 
respectively, and HS– is a potent nucleophile that can react with different electrophilic 
cellular targets including RSONS. Additionally, the different protonation states afford 
different metal-ligation and redox properties. The complex redox landscape of biological 
sulfur, with oxidation states ranging from -2 in H2S to +6 in SO42–, means that H2S/HS– 
can be readily oxidized to other biologically-relevant reactive sulfur species. Indeed, the 
redox-labile / sulfane-sulfur pool may provide an important method of sulfide storage and 
transport, but also may provide new signaling pathways distinct from those associated 
with H2S alone (vide infra).7  
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Enzymatic H2S biosynthesis stems primarily from cystathionine-g-lyase (CSE), 
cystathionine-b-synthase (CBS), and 3-mercaptopyruvate sulfurtransferase (3-MST) / 
cysteine aminotransferase (CAT). In each of these pathways, the sulfur atom incorporated 
into H2S is derived from the sulfhydryl group of homocysteine (Hcy) or L-cysteine (L-
Cys). Details of these pathways have been recently reviewed in significant detail and are 
summarized briefly here (Figure I-1).1-4 CSE catalyzes the formation of H2S and 
homolanthionine from 2 equiv. of Hcy, but can also work in concert with CBS to convert 
Hcy and Cys to H2S and cystathionine. CBS can also catalyze the condensation of Hcy 
with Serine (Ser) to generate cystathionine and H2O. Upon reaction with CSE, 
cystathionine is converted back to L-Cys with concomitant formation of homoserine. 
This generated Cys can either participate in the above pathways, can be hydrolyzed to Ser 
and H2S by CBS or CSE, or can be condensed with a second equivalent of Cys by the 
same two enzymes to form lanthionine and H2S. Cysteine is also a viable substrate for 
CAT, which generates 3-mercaptopyruvate (3-MP), which is then converted to pyruvate, 
NH3, and H2S by 3-MST. The 3-MST pathway also accounts for H2S formed from D-
Cys, which is first converted to 3-mercaptopyruvate by DAO. 
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Figure I-1. Enzymatic H2S production pathways. CSE: cystathionine g-lyase; CBS: 
cystathionine b-synthase; CAT: cysteine aminotransferase; DAO: D-aminoacid oxidase; 
3-MST: 3-mercaptopyruvate sulfurtransferase. Grey boxes indicate common substrates 
for H2S-producing enzymes. 
Practical Handling and Safety Considerations 
Hydrogen sulfide is a highly toxic gas, and adequate care must be given when 
handling H2S gas, sulfide salts, and synthetic H2S donors. Although the characteristic 
rotten egg odor is detectable as low as 0.01 ppm in air, odor alone should never be used 
as the primary method of safety monitoring. Rapid olfactory fatigue results upon 
exposure to concentrations greater than 100 ppm but also after continuous exposure to 
significantly lower levels. H2S concentrations as low as 20 ppm cause eye and lung 
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irritation, 300-500 ppm levels result in serious eye damage, and 700 ppm or higher levels 
can result in unconsciousness, respiratory failure, and death.8 The combination of high 
toxicity with rapid olfactory fatigue necessitates handling in a well ventilated fume hood 
equipped with an H2S alarm, which detects H2S gas and typically reports in the 5-10 ppm 
range, especially when using H2S gas directly or quantities of sulfide salts sufficient to 
provide a potentially toxic response.9 It is also practical, both from a safety and odor-
mediation standpoint, to quench any H2S-containing solutions after use. Such quenching 
can be readily accomplished by preparation and use of a Zn2+ quenching solution, which 
rapidly reacts with free sulfide to generate insoluble ZnS. This quenching slurry can be 
prepared by adding 30 g Zn(OAc)2, 9 g sodium citrate, and 12 g NaOH to 1 L of H2O.8  
For experiments involving aqueous sulfide solutions, it is often more practical to 
use sulfide salts, such as NaSH or Na2S, rather than H2S gas directly. Despite their 
convenience, the commercial purity of NaSH or Na2S is often poor, and many samples 
contain significant quantities of elemental sulfur or polysulfides.5,10-11 In general, sulfide 
salts should be free-flowing white powders – any inclusion of yellow or other highly 
colored impurities should signal to the user that the sample does not have the appropriate 
purity and should be discarded. Because of the propensity of H2S/HS– to oxidize, 
especially in the presence of trace metal ions and oxygen, H2S solutions should be 
prepared in anaerobic buffer under a blanket of nitrogen or argon in clean, metal-free, 
glass- or plastic-ware. Such solutions should also be prepared in septum-sealed vials to 
prevent significant loss from H2S volatilization and also to enable easy transfer of sulfide 
solutions via gas-tight syringe. Because of this volatility and potential for oxidation, it is 
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most practical to prepare sulfide-containing solutions immediately prior to use rather than 
to re-use solutions from previous experiments. 
Interactions with the Sulfane-Sulfur Pool 
Complementing the signaling roles of biological H2S, significant evidence 
suggests that sulfane-sulfur compounds, such as polysulfides, persulfides, and other 
sources of reductant-labile sulfur, play important biochemical roles.7,10-11 The term 
“sulfane sulfur” refers to a sulfur atom with formally six valence electrons and no charge 
(S0), which is bound to one or more sulfur atoms.12 Upon reaction with cellular reductants 
or thiols, sulfane-sulfur compounds can release sulfide, thus providing a convenient 
source of H2S storage. Additionally, sulfane-sulfur species have distinct chemical 
reactivities that may contribute to additional modes of action. For example, persulfides 
(RSSH) are more nucleophilic than the corresponding thiols, and S-persulfidation of 
nucleophilic Cys residues in enzymes is known to modify enzymatic activity.1 As 
completely inorganic species, hydropolysulfides (HSSxH) are also important sulfane-
sulfur species, as evidenced by a recent report demonstrating that 3-MST not only 
generates H2S, but also H2S3.10 The use of small molecule persulfides and persulfide-
releasing motifs as H2S donors (vide infra) and as model systems is quickly providing 
more information on persulfide reactivity and its role in the intricate chemistry of 
RSONS.13 Although isolated persulfides are typically unstable in solution and have not 
yet found utility in biochemical investigations, caged persulfides, which release 
persulfides upon hydrolysis or reaction with nucleophiles, or persulfides generated in-situ 
from reaction of GSSG with HS–, have been used to investigate different roles of 
persulfides in reactive sulfur species regulation and action.14 
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One of the most basic methods for sulfane-sulfur detection and quantification is 
the cold cyanolysis assay, which utilizes the reaction of sulfane sulfur atoms with CN– at 
basic pH to form thiocyanate (SCN–). Addition of excess ferric iron results in the 
formation of [Fe(SCN)(H2O)5]2+, which can be readily detected and quantified by the 
characteristic absorbance at 460 nm (Scheme I-1a).15 In practice, the cold cyanolysis 
method is usually used for purified proteins or samples in simple matrices and cannot 
differentiate between individual components, such as persulfides and polysulfides, in the 
sulfane-sulfur pool. 
One significant limitation of the cold cyanolysis method is that persulfides are not 
differentiated from polysulfides or other sulfane-sulfur sources. As a step toward 
addressing this challenge, a tag-switch method to detect and assay persulfides was 
recently reported (Scheme I-1b).16 In this method, all sulfhydryl groups, both from thiols 
(-SH) and persulfides (-SSH) are labelled with an electrophile, such as methylsulfonyl 
benzothiazole (MSBT), to generate the corresponding benzothiazole thioether and 
disulfide, respectively. Importantly, the resultant benzothiazole disulfide remains reactive 
toward specific carbon-based nucleophiles, allowing for conjugation with biotin tags. The 
biotinylated proteins can then be subjected to streptavidin pulldown and detection by 
standard Western blot or mass spectrometric techniques.16 Complementing these 
strategies, selective reaction-based fluorescent probes for polysulfides and sulfane sulfur 
have been reported and are the subject of a recent review.2 These, as well as other 
emerging tools, are poised to help differentiate between the genesis of H2S and other 
reactive polysulfides. 
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Scheme I-1. (a) Cold cyanolysis detection/quantification of sulfane sulfur. (b) General 
strategy for tag-switch labelling of protein persulfides. 
Methods for Modulating H2S Levels 
The ability to modulate cellular H2S levels provides a cornerstone for 
investigating the actions of H2S in biology. Such control can be achieved by selective 
knockout and/or knockdown of H2S-producing enzymes, use of small-molecule 
competitive inhibitors or stimulators, or by administration of synthetic H2S donors. In 
model cell lines and organisms, supplementation with exogenous H2S can often provide 
protection (or rescue) from various (patho)physiological disease states associated with 
abnormal H2S biosynthesis. These insights suggest that synthetic H2S donors may not 
only provide important chemical tools for understanding biological H2S, but may also 
offer viable therapeutic potential for diseases associated with H2S misregulation. 
KO Mouse Models. 
Selective knockout (KO) of CSE, CBS, or 3-MST in different cell lines has been 
utilized in specific investigations (vide infra), but the development of KO mouse models 
has provided a more broad platform on which to study the impacts of reduced enzymatic 
H2S generation.17 Homozygous CBS–/– KO in mice results in severe developmental 
growth problems, and few of the mice live past 4 weeks of age.18 The heterozygous 
CBS+/– KOs exhibit better viability and present hyperhomocysteinemia (high levels of 
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homocysteine in the blood) but have not been used extensively in H2S-related 
investigations.18 By contrast, the CSE–/– mouse model19 has found significantly more 
utility in H2S-related investigations, including studies on the role of H2S in blood 
pressure regulation, angiogenesis, and neurodegeneration, as well as many other studies. 
A second CSE–/– mouse model exhibiting somewhat different phenotypes was also 
subsequently developed and used as an animal model for cystathionemia.20 Homozygous  
3-MST–/– mice have been developed more recently and may also provide a useful animal 
model for H2S-related investigations.21 As a whole, the availability of KO mouse models 
provide a key tool in studying the impacts of H2S in contextually-rich biological 
environments and overcome some of the limitations of small molecule inhibitors or 
sulfide donors (vide infra). 
RNA Knockdown Methods. 
In addition to enzyme KO methods, gene knockdown by RNA interference 
(RNAi) methods has been used to silence CSE, CBS, and 3-MST. Importantly, these 
methods often provide a simpler approach to overcome the limitation of animal models or 
small-molecule inhibitors, and also offer a complementary approach for other enzyme 
modulation experiments. For example, small interfering RNA (siRNA) methods have 
been used to silence CSE and CBS.22 Unlike small-molecule inhibitors for 3-MST (vide 
infra), siRNA methods aimed at this enzyme have proven efficacious in reducing H2S 
production, leading to important insights into mitochondrial electron transport and 
cellular bioenergetics.23  
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Small-Molecule Inhibitors. 
Small-molecule competitive inhibitors of H2S-producing enzymes are commonly 
used to decrease H2S synthesis in studies using isolated enzymes or cell culture models. 
On the basis of this widespread use, significant efforts have been made to discover or 
develop potent enzymatic inhibitors for CBS, CSE, and 3-MST. Although these studies 
have provided a useful suite of compounds for partial inhibition of H2S-producing 
enzymes, identifying inhibitors with specificity for one enzyme over another and low 
inhibitory constant (Ki) values remains a significant challenge. 
 
Figure I-2. Selected common CSE and CBS inhibitors with associated IC50 values. 
Commonly-used CSE inhibitors with IC50 < 1 mM are L-
aminoethoxyvinylglycine (AVG, 1 µM), b-cyano-L-alanine (BCA, 14 µM), and 
propargylglycine (PAG, 40 µM) (Figure I-2).17,24 Each of these inhibitors also affect 
other proximal phosphate (PLP)-dependent enzymes at mM concentrations, making it 
likely that off-target inhibition is observed at practical concentrations. Inhibition of CBS 
has proven significantly more challenging, with fewer inhibitors with IC50 < 1 mM 
identified. Hydroxylamine (HA, 278 µM), aminooxyacetic acid (AOAA, 8.52 µM), and 
trifluoroalanine (66 µM) are among the most commonly used competitive inhibitors for 
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CBS,24 but none of these show marked selectivity for CBS over CSE. Recent studies have 
used high-throughput screening methods, often in combination with H2S fluorescent 
probes (vide infra), to identify CBS inhibitors. Such screens have identified new lead 
compounds with good IC50 values in the low micromolar range, but many hits have not 
been compared directly with commonly-used inhibitors and their selectivity for CBS over 
CSE remains to be fully elucidated. Similar to the challenges with developing selective 
CBS inhibitors, selective inhibition of 3-MST has been unsuccessful to date.17 Given the 
overall difficulty in selectively inhibiting individual H2S producing enzymes, the 
identification and development of new inhibitors for H2S-producing enzymes is needed. 
Such inhibitors, if selective and functional at pharmacologically-reasonable 
concentrations, would provide important research tools for modulating cellular H2S 
levels. 
Enzymatic Stimulators. 
Complementing methods to reduce H2S synthesis using small-molecule inhibitors, 
H2S synthesis can also be increased by use of different enzymatic stimulators. The most 
common of such methods is use of S-adenosylmethionine (AdoMet), an allosteric 
activator of CBS, to increase enzymatic H2S production.25-27 In addition to CBS, CSE 
stimulation has also been demonstrated using cytokines and endotoxins, such as tumor 
necrosis factor a (TNF-a) or lipopolysaccharides (LPS), involved in immune response.28-
29 By contrast to CBS and CSE stimulation, common stimulators of 3-MST are not 
readily available and remain an active area of research.  
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Small-Molecule H2S Donors. 
Complementing methods to modulate endogenous H2S synthesis, the ability to 
increase endogenous H2S levels using exogenous sulfide sources provides an important 
research and pharmacological tool for studying the roles of biological H2S. Commonly-
used sources of exogenous H2S include inorganic salts, such as NaSH and Na2S, as well 
as small-molecule synthetic donors. Although NaSH and Na2S provide convenient 
sources of sulfide, the large dose of H2S released upon addition to buffer does not match 
the slower, continuous, enzymatic production characteristic of endogenous H2S synthesis. 
Additionally, the large bolus of H2S often results in a toxicological response and is 
quickly oxidized/metabolized by the cellular environment. Motivated by these 
limitations, researchers have developed slow-release sulfide donors that better mimic the 
gradual H2S release of enzymatic synthesis. As our understanding of sulfide biology 
continues to evolve, one common observation is that slow-releasing H2S donors often 
elicit different cellular responses than inorganic sulfide salts.30 For example, sulfide salts 
and slow-releasing donors have been shown to be pro- and anti-inflammatory, 
respectively, in different models of inflammation, including sepsis.30 These differences 
highlight the importance of experimental design when using different sulfide sources, but 
also highlight the potential pharmacological importance of such slow-releasing donors. 
Here we provide a brief overview of the most commonly-used donor motifs along with 
their sulfide release mechanisms when known. We also refer interested readers to recent 
reviews on this topic.14,31-32 
Some of the most simple sulfide-donating motifs are organic polysulfides, which 
are often found in natural products. For example, diallyltrisulfide (DATS), isolated from 
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garlic and other alliums, is a commonly used donor molecule, and other organic 
polysulfides such as varacin have also been implicated in H2S release.33 Because 
polysulfides are electrophilic, attack by GSH or other thiols results in formation of an 
intermediate persulfide, which after a second reaction with GSH releases H2S (Scheme 
I-2a).34 Although DATS is the most commonly-used polysulfide donor, it is likely that 
other small molecule polysulfides are also potential platforms for H2S release. 
Inspired by disulfide exchange chemistry, chemists have also developed H2S 
donors that are activated by nucleophilic attack by endogenous thiols.14 For example, 
protection of the thiol in penicillamine derivatives with an acyldisulfide results in 
persulfide formation after nucleophilic attack by Cys (Scheme I-2b).35 Once the 
persulfide is released, reaction with a second thiol generates a stable disulfide and 
extrudes H2S. Application of such donors to the treatment of myocardial 
ischemia/reperfusion (MI/R) injury in murine models results in reduced circulating levels 
of MI/R biomarkers suggesting these and similar donor motifs exhibit cardiac protection, 
and may have potential therapeutic applications.35-36 
Operating by similar Cys-activated H2S release mechanisms, donors containing 
N-mercapto (N-SH) motifs also generate a persulfide intermediate en route to H2S release 
(Scheme I-2c).37 In these donors, thiol exchange between Cys and the donor generates an 
S-acylated Cys intermediate, which undergoes native chemical ligation to rearrange to N-
acylated Cys and an N-mercaptobenzamide intermediate. This N-SH compound reacts 
with Cys to generate Cys persulfide, which reacts with a second equivalent of thiol to 
release H2S. The rate of H2S release from these scaffolds can be tuned by the addition of 
electron donating or withdrawing groups on the scaffold. Additionally, new H2S-donating 
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materials activated by thiol activation are also emerging, indicating the potential viability 
of this strategy for incorporation into therapeutics such as wound dressing to encourage 
angiogenesis.4,38 
In addition to donor activation by nucleophilic attack of thiols, other common 
donor constructs are activated by hydrolysis. For example, one of the most commonly 
used synthetic donors, GYY4137,39 is a phosphino-dithioate derived from Lawson’s 
reagent. GYY4137 undergoes slow hydrolysis in water to release H2S (Scheme I-2d), 
although the efficiency of sulfide release remains low.40 The rate of hydrolysis is pH 
dependent and slow at physiological pH, contrasting the rapid release of H2S by inorganic 
salts. For example, treatment of precontracted aortic rings with NaSH results in relaxation 
in 20 to 30 seconds, whereas GYY4137 treatment requires nearly 10 minutes to achieve 
similar relaxation.41 
 
Scheme I-2. Common motifs for small-molecule H2S donors. (a) Organic polysulfides, 
(b) Cysteine-activated H2S donors, (c) Cysteine-activated H2S donors with N-SH motifs, 
(d) Hydrolysis-based donors, and (e) Anethole 1,2-dithiole-3-thione (ADT) derived 
donors. 
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Another common class of H2S donors is based on 1,2-dithiole-3-thiones, with the 
most often used being 5-(4-hydroxyphenyl)-3H-1,2-dithiole-3-thione (ADT-OH) 
(Scheme I-2e).42 Although the mechanism of H2S release from these scaffolds remains to 
be fully elucidated, one benefit of this donor motif is the ease with which it can be 
tethered to different molecules through ester or hydrolytically-stable amide linkages.43 
For example, linkage of a triphenylphosphonium cation imparts mitochondrial targeting 
for AP39, whereas ligation to common non-steroidal anti-inflammatory drugs (NSAIDs) 
has resulted in significant reduction in GI damage scores.42 The use of ADT derivatives 
in NSAID applications highlight the potential therapeutic action of H2S donors;42 
however, insights into the H2S release mechanism from such donors is poised to make 
significant impacts into our understanding of the therapeutic action of these donor motifs. 
All of the above donor motifs provide sources of sulfide in aqueous solution, but 
researchers interested in H2S/HS– using biomimetic compounds in organic solvents also 
have access to organic-soluble sources of sulfide. In practice, H2S gas is sufficiently 
soluble in organic solutions for most investigations, however NaSH or Na2S are generally 
insoluble in organic solvents. To aid in such investigations, we have recently reported 
simple method to prepare organic-soluble sources of HS–, such as NBu4SH.44 Such 
compounds offer a convenient source of HS– in organic solution, enabling the separation 
of HS– from H2S in different bio(in)organic model studies, which is otherwise not 
possible in aqueous solution. 
H2S Detection and Quantification 
Coincident with the increased biological importance of H2S, new methods for H2S 
quantification and detection are rapidly emerging. Ranging from binary presence/absence 
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tests based on the formation of PbS from PbII salts to complex molecular architectures 
aimed at real-time H2S detection, analytical methods of H2S determinations comprise an 
important area of H2S research. We highlight here general classes of analytical tools for 
H2S research and describe their general benefits and pitfalls. On the basis of the rapid 
expansion of new methods for H2S detection and quantification, as well as revisions and 
refinements of current methods, we refer the interested reader to a number of recent 
reviews on these topics.45-46 
Quantification Methods. 
Commonly used sulfide quantification methods typically require sample 
homogeneity, which is straightforward for biological fluids such as blood or serum, but 
significantly more complicated for naturally heterogeneous samples such as those from 
cell or tissue culture experiments. Spectrophotometric methods such as the methylene 
blue (MB) assay have constituted one of the classical methods of H2S quantification. This 
method leverages the FeCl3-catalyzed electrophilic aromatic substitution of p-
dimethylamino aniline with sulfide to form MB, which has a characteristic absorbance at 
670 nm and allows for sulfide quantification (Scheme I-3a). Despite its widespread use, 
recent studies have demonstrated that the detection limit of the MB assay for sulfide is 
only 2 µM rather than previously-reported lower values, making it insufficiently sensitive 
to differentiate between sulfide levels in normal versus CSE–/– mice.47 Furthermore, the 
MB method is performed under highly acidic conditions, which can result in sulfur 
extraction from other biological sources and diminishes the accuracy of sulfide levels 
measured with this method. Researchers new to the field of sulfide quantification will 
notice the large number of past studies using the MB method but are cautioned when 
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comparing H2S levels measured with this method, especially when more accurate 
contemporary methods are available. For example, the monobromobimane (mBB) 
method, which utilizes the reaction of two equivalents of mBB with H2S under basic 
conditions to generate fluorescent sulfide dibimane (SdB), enables quantification of H2S 
by fluorescence HPLC with a detection limit of 2 nM (Scheme I-3b).47 Because mBB 
reacts with both H2S and thiols, separation of the fluorescent signals by HPLC is required 
for quantification. Despite this limitation, a significant benefit of this method is that 
workflows have been developed to analytically separate the free, reductant-labile / 
sulfane-sulfur, and acid-labile sulfide pools, enabling more detailed investigations across 
distributions in complex systems.47 Additionally, the mBB method has been used more 
recently to also detect and quantify different poly- and persulfides, providing analytical 
information about these important reactive sulfur species.48 
 
Scheme I-3. (a) Methylene blue (MB) and (b) monobromobimane (mBB) methods for 
H2S quantification. 
Complementing spectrophotometric H2S quantification methods are other 
analytical tools, such as sulfide selective electrodes. These tools can provide both the 
ability to quantify H2S, based on a calibration curve, and provide real-time H2S detection 
in solution. Readers interested in the differences in available sulfide electrodes are 
referred to a recent review focused on this topic.45 In general, sulfide electrodes employ 
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an ion-selective membrane that allows H2S permeability for solution-based 
measurements. In the solution phase of the electrode, a strongly basic environment allows 
the dianionic sulfide ion to reduce Fe(CN)63– to Fe(CN)64–, which is subsequently re-
oxidized at the platinum electrode to produce a current relative to H2S concentration. One 
advantage of sulfide electrodes is that they can be used directly in mammalian tissues;45 
however, these electrodes cannot provide sub-cellular resolution of sulfide generation, 
storage, or transport. Even so, sulfide electrodes provide a convenient, time-resolved 
method for sulfide quantification or detection.45 
Detection Methods. 
The development, refinement, and application of reaction-based probes for H2S 
detection has expanded rapidly in the last few years. Such scaffolds typically couple 
various H2S-selective reactions with different chromophores to generate a colorimetric or 
fluorescence response. Because of this design strategy, such methods are irreversible and 
the resultant methods measure accumulated probe activation rather than real-time H2S 
dynamics. Despite these limitations, such constructs offer the potential to provide 
significantly higher spatiotemporal resolution than current H2S quantification methods 
and also provide access to live cell and tissue imaging experiments. The predominant 
strategy for developing reaction-based probes for H2S has been to utilize a fluorescence-
quenching group on a fluorophore that can be modified or removed selectively by H2S. 
As is common with most small molecule fluorescent probes, different detection strategies 
exhibit somewhat different selectivity patterns and each strategy may be better suited for 
certain types of investigations. The interested reader is referred to recent reviews on 
different aspects of reaction-based H2S probe development.46 
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The most common reaction-based detection strategy to date is H2S-mediated azide 
(R-N3) reduction (Scheme I-4a).46 Based on the ease of appending azides onto 
fluorogenic scaffolds, over 70 papers in the last few years described H2S-detecting 
scaffolds using an azide to generate turn-on fluorescent probes (Scheme I-4a).49-51 
Reduction of other oxidized nitrogen functional groups, such as nitro groups, has also 
been utilized for H2S detection.51 For most fluorophores, the azide moiety quenches 
fluorescence by a push-pull energy transfer mechanism, although other quenching 
mechanisms are also possible. Although the selectivity of azides for reduction by H2S 
rather than biological thiols is predominantly empirical, most azide-based probes provide 
good to excellent selectivity for H2S over other RSONS. A recent mechanistic 
investigation established that HS– is the active species involved in H2S-mediated probe 
activation, and that sulfide is oxidized to sulfane sulfur, such as HSS–, during azide 
reduction.52 
Further leveraging the high nucleophilicity of HS–, a variety of H2S sensing 
strategies have been developed in which sulfide attacks an electrophilic, fluorescence-
quenching protecting group appended on a fluorophore. Such scaffolds generally rely on 
the ability of H2S to participate in two sequential nucleophilic reactions to remove or 
modify the group. One benefit of this strategy is that it imparts inherent selectivity 
because thiols, which can only participate in one nucleophilic attack, are unable to 
remove the protecting group.46 One consequence of this selectivity, however, is that in 
many cases thiols can react with the electrophilic scaffolds, thus effectively consuming 
the probe prior to reaction with H2S. This general strategy for H2S sensing has been used 
  21 
to attack activated disulfides, a-b-unsaturated ketones, and activated benzylic 
electrophiles (Scheme I-4b).53-56 
In addition to exploiting the high nucleophilicity of HS– for sensing, the high 
metallophilic nature of sulfur has also been exploited.57 For example, ligation of a 
paramagnetic metal ion, such as Cu2+, to a fluorescent molecule results in fluorescence 
quenching. Subsequent reaction with H2S results in CuS formation and precipitation, thus 
releasing the fluorophore and producing a turn-on response. This strategy is inherently 
selective for sulfide over other biological thiols, but depending on the ligand 
characteristics may also be prone to metal reduction and release by cellular reductants or 
thiols, or exchange of the quenching paramagnetic metal ion with more prevalent 
diamagnetic ions like Zn2+. 
Beyond H2S, polysulfides and persulfides are quickly becoming reactive sulfur 
species of interest. In addition to contributing to the biological chemistry associated with 
H2S, it is likely that these sulfane-sulfur species provide signaling pathways distinct to 
those associated with sulfide. Aligned with this importance, reaction-based probes for 
polysulfides and other sulfane-sulfur sources are now beginning to emerge.58-60 The 
development and refinement of these, as well as other, tools appear poised to provide 
complementary information on the different pools of biological sulfide and further inform 
on the role of H2S and sulfane-sulfur in the RSONS landscape. 
  22 
 
Scheme I-4. Common motifs in reaction-based probes for H2S, including reactions based 
on (a) reduction, (b) nucleophilic attack, and (c) metal precipitation. 
Conclusions and Outlook 
Hydrogen sulfide is an increasingly important biological molecule joining NO and 
CO as a key signaling agent and adding a new level of complexity to the RSONS 
landscape. Importantly, many of the unanswered questions in the field lay at the interface 
of chemistry and biology, thus requiring collaborative investigations and innovation to 
develop, refine, and apply new investigative tools in this rapidly expanding area of 
research. Key challenges include developing selective inhibitors of H2S producing 
enzymes, generating new classes of sulfide donors that do not consume cellular thiols for 
activation or that can be programmed to release H2S in response to certain stimuli, and 
refining H2S imaging methods so that they do not irreversibly consume sulfide. As 
researchers progress toward these goals, the toolbox of available methods for studying 
biological H2S will continue to grow and become more accessible to researchers in 
adjacent fields (such as NO or CO biochemistry, redox biology, and pharmacology), thus 
broadening the potential impact of H2S-related investigations in these diverse scientific 
communities. 
  23 
Bridge 
The last few decades have witnessed the acceptance of other small molecule 
gases, namely carbon monoxide (CO), and nitric oxide (NO), with hydrogen sulfide 
(H2S), as important endogenously produced gaseous signaling molecules involved in 
physiological functions including smooth muscle relaxation, neurotransmission, and 
vasoregulation.26,61 Beyond the study of H2S in biology from a visualization and 
modulation standpoint, the interaction between heme-containing metalloproteins and gas 
molecules plays a significant role in biological systems. In addition to being a strong 
reductant, highly metallophilic, and oxygen sensitive, H2S exists in various protonation 
states at physiological pH, thus complicating whether H2S or HS– is the active species 
when reacting with bioinorganic centers.62 To begin understanding the different 
interaction of H2S and HS– toward different biological targets, we chose to investigate the 
differential reactivity between the diprotic (neutral) and monoprotic (monoanionic) forms 
of sulfide toward different model complexes. Chapter II highlights the preference of 
simple metalloporphyrin derivatives to react with the monoanionic HS– over H2S. 
Each chapter contains previously published or will be published co-authored 
material. Chapter I was co-authored with Dr. Michael Pluth. Chapter II was co-authored 
with Dr. Michael Pluth, Dr. Samantha Sommer, and Stephen Dietrich. Chapter III was 
co-authored with Dr. Daniel Meininger, Dr. Lev Zakharov, Dr. Zacharary Tonzetich, and 
Dr. Michael Pluth. Chapter IV was co-authored by McKinna Tillotson and Dr. Michael 
Pluth. Chapter V was co-authored by Dr. James Prell and Dr. Michael Pluth. Chapter VI 
was co-authored by Maira Delgado, Dr John Gilbertson, and Dr. Michael Pluth. Chapter 
VII was co-authored by Ryan Hansen, Dr. Blakely Tresca, Sam Prakel, Dr. Lev 
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Zakharov, Dr. Michael Haley, Dr. Michael Pluth, Dr. Darren Johnson. Specifica 
contributions can be identified in the opening paragraph of each chapter. 
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CHAPTER II  
CHEMICALLY REVERSIBLE REACTIONS OF HYDROGEN SULFIDE WITH 
METAL PHTHALOCYANINES 
Published as Hartle M. D., Sommer, S. K., Dietrich, S. R., and Pluth M. D. 
“Chemically Reversible Reactions of Hydrogen Sulfide with Metal Phthalocyanines” 
Inorg. Chem. 2014 53(15) 7800-7802. The experimental work was performed by me, 
with preliminary experiments by S. R. Dietrich under the direction of S. K. Sommer. M. 
D. Pluth provided experimental design advice and editorial assistance. Associated content 
can be located in Appendix A. 
Preface 
Hydrogen sulfide (H2S) is an important signaling molecule that exerts action on 
various bioinorganic targets. Despite this importance, few studies have investigated the 
differential reactivity of the physiologically-relevant H2S and HS– protonation states with 
metal complexes. In this chapter, we investigate the distinct reactivity of H2S and HS– 
with Zn(II) and Co(II) phthalocyanine (Pc) complexes and highlight the chemical 
reversibility and cyclability of each metal. ZnPc reacts with HS–, but not H2S, to generate 
[ZnPc-SH]–, which can be converted back to ZnPc by protonation. CoPc reacts with HS–, 
but not H2S, to form [Co(I)Pc]–, which can be reoxidized to CoPc by air. Taken together, 
these results demonstrate the chemically reversible reaction of HS– with metal Pc 
complexes and highlight the importance of H2S protonation state in understanding the 
reactivity profile of H2S with biologically relevant metal scaffolds. 
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Introduction 
Hydrogen sulfide (H2S) is an endogenously-produced molecule that plays 
important and diverse roles in both vasoregulation and neurotransmission, as well as 
other physiological processes.1,19,26,61,63-68 As a gaseous small molecule signaling agent, 
endogenous H2S joins NO and CO as a gasotransmitter, and all three mediate important 
functions through action on bioinorganic targets.1,26,61,68 Unlike NO and CO, however, 
H2S exists in different protonation states at physiological pH, which can facilitate lipid 
and water solubility in the diprotic (H2S) and monoanionic (HS–) forms, respectively. 
Furthermore, the redox potential, nucleophilicity, and tendency to form insoluble metal 
salts also vary with H2S protonation state, thus complicating reactivity with transition-
metal centers.65 Despite its widespread importance, the coordination chemistry of H2S 
with bio-inspired transition-metal scaffolds remain underexplored by comparison to CO 
and NO.69 Although H2S binding to Ru- and Fe-based complexes have been reported,69-74 
investigations of isolated porphyrinoid scaffolds remain limited.75-78 Motivated by the 
growing interest in the biochemical functions of H2S and lack of information on the 
differential reactivity of H2S and HS– in bioinorganic contexts, we report here the 
differential reactivity of H2S and HS– toward metal phthalocyanine (Pc) complexes and 
highlight the chemically reversible reactions of HS– with these platforms. 
Phthalocyanines are planer, aromatic porphyrin derivatives that have been used 
previously as models of bioinorganic reactivity including the reversible binding of NO, 
CO, and O2 to heme mimics79 and the reduction of CO.80 Metal Pc complexes have 
characteristic UV-Vis spectroscopic signatures81 including the Q-band (600-700 nm), 
which provides information on the oxidation state and binding modes of the central metal 
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ion, as well as the B-band (300-400 nm), and window region (400-550 nm), which 
provide information about bound ligands and metal oxidation state.82 Based on these 
characteristics, as well as solubility81 and redox properties,82 we viewed ZnPc and CoPc 
as promising initial platforms on which to investigate the differential reactivity of H2S 
and HS– with redox inactive and active metal complexes. 
Results and Discussion 
Due to its redox inactivity, we reasoned that treatment of ZnPc with H2S or HS– 
would result in metal ligation rather than metal-based redox chemistry. To probe such 
reactivity, we titrated ZnPc in THF with H2S gas (up to 100 equiv. or by bubbling for 15 
min.) but failed to observe any reaction by UV-Vis spectroscopy. By contrast, titration of 
ZnPc in THF with NaSH dissolved in DMSO resulted in clean conversion to a new 
species as evidenced by a 5 nm bathochromic shift of the Q-band, appearance of a broad 
absorbance centered at 410 nm, and well-anchored isosbestic points at 329, 381, and 667 
nm (Figure II-1a). Control experiments titrating ZnPc in THF with DMSO, H2O, KOH in 
DMSO, H2S in DMSO, or S8 failed to change the ZnPc UV-Vis spectrum. Addition of 
aqueous NaSH to ZnPc in THF resulted in identical reactivity to the DMSO experiments, 
suggesting that the availability of weakly-acidic protons does not influence the reactivity. 
Similarly, addition of [NBu4][BH4], a stronger reductant than H2S or HS–,83 failed to 
change the UV-Vis spectrum of ZnPc, suggesting that HS–-mediated reduction of the 
metal or ligand was not occurring. To probe the binding stoichiometry, we constructed a 
Job plot by monitoring changes in absorbance as a function of the ZnPc and NaSH molar 
ratios, which resulted in data consistent with 1:1 binding (Figure A-2). Taken together 
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with the above experiments, these studies suggest formation of a [ZnPc-SH]– adduct upon 
treatment of ZnPc with HS–. 
To confirm that HS– was binding to the Zn(II) center and not reacting with the Pc 
ring directly, we used 1H NMR spectroscopy to investigate changes in the Pc resonances 
upon reaction with NaSH. Treatment of ZnPc in THF-d8 with 2 equiv. of NaSH in 
DMSO-d6 resulted in an upfield shift in the Pc 1H NMR resonances from 9.59 and 8.20 
ppm to 9.41 and 8.06 ppm, respectively (Figure II-1b). Furthermore, the dd splitting 
pattern of the Pc ring is maintained upon treatment with NaSH, indicating that C4 
rotational symmetry is preserved. This symmetry preservation precludes the possibility of 
HS– nucleophilic addition or HS• radical addition into the Pc ring because such addition 
would lower the overall symmetry of the complex and subsequently increase the 
complexity of the coupling. Treatment of ZnPc in THF-d8 with two equiv. of KOH in 
DMSO-d6 failed to change the 1H NMR spectrum of ZnPc significantly, indicating that 
the changes in chemical shift upon treatment of ZnPc with HS– were not simply derived 
from acid-base chemistry (Figure II-1b). 
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Figure II-1(a) UV-Vis titration of ZnPc (6.3 µM in THF, black) with NaSH (0.25 equiv. 
increments of 8 mM in DMSO up to 5 equiv.). (b) 1H NMR (600 MHz, THF-d8) spectra 
of 600 µM ZnPc (top, black), 600 µM ZnPc with 2 equiv. of KOH in DMSO-d6 (middle, 
green), and 600 µM ZnPc with 2 equiv. of NaSH in DMSO-d6 (bottom, blue). 
Because ZnPc binds HS– but not H2S, we reasoned that bound HS– should be acid 
labile, thus allowing for chemically reversible coordination of HS– by addition of a 
suitable proton source (Scheme II-1). To test this hypothesis and to demonstrate the 
chemically reversible binding of HS– to ZnPc, we first generated [ZnPc-SH]– in situ by 
treating ZnPc in THF with 10 equiv. of NaSH in DMSO and then added an equimolar 
amount of AcOH. As predicted, the characteristic spectral features of [ZnPc-SH]– at 410 
and 670 nm reverted to the 342 and 665 nm absorbances corresponding to the parent 
ZnPc (Figure II-2). Further addition of NaSH in DMSO regenerated the 410 and 670 nm 
[ZnPc-SH]– spectral features (Scheme II-1).* 
                                                
* The solution becomes naturally buffered, so each addition of NaSH or AcOH required more equivalents. 
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Scheme II-1. Reaction of ZnPc with HS– and reversibility with acid. 
 
Figure II-2. UV-Vis spectra of ZnPc (2 µM in THF, black) treated with 10 equiv. of 
NaSH in DMSO (red). Treatment with 10 equiv. of AcOH regenerates the original ZnPc 
spectrum. This system can be cycled numerous times (inset). 
Having established that redox inactive ZnPc binds HS– but not H2S, we next 
investigated the reactions of HS– and H2S with a redox active CoPc. We chose CoPc due 
to its well-defined and readily-monitored redox states of blue Co(II)Pc and green 
[Co(I)Pc]–.84-85 Paralleling the chemistry observed for ZnPc, CoPc does not react with 
H2S gas (up to 100 equiv. or by bubbling for 15 min.). Titration of CoPc in THF with 
NaSH in DMSO, however, resulted in a significant bathochromic shift of the Q-band 
from 656 to 697 nm, emergence of a broad absorbance at 467 nm centered in the window 
region, and well-anchored isosbestic points at 316, 370, 555, and 676 nm (Figure II-3). 
These new absorbances match the reported spectrum of [Co(I)Pc]–,84 and also match the 
spectrum of [Co(I)Pc]– generated from CoPc and [NBu4][BH4] (Figure A-1). A Job plot 
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constructed by monitoring the absorbance at 467 nm as function of the CoPc and HS– 
molar ratio is consistent with a 1:1 reaction of CoPc with HS– (Figure A-3). This reaction 
stoichiometry, as well as previous work using CoPc to oxidize thiolates to disulfides, is 
consistent with initial oxidation of HS– to HSSH with potential conversion to further 
oxidation products.86-90 
 
Figure II-3. UV-Vis titration showing the reduction of CoPc (7 µM in THF, black) to 
[Co(I)Pc]– (red) by NaSH (21.7 mM in DMSO in 1 equiv. increments up to 10 equiv.) 
Based on the observed HS–-mediated reduction of CoPc, we reasoned that the 
observed reactivity could be reversed by oxidation with atmospheric oxygen to generate a 
chemically-reversible and cycleable system. To demonstrate this redox cycling, we first 
treated a THF solution of CoPc with 10 equiv. of NaSH under N2 to generate [Co(I)Pc]– 
and then exposed the solution to air, which resulted in rapid oxidation back to the parent 
CoPc (Figure II-4). Subsequent addition of NaSH regenerates [Co(I)Pc]–. If protected 
from O2 and under an N2 atmosphere, the [Co(I)Pc]– product is stable and does not 
spontaneously revert to CoPc. Unlike ZnPc, this chemically-reversible reaction with HS– 
results in a color change that can be easily detected by the naked eye (Figure II-4, inset), 
highlighting the potential for future use in chemically-reversible colorimetric HS– 
detection (Scheme II-2). 
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Scheme II-2. Reaction of CoPc with HS– and subsequent oxidation. 
 
Figure II-4. UV-vis spectra of CoPc (7 µM in THF, black trace, blue cuvette) after 
treatment with 10 equiv. of NaSH in DMSO (red trace, green cuvette). Subsequent 
exposure to atmospheric oxygen regenerates CoPc. The inset shows changes in the Q-
band, corresponding to three cycles of treatment with HS– followed by exposure to air. 
Conclusion 
Taken together, these studies with ZnPc and CoPc demonstrate the differential 
reactivity of HS– and H2S toward metal centers and highlights how these changes in a 
protonation state can be used to generate chemically-reversible HS– ligation. 
Additionally, these examples of chemical reversibility clarify the fundamental reaction 
chemistry of porphyrin-derived scaffolds with H2S and expand the fundamental 
understanding of how H2S interacts with biologically relevant metal scaffolds. 
Bridge 
This chapter highlighted the different reactions of HS– and H2S toward metal 
phthalocyanines. Because of the low solubility of NaSH in non-polar organic solvents, 
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we needed to use DMSO stock solutions of HS– for our investigations. Unfortunately, 
DMSO is a highly polar solvent and can also act as a competitor for hydrogen bonding 
systems and metal ligation. To address these challenges and provide a means for 
conducting biomimetic investigations involving HS– in organic solution, we sought to 
develop a simple method to prepare an organic-soluble form of HS–, which we describe 
in Chapter III. 
Experimental 
Materials and Methods. 
All manipulations were performed under an inert atmosphere using standard 
Schlenk techniques or an Innovative Atmospheres N2-filled glove box. Metal 
phthalocyanines (ZnPc, CoPc) were purchased from Strem Chemicals and used as 
received. Anhydrous sodium hydrogen sulfide (NaSH) was purchased from Strem 
Chemicals and handled under nitrogen. Hydrogen sulfide gas was purchased from Sigma 
Aldrich and transferred through a custom-built stainless steel transfer line to a glass 
storage bulb prior to use. Note: Hydrogen sulfide and its salts are highly toxic and should 
be handled carefully to avoid exposure. Spectroscopic grade THF was degassed by 
sparging with argon followed by passage through a Pure Process Technologies solvent 
purification system to remove water and stored over 4Å molecular sieves. THF-d8 was 
purchased from Cambridge Isotope Laboratories and vacuum transferred from 
sodium/benzophenone ketyl, subjected to three freeze-pump-thaw cycles, and stored in an 
inert atmosphere glove box over 4Å molecular sieves. [NBu4][BH4] was purchased from 
TCI and used as received. Glacial acetic acid was purchased from EMD Chemicals and 
used as received. Anhydrous DMSO was purchased from EMD Chemicals, degassed 
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using four freeze-pump-thaw cycles, and stored in an inert atmosphere glove box over 4Å 
molecular sieves. Phthalocyanine stock solutions were prepared in dry THF and stored in 
amber vials at -20 °C in an inert atmosphere glove box until immediately prior to use. 
Spectroscopic Methods. 
UV-vis measurements were acquired on an Agilent Cary 100 UV-Vis 
spectrophotometer equipped with a QNW dual cuvette temperature controller at 25.00 ± 
0.05 °C. All spectroscopic samples were prepared under an inert atmosphere in septum-
sealed cuvettes obtained from Starna Scientific. NMR spectra were acquired on a Brüker 
Avance-III-HD 600 spectrometer with a Prodigy multinuclear broadband CryoProbe at 
25.0 °C. Chemical shifts are reported in parts per million (d) and are referenced to 
residual protic solvent resonances.  
General procedure for UV-vis spectroscopic studies. 
In a glove box, the phthalocyanine stock solutions were diluted to the desired 
concentration and 3.0 mL of the resultant solution was transferred to a septum-sealed 
cuvette and removed from the glove box. Non-phthalocyanine reagents were prepared 
approximately 105 times more concentrated than the phthalocyanine to provide minimal 
dilution during the study. NaSH, H2S, and other reagents were added to the septum-
sealed cuvettes by gas-tight syringe. Titration studies were performed using 0.25 equiv. 
increments unless otherwise noted.  
General procedure for NMR studies. 
In a glove box, 3.0 mL of a ZnPc stock solution (0.60 mM in THF-d8) was 
prepared and 1.0 mL added to three septum-capped NMR tubes. Stock solutions of NaSH 
and KOH (35.6 mM in DMSO-d6) were prepared, and 17 µL of each stock solution was 
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added to two of the NMR tubes using a gas-tight syringe. A control experiment using 17 
µL DMSO-d6 was also performed. 
General Procedure for Job Plot Experiments 
A 183 µM stock solution of ZnPc in 1:1 THF:DMSO was prepared in a glove 
box. Aliquots of various volumes were added to septum-capped air-tight cuvettes in the 
glove box. A 183 µM stock solution of NaSH in 1:1 THF:DMSO was prepared outside of 
the glove box using standard Schlenk technique. Each of the ZnPc cuvettes was diluted to 
3 mL total volume with NaSH solution maintaining a total cuvette concentration of 183 
µM, and the UV-vis spectra was immediately taken for all fractions. The job plot was 
constructed by following 427 nm across all concentrations. 
A 38 µM stock solution of CoPc in 1:1 THF:DMSO was prepared in a glove box. 
Aliquots of various volumes were added to septum-capped air-tight cuvettes in the 
glovebox. A 39 µM stock solution of NaSH in 1:1 THF:DMSO was prepared outside of 
the glovebox using standard Schlenk technique. Each of the CoPc cuvettes was diluted to 
3 mL total volume with NaSH solution maintaining a total cuvette concentration of 38 
µM, and the UV-vis spectra was immediately taken for all fractions. The job plot was 
constructed by following 467 nm across all concentrations. 
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CHAPTER III  
TETRABUTYLAMMONIUM HYDROSULFIDE PROVIDES A CONVENIENT 
SOURCE OF HS– SOLUBLE IN ORGANIC SOLUTION FOR H2S AND ANION-
BINDING RESEARCH 
Published as Hartle M. D., Meininger, D. J., Zakharov, L. N., Tonzetich, Z. J., 
and Pluth M. D. “NBu4SH Provides a Convenient Source of HS– Soluble in Organic 
Solution for H2S and Anion-Binding Research” Dalton Transactions. 2015 44(46) 
19782-19785. The experimental work was performed by me, cyclic voltammetry was 
performed by D. J. Meininger, and crystallography was performed by L. N. Zakharov. I 
wrote the majority of the manuscript and Z. J. Tonzetich and M. D. Pluth provided 
editorial advice. Associated content can be located in Appendix B. 
Preface 
Hydrogen sulfide (H2S) has gained significant interest within the scientific 
community due to its expanding roles in different (patho)physiological processes. Despite 
this importance, the chemical mechanisms by which H2S exerts its action remain under 
investigated. Biomimetic investigations in organic solution offer the potential to clarify 
these mechanisms and to delineate the differential reactivity between H2S and  
HS–; however, such studies are hampered by the lack of readily-available sources of HS– 
that are soluble in organic solution. In this chapter, we present a simple method for 
preparing analytically pure tetrabutylammonium hydrosulfide (NBu4SH), which we 
anticipate will be of significant utility to researchers in the H2S and anion-binding 
communities. 
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Introduction 
Hydrogen sulfide (H2S), although historically recognized for its toxicity and roles 
in geochemistry, is now accepted to have broad biological importance and is implicated 
in physiological processes ranging from vasodilation to neurotransmission.1 This recent 
surge of interest in the biomedical and pharmacological roles of H2S has resulted in the 
need for versatile sulfide sources amenable to use under different experimental 
conditions. For example, most aqueous studies have used inorganic salts, such as NaSH 
or Na2S, to generate sulfide solutions. Slow-releasing H2S donor molecules, however, 
have emerged as promising alternatives with better pharmacological profiles due to their 
slow, continuous release by comparison to the large bolus of sulfide released by inorganic 
salts.14,31-32,91 In contrast to their utility in aqueous solution, NaSH and Na2S salts are 
generally insoluble in organic solvents, and slow-release H2S donors are often much less 
efficacious in organic solution. Moreover, slow-release H2S donors can also generate 
side-products other than H2S, thus complicating precise reactivity studies under 
controlled conditions. One benefit of using organic solutions to investigate H2S/HS– 
reaction chemistry with bio(in)organic models, such as transition metals62,71,75,77,92-94 or 
reactive sulfur species,95-99 is that such constructs enable differentiation of H2S reactivity 
from that of HS–, which is otherwise challenging in protic media. For example, we have 
previously demonstrated that HS– and H2S react differently with Zn and Co 
phthalocyanine complexes.62 Furthermore, HS– is a significantly more potent nucleophile 
than H2S, resulting in different reactivity toward common electrophiles (Figure B-3, B-4). 
Although H2S is readily available and soluble in organic solutions, simple sources of HS– 
that are soluble in common organic solvents remain scarce. Based on the growing need 
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for such organic-soluble sources of the hydrosulfide ion, we describe a simple method of 
preparing and characterizing NBu4SH in this chapter. 
Use of tetraalkylammonium cations to enhance the solubility of HS– in organic 
solution has been cited since the 1960s, however most reported syntheses rely on in situ 
salt generation or reaction of H2S gas with tetralkylammonium hydroxides.100 Such 
preparative methods introduce complications involving removal of the water by-product 
in the case of hydroxide precursors,101 and limit the reaction scale in cases where H2S gas 
is employed.102 Additionally, compounds prepared in this fashion suffer from limited 
product characterization, and previously-available commercial sources of NBu4SH were 
not of analytical purity. To provide a convenient source of HS– soluble in organic 
solution, we chose to prepare NBu4SH by simple anion exchange chemistry.* 
Additionally, NBu4+ is the most common counterion used for host-guest anion binding 
studies in organic solution, which to date have focused primarily on halides and 
oxoanions but have omitted investigations with HS–.103 
Results and Discussion 
We found that simply stirring NBu4Cl with NaSH in MeCN for several days 
resulted in an efficient cation exchange, allowing for isolation of analytically-pure 
NBu4SH after removal of solvent and washing with Et2O (eq. III-1). Complete Cl– 
exchange was confirmed by elemental analysis. The resultant NBu4SH product provides a 
characteristic S-H stretch at 2550 cm–1 by IR spectroscopy (Figure B-5), which is similar 
to the 2540 cm–1 S-H stretch observed for NaSH under identical conditions (Figure B-4). 
                                                
* During the review of this paper, a recent report of HS--containing organic liquids was reported. See: L. H. 
Finger, F. Wohde, E. I. Grigoryev, A. K. Hansmann, R. Berger, B. Roling, and J. Sundermeyer Chemical 
Communications 2015, 51(90), 16169-16172. 
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Additionally, 1H NMR spectroscopy in anhydrous CD3CN revealed a resonance at -3.85 
ppm corresponding to the sulfur-bound hydrogen atom, which broadens significantly 
upon addition of proton sources, such as water. T1 measurements of the resonance at -
3.85 demonstrated a slow relaxation of 14 s. 
  
NaSH + NBu4Cl → NBu4SH + NaCl   (eq. III-1) 
 
Supporting the purity of NBu4SH, we titrated with 4-chloro-7-
nitrobenzo[d][1,2,3]oxadiazole (NBD-Cl) with NBu4SH to analyze the sulfur content. 
Treatment of NBD-Cl with HS– initially forms NBD2S, which is then converted to NBD-
SH upon further reaction with HS– (Figure III-1). The final NBD-SH product of the 
titration has a characteristic absorbance at 534 nm, allowing for facile quantification of 
the sulfide content of NBu4SH.104 
 
Figure III-1. Top: Quantification of the HS– content in NBu4SH. Bottom: Titration of 
NBD-Cl with NBu4SH to confirm HS– stoichiometry. UV-Vis spectra of 66 µM NBD-Cl 
treated with 0.05 increments of NBu4SH with 3 min. incubation between scans. 
Conditions: 50 mM PIPES, 100 mM KCl, pH 7.4, and 37 °C. 
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We further verified the identity of NBu4SH by X-ray diffraction using single 
crystals grown by the slow diffusion of heptane into a toluene solution of NBu4SH 
containing a drop of MeCN. Solution of the diffraction data confirmed the molecular 
structure of NBu4SH, which crystallized in C2/c (Figure III-2, CCDC 1421021). Under 
these crystallization conditions, residual electron density corresponding to 0.5 equiv. of 
toluene within the asymmetric unit was observed. The solid-state structure also revealed 
six short contacts ranging from 2.74-2.92 Å from the sulfur atom to the a- and 
b-hydrogens of NBu4+. These intermolecular interactions are consistent with C-H 
hydrogen bonding to the anions105 and suggest that NBu4SH may provide a useful anionic 
source of HS– of significant interest for the anion-binding community.106-109 The 
availability of an organic solvent-soluble HS– source will hopefully enable investigations 
into the reversible binding of this important analyte in synthetic receptors, thus 
potentially leading to new reversible sensing platforms for H2S and HS–. 
 
Figure III-2. Left: ORTEP diagram of NBu4SH. Thermal ellipsoids are drawn at the 
50% probability level. Hydrogens omitted for clarity. Right: Schematic of the 
intermolecular CH-anion hydrogen bonding interactions. Full crystallographic details are 
available in Appendix B. 
Given the well-defined nature of NBu4SH in organic solvent, we elected to 
investigate its electrochemical properties in acetonitrile. Displayed in Figure III-3 is the 
cyclic voltammogram of NBu4SH at a glassy carbon electrode. The compound 
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demonstrates an irreversible oxidation wave at -0.365 V (vs Fc/Fc+) consistent with 
facile oxidation to polysulfide species.110-111 The return reduction wave is greatly 
attenuated, most likely as a consequence of subsequent chemical reactions involving the 
oxidized sulfur species. 
 
Figure III-3. Cyclic voltammogram of NBu4SH (2 mM) at a 3 mm glassy carbon disk 
electrode in acetonitrile. Scan rate is 50 mV/s and the supporting electrolyte is 0.1 M 
NBu4PF6. 
To highlight the diverse solubility of NBu4SH, we compared the solubility of this 
sulfhydryl source with that of NaSH in various solvents (Table III-1). As expected, 
NBu4SH is soluble in a significantly broader range of organic solvents than NaSH, thus 
highlighting its utility as a source of organic-soluble HS–. 
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Table III-1. Comparison of the solubility of NaSH and NBu4SH in different solvents. 
 NaSH NBu4SH   NaSH NBu4SH 
H2O Yes Yes  DMF Sparingly Yes 
MeOH Yes Yes  DMA Sparingly Yes 
CH2Cl2 No Yes  DMSO * * 
CHCl3 No *  Acetone No Yes 
THF No Yes  Toluene No Sparingly 
MeCN No Yes  Hexanes No No 
*Some reactivity with solvent observed. 
 
Conclusion 
In summary, we provide a simple method to prepare and characterize NBu4SH, a 
source of HS– that is soluble in many organic solvents. We anticipate that this convenient 
hydrosulfide source will be of significant utility for the field of bioorganic and 
bioinorganic H2S chemistry and will also provide a new analyte of interest for the 
community interested in anion binding mediated by host-guest supramolecular 
interactions. 
Bridge 
Having established a method for the synthesis and characterization of analytically 
pure HS– in organic solution, we turned our attention to understanding how hydrogen 
sulfide reacts with different common metal-containing motifs in biology. The study of 
porphyrin complexes, in particular, provide a relatively simple system for investigating 
the ligation and redox properties of hydrogen sulfide with bioinorganic model complexes. 
Iron porphyrin compounds have received the most attention,77,112-113 while other 
important metal porphyrin complexes remain absent. In Chapter IV, we survey a range of 
metal protoporphyrin IX complexes, classifying their reaction into three categories: 
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unreactive toward H2S and HS–, binding of H2S or HS–, or reduction followed by binding 
of H2S or HS–. 
Experimental 
Materials and Methods. 
All manipulations were performed under an inert atmosphere using standard 
Schlenk techniques or an Innovative Atmospheres N2-filled glove box unless otherwise 
noted. All chemicals were used as received. Tetrabutylammonium chloride was 
purchased from Sigma-Aldrich. NaSH (anhydrous) was purchased from Strem chemicals 
and handled under nitrogen. Note: Hydrogen sulfide and its salts are highly toxic and 
should be handled carefully to avoid exposure. Spectroscopic grade acetonitrile was 
degassed by sparging with argon followed by passage through a Pure Process 
Technologies solvent purification system to remove water and stored over 4Å molecular 
sieves in an inert atmosphere glove box. Acetonitrile-d3 was purchased from Cambridge 
Isotope laboratories and distilled from calcium hydride, deoxygenated by three freeze-
pump-thaw cycles, and stored in an inert atmosphere glove box. 
Spectroscopic Methods. 
UV-Vis measurements were acquired on an Agilent Cary 100 UV-Vis 
spectrophotometer equipped with a QNW dual cuvette temperature controller at 25.00 ± 
0.05 °C. All spectroscopic samples were prepared under an inert atmosphere in septum-
sealed cuvettes obtained from Starna Scientific. NMR spectra were acquired on a Brüker 
Avance-III-HD 600 spectrometer with a Prodigy multinuclear broadband cryoProbe at 
25.0 °C. Chemical shifts are reported in parts per million (d) and are referenced to 
residual solvent resonances. IR spectra were acquired on a Thermo Scientific Nicolet 
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6700 spectrometer equipped with a diamond crystal Smart ATR Attachment. Cyclic 
voltammetry was performed at 25 °C on a CH Instruments 620D electrochemical 
workstation. A 3-electrode set-up was employed comprising a glassy carbon working 
electrode, platinum wire auxiliary electrode, and a silver quasi-reference electrode. Triply 
recrystallized NBu4PF6 was used as the supporting electrolyte. All electrochemical data 
were referenced externally to the ferrocene/ferrocenium couple at 0.00 V.  
X-ray crystallography details. 
Diffraction intensities for NBu4SH were collected at 173(2) K on a Bruker Apex2 
CCD diffractometer using CuKa source, l= 1.54178 Å. The space group was determined 
based on systematic absences. Absorption corrections were applied by SADABS.114 The 
structure was solved by direct methods and Fourier techniques and refined on F2 using 
full matrix least-squares procedures. The H atoms for the NBu4+ cation were refined in 
calculated positions using the rigid group model. The H atom in the HS– anion was not 
explicitly located. The solvent molecule (toluene) was disordered around an inversion 
center and was not involved in specific intermolecular interactions, therefore was treated 
by SQUEEZE.115 Corrections of the X-ray data by SQUEEZE results in a change of 232 
electron/cell, which matches well with the expected value of 200 electron/cell for four 
toluene molecules in the full unit cells. All calculations were performed by the Bruker 
SHELXTL (v. 6.10) package.98 
Synthetic procedure for NBu4SH. 
In an inert atmosphere glove box, NaSH (1.0 g, 18 mmol, acquired from Strem 
Chemicals) and NBu4Cl (4.93 g, 17.7 mmol) were added to a 250 mL round bottom flask, 
after which 100 mL of anhydrous, degassed MeCN was added. (Note: The commercial 
  45 
purity of many NaSH sources is poor, and use of high purity NaSH is essential for 
preparation of NBu4SH. Additionally, should complete anion exchange not occur, a 2 
equiv. excess of NaSH can be used to facilitate full exchange.) The flask was sealed with 
a septum and electrical tape and stirred for 3 days. The yellow-brown solution was 
filtered under an inert atmosphere, and the solvent was removed under vacuum. The 
resultant solid was washed with Et2O until a white solid was obtained, which was dried 
under vacuum to yield 2.6 g (53%) of NBu4SH. The product is very hydroscopic and 
should be protected from atmospheric water and oxygen to prevent hydration or 
unwanted oxidation. The HS– content can be conveniently determined by titration with 
NBD-Cl as described previously for NaSH.104 FTIR (ATR, neat) cm-1: 2960 (s, C-H), 
2870 (m, C-H), 2550 (w, S-H); 1H NMR (600 MHz, CD3CN) δ: 3.16-3.10 (m, 8H), 1.61 
(p, J = 7.9 Hz, 8H), 1.35 (h, J = 7.4 Hz, 8H), 0.96 (t, J = 7.4 Hz, 12H), -3.85 (s, 1H); 
13C{1H} NMR (151 MHz, CD3CN) δ 59.3, 24.4, 20.3, 13.8; Calcd. for C16H37NS: C, 
69.75; H, 13.54; N, 5.08; S, 11.64. Found: C, 70.22; H, 13.23; N, 5.23; S, 11.46; Cl, 0.00. 
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CHAPTER IV  
SPECTROSCOPIC INVESTIGATION OF THE REACTION OF METALLO-
PROTOPORPHYRINS WITH HYDROGEN SULFIDE 
Submitted for publication as Hartle M. D., Tillotson, M. R., and Pluth M. D. 
“Spectroscopic investigation of the reaction of metallo-protoporphyrins with hydrogen 
sulfide” Journal of Inorganic Biochemistry 2016. Experimental design and EPR 
spectroscopy work was performed by me, all other experimental work completed by M. 
R. Tillotson. I wrote the manuscript and M. D. Pluth provided editorial advice. 
Associated content can be located in Appendix C. 
Preface 
Hydrogen sulfide (H2S) is the most recently discovered gasotransmitter molecule 
joining nitric oxide and carbon monoxide. In addition to being biologically important 
small gases, these gasotransmitters also provide distinct modes of reactivity with 
biomimetic metal complexes. The majority of previous investigations on the reactivity of 
H2S with bioinorganic models have focused on Fe-based porphyrin systems, whereas 
investigations with other metals remains underinvestigated. To address this gap, we 
report here an examination of the reactions of H2S, HS–, and S8 with MgII, CuII, CoII, ZnII, 
CrII, SnIV, and MnII/III protoporphyrins. 
Introduction 
Hydrogen sulfide (H2S) is a malodorous and toxic gas, but also plays important 
roles in biology alongside nitric oxide (NO) and carbon monoxide (CO) as an 
endogenously produced gasotransmitter.1,116 Each of these gasotransmitters has 
significantly different physicochemical properties and exerts different actions on 
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biological targets, but all share postulated roles in neurotransmission and 
vasorelaxation.6,19,21,117 Additionally, each gasotransmitter exhibits rich coordination 
chemistry, suggesting that bioinorganic molecules may constitute major targets.62,118-122 
For example, CO is widely used to probe structure in heme protein active sites because of 
its strong ligand back-bonding interaction which affords detailed information about the 
presence of other proximal ligands.122 By contrast, NO reaction with bioinorganic targets 
often results in metal nitrosyl formation or translation to oxidized forms of NO, including 
NO+ or NO2.123-124 Given this rich bioinorganic chemistry of NO and CO, it is likely that 
H2S also provides diverse reactions with bioinorganic targets. Furthermore, the redox 
activity of both NO and H2S suggests that metals may provide an important regulatory 
platform for interconversion between different redox states of these gasotransmitters.1,116 
Although both NO and CO benefit from significant previous work focusing on the 
coordination chemistry of these important ligands,119-120,122,125-126 significantly fewer 
investigations have focused on the reaction of H2S with bioinorganic scaffolds. 
H2S is metallophilic, nucleophilic, acidic (pKa = 7), and reducing; all of which 
complicate the potential modes of reactivity with bioinorganic targets.116 For example, 
demetallation,127 covalent modification of ligand scaffolds,128 acid/base equilibria,71 
metal reduction,62,75 and binding of H2S/HS–75,112,129 have all been observed. 
Additionally, differentiating the observed reactivity of H2S from HS– in water remains a 
significant challenge, whereas investigations in organic solution enable clear delineation 
of how the different protonation states contribute to observed reactivity.44 Based on the 
importance of heme iron in biological systems, the majority of investigations on H2S 
reactivity have focused on iron-based systems, although tin, gallium, and manganese 
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porphyrins have also been investigated.130-132 Recent iron-based investigations have 
encompassed various synthetic porphyrins,70,75,77,112,132 protein-based systems,121,128,133-
134, microperoxidase (MP11) oligopeptides,135 and cyclodextrin-bound hemes.94 To 
expand these investigations to include other metal complexes, we report here the 
investigation of the reactivity of H2S/HS– with MgII, CuII, ZnII, SnIV, CrIII, CoII, and 
MnIII/II protoporphyrin IX (PPIX) complex to better establish the fundamental reactivity 
of each of these metals with sulfide species (Figure IV-1). Together, these compounds 
represent a broad spectrum of metals, reduction potentials, and biologically relevant 
targets for understanding the chemistry of H2S in biological systems. 
Results and Discussion 
To investigate the reaction of different sulfide species with metal protoporphyrins, 
we used H2S and NBu4SH (an organic-soluble source of HS–) in THF to isolate the 
individual protonation states.44 We expected that the reaction of the various metal 
protoporphyrins with sulfide (H2S or HS–) would result in three possible outcomes: no 
reaction, H2S/HS– coordination, and/or metal reduction (Figure IV-1). We hypothesized 
that protoporphyrins housing redox-inactive or fully oxidized metal ions, such as MgII, 
ZnII, and SnIV, would be either unreactive or would bind sulfide. By contrast, CuII, CrIII, 
MnIII, and CoII are all redox active, and HS– is expected to reduce MnIII or CuII on the 
basis of accessible redox potentials.62,136-138 
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Figure IV-1. Metal protoporphyrin IX scaffold and possible H2S/HS– reaction pathways. 
Metal PPIX complexes that bind sulfide 
ZnPPIX. 
Titration of NBu4SH into a THF solution of ZnPPIX resulted in clean conversion 
to a new species as evidenced by a shift in the soret band from 413 nm to 441 nm, with a 
well-anchored isosbestic point at 425 nm (Figure IV-2b). The two Q-bands at 544 and 
582 nm also coalesce into a single peak at 563 nm with a small shoulder at 602 nm, 
proceeding through well-anchored isosbestic points at 523, 552, 572 and 590 nm. The 
titration data fits a 1:1 binding isotherm, producing a Ka for HS– binding of 17500 ± 700 
M-1 (Figure C-6).139 By contrast, bubbling H2S or addition of S8 to a THF solution of 
ZnPPIX failed to produce a change in the UV-Vis spectrum. The two carboxylic acids of 
ZnPPIX have pKa values (in water) of 6.3 and 9.4,140 suggesting that HS– (pKb = 7.4) 
should deprotonate one, but not both, of the carboxylic acids to generate [Zn(PPIX)SH]2–. 
Treatment of ZnPPIX with excess 1,8-diazabicylco[5.4.0]undec-7-ene (DBU) or 
dicyclohexylamine (Cy2NH) resulted in deprotonation of one carboxylate and generated a 
final spectrum consistent with ligation of a nitrogen base (Figure C-4 and C-5).141-143 
Addition of excess HS– to the nitrogen base ligated spectrum cleanly generated the 
[Zn(PPIX)SH]2– spectrum observed previously. Treatment of ZnPPIX with NBu4OAc 
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failed to produce significant changes in the spectrum, suggesting that the deprotonated 
carboxylate on the PPIX ligand was not coordinating to metal centers in solution (Figure 
C-3). Taken together, the NBu4OAc and DBU/Cy2NH studies suggest that deprotonation 
of the carboxylic acid moieties does not significantly change the spectrum of metal PPIX 
scaffolds, and that the final product formed from the addition of HS– is [Zn(PPIX)SH]2–. 
 
Figure IV-2. (a) Schematic representation of the reaction of ZnPPIX with HS–. (b) 
Titration of ZnPPIX (1.8 µM in THF) with NBu4SH (73 equiv.); inset: Q-band region of 
the spectrum. 
To further establish HS– binding, rather than covalent modification of the PPIX 
scaffold, we measured the 1H NMR spectrum of both free and hydrosulfide bound 
ZnPPIX (Figure IV-3). Upon addition of NBu4SH to a 3.6 mM solution of ZnPPIX in 
THF-d8, we observed a small upfield shift in the terminal alkene (2bc, 2bt, 4bc, 4bt) 
protons and a shift of the meso (a, b, g, d) protons.144 We note that the splitting pattern of 
the alkene and meso protons remain constant, indicating no covalent modification of the 
electrophilic positions of the porphyrin scaffold. By contrast, the methylene protons (6a, 
7a, 6b, and 7b) split, indicating differentiation of the top and bottom faces of the 
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porphyrin and rotational restriction of the ethylene spacers (6a, 7a, 6b, and 7b) on the 
NMR time-scale, resulting from an internal hydrogen bond between the carboxylate / 
carboxylic acid moieties. We were unable to observe the sulfhydryl hydrogen in 
[Zn(PPIX)SH]2– by 1H NMR spectroscopy. 
 
Figure IV-3. (a) Labeled structure of ZnPPIX. 1H NMR spectra of ZnPPIX (3.6 µM, 
THF-d8) before (b) and after (c) addition of 23 equiv. of NBu4SH. 
We reasoned that because ZnPPIX bound HS– but not S8 or H2S, that addition of 
acid would protonate the Zn-SH resulting in release of H2S gas and regeneration of the 
ZnPPIX spectrum. Similarly, oxidation of the bound hydrosulfide ligand should also 
regenerate the parent spectrum. Consistent with these hypotheses, exposure of 
[Zn(PPIX)SH]2– to acetic acid resulted in immediate regeneration of the original ZnPPIX 
UV-Vis spectrum (Figure C-1). Similarly, exposure of [Zn(PPIX)SH]2– to atmospheric 
oxygen results in HS– oxidation and also regenerates the parent ZnPPIX/[ZnPPIX]– UV-
Vis spectrum, likely forming polysulfide species (Figure C-2). 
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CrIIIPPIX. 
Titration of Cr(PPIX)Cl (Figure IV-4b) with NBu4SH reduced the intensity of the 
soret band at 435 nm in the UV-Vis spectrum and resulted in formation of a broad 
shoulder at 480 nm. Although Cr(PPIX)Cl is redox active, the observed changes in the 
UV-Vis spectrum are similar to those observed for thiolate binding to CrIIIPPIX, 
suggesting HS– binding, rather than reduction to CrII.145 The addition of DBU or Cy2NH 
to deprotonate the carboxylic acids in Cr(PPIX)Cl failed to change the UV-Vis spectrum, 
suggesting that the observed spectral changes from HS– addition were not merely due to 
deprotonation. As in the case of ZnIIPPIX, Cr(PPIX)Cl was inert toward H2S gas or S8.146 
The UV-Vis titration data of HS– addition to Cr(PPIX)Cl fit cleanly to a 1:1 binding 
model, with a Ka of 8600 ± 300 M–1 (Figure C-9).139 
 
Figure IV-4. (a) Schematic representation of CrIII(PPIX)Cl reaction with HS–. (b) 
Titration of CrPPIX (2.4 µM in THF) with NBu4SH (26 equiv.); inset: Q-band region of 
the spectrum. 
Based on the results from ZnPPIX, we reasoned that Cr(PPIX)Cl could be 
regenerated by protonation of the ligated HS– by AcOH or by oxidation of the bound HS– 
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by atmospheric oxygen. As expected, treatment of Cr(PPIX)SH with AcOH protonated 
the bound HS– to form H2S and dissociate from the porphyrin, and atmospheric O2 
resulted in HS– oxidation to polysulfide and regeneration of the parent CrIIIPPIX complex 
(Figure C-7 and C-8). These studies suggest that Cr and Zn porphyrin scaffolds undergo 
similar reaction chemistry. 
SnIVPPIX. 
In contrast to the observed ZnII and CrIII chemistry with HS–/H2S, SnIV(PPIX)Cl2 
displayed significantly different reactivity. To generate free binding sites, SnIV(PPIX)Cl2 
was treated with AgPF6 and filtered to generate [SnIV(PPIX)]2+ (Figure C-10). Bubbling 
H2S through a THF solution of [SnIVPPIX]2+ produced a bathochromic shift in the soret 
band from 403 to 407 nm, consistent with H2S binding to form [SnIV(PPIX)(H2S)]2+ 
(Figure IV-5b). [SnIVPPIX]2+ also reacts with NBu4SH in THF to produce a decrease and 
bathochromic shift in the soret band from 403 to 410 nm (Figure IV-5c), with 
consecutive isosbestic points at 410 and 428 nm, respectively. Plotting the concentration 
of HS– vs. the absorbances at 428 or 403 nm show several distinct chemical processes, 
which include initial deportation of one of the carboxylic acids, followed by HS– binding 
to Sn, and finally deprotonation of the acidic Sn-SH proton.130 Similarly, initial 
carboxylic acid deprotonation using DBU or Cy2NH (Figure C-12  through C-14), 
followed by addition of excess HS– also resulted in formation of the [SnIV(PPIX)(S)]– 
spectrum. Due to the range of species in solution with overlapping peaks, we were unable 
to obtain a binding constant for sulfide to SnIVPPIX. Acidification of the bound 
hydrosulfide species produced the [SnIV(PPIX)(H2S)]2+ spectrum (Figure C-11), which 
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could not be modified by sparging with dry N2 or opening the cuvette to atmospheric 
oxygen, suggesting the that formation of [SnIV(PPIX)(H2S)]2+ is irreversible. 
 
Figure IV-5. (a) Schematic for the addition of HS– to SnPPIX. (b) SnPPIX (4.95 µM) in 
THF before (black) and after (red) bubbling with H2S(g) for 5 minutes. (c) Titration of 
SnPPIX (4.95 µM) with NBu4SH in THF. The starting SnPPIX spectrum (black) shows a 
Soret band at 403 nm, which transitions to a new Soret band at 407 nm (red) in route to 
the final absorbance at 410 nm (blue). Inset: Absorbances at 403 and 428 nm as a 
function of [HS–]. 
Metal PPIX complexes that are reduced by sulfide. 
Mn(PPIX)Cl. 
Upon titration of MnIII(PPIX)Cl with NBu4SH, the UV-Vis spectrum was cleanly 
converted to reduced MnIIPPIX, as evidenced by a decrease in the peaks at 366 and 462 
nm and concomitant increase at 430 nm (Figure IV-6b).147-148 Further addition of 
NBu4SH resulted in further spectral changes, producing a final spectrum similar to that 
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obtained after addition of various thiolates to MnII porphyrins,147-148 suggesting sulfide 
binding to the MnII product. This outcome was confirmed by titration of authentic 
MnIIPPIX (Figure C-21) with NBu4SH (Figure IV-6c), which was fit to a 1:1 binding 
isotherm to afford a Ka for HS– binding of 23000 ± 2000 M-1 (Figure C-22).139 Bubbling 
H2S or adding S8 to a solution of MnIII(PPIX)Cl or MnIIPPIX did not change the UV-Vis 
spectrum. Similarly, the addition of DBU or Cy2NH did not change the spectrum for 
either MnIIIPPIX or MnIIPPIX (Figure C-18 through C-20). Similar to the chemistry 
observed for ZnPPIX and CrIIIPPIX, the addition of AcOH results in protonation and 
release of the bound HS– to regenerate MnIIPPIX and H2S (Figure C-15 and C-16). 
Exposure of MnII(PPIX)(SH) to atmospheric oxygen resulted in the partial reversion to 
MnIII(PPIX)Cl, with some degradation (Figure IV-6a and C-17). The sequence of HS– 
first reducing the central metal of a porphyrin complex, followed by ligation of HS– has 
been observed in other iron porphyrin systems.75,77,112 
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Figure IV-6. (a) Schematic for the reactivity of MnPPIX with HS–. (b) Titration of 
MnIIIPPIX (9.6 µM in THF, black) with NBu4SH (14 equiv., blue), proceeding through 
going through a MnIIPPIX intermediate (red). (c) Titration of MnIIPPIX (10.3 µM, red) 
with NBu4SH (3.6 equiv., blue). 
To further characterize the reactivity of HS– with Mn protoporphyrins, we used 
EPR spectroscopy to investigate sulfide ligation. Frozen solutions of MnIIPPIX in 1:2 
DMSO:DCM at 5 K of provided a typical high spin (S = 5/2) axial spectrum with two 
observable resonances at g^ = 6.9 and g|| = 2.14 (Figure IV-7a). The g^  value shows six 
lines, characteristic of hyperfine coupling to the nuclear spin (I) of 5/2 for Mn. These 
features are similar to other high-spin Mn porphyrin systems reported with g^ ≈ 6 and g|| 
≈ 2.149-151 Using the simulation package EasySpin152-153 we estimated the zero-field 
splitting (zfs) parameters D and E (Table 1), which correspond to the axial and rhombic 
components, respectively, and hyperfine coupling constants (A) to the Mn nucleus.150,153 
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The MnIIPPIX provided values of 0.00043 and 0.00045 cm-1 for D and E, respectively. 
These are comparable to values for other Mn porphyrin systems and reflect an axial 
field.149-151 The 55Mn nuclear hyperfine coupling constants are also consistent with 
reported values, with Ax ≈ Ay = 0.021 cm-1 and Az = 0.0087 cm-1.149-151 The addition of 
excess HS– to MnIIPPIX resulted in the hyperfine coupling becoming more resolved and 
a small change in g-values to g^ = 7.21 and g|| = 2.14 (Figure IV-7b) that we have 
assigned to MnII(PPIX)(SH). The values for D and E were simulated to be 0.00016 cm-1 
and 0.0015 cm-1, respectively, indicating a more distorted axial system. These zfs 
parameters are smaller than mono-halogenated iron and manganese porphyrins, and are 
consistent with HS– ligation.149-151 Also, because HS– has a stronger field strength than 
Cl– in the spectrochemical series,154 the observed axial spectrum with lower E/D ratio 
than for Cl– is consistent with HS– ligation. In addition, this indicates an increase in the 
distortion and loss of planarity in the porphyrin ring, as observed in sulfide-bound iron 
porphyrin complexes.70,75,77,155 In contrast, diamagnetic MnIII(PPIX)Cl is EPR silent 
(Figure IV-7a). The addition of excess HS– displayed a nearly identical spectrum to that 
of the MnII(PPIX)SH. 
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Figure IV-7. Continuous wave EPR spectra (1:2 DMSO:CH2Cl2, 5 K) of (a) MnIIPPIX 
(5 mM), (b) MnIIPPIX upon addition of 6.5 equiv. of NBu4SH. (c) MnIII(PPIX)Cl (2 
mM), (c) MnIII(PPIX)Cl upon addition of 8.2 equiv. of NBu4SH. Spectra simulated with 
EasySpin are in red. 
Table IV-1. EPR parameters for Mn(PPIX) species. 
 Spin gxa gya gza T(K) Db Eb Axb Ayb Azb l(E/D) 
MnII(PPIX) 5/2 6.2 5.7 1.97 5 0.43 0.45 21.7 20.7 8.8 1.05 
MnII(PPIX)(SH)c 5/2 6.2 5.7 1.97 5 0.16 1.49 22.5 21.0 9.3 9.19 
MnII(PPIX)(SH)d 5/2 6.2 5.7 197 5 0.16 1.48 22.4 21.0 9.3 9.43 
a Estimated using EasySpin b Values in dam-1 c From MnII(PPIX) d From 
MnIII(PPIX)Cl  
 
 
Metal PPIX complexes that show no reaction with sulfide 
The addition of NBu4SH, H2S gas, or S8 to MgIIPPIX or CuIIPPIX failed to 
produce changes in the UV-Vis spectra, suggesting that MgIIPPIX and CuIIPPIX are inert 
to these sulfur sources. Finally, treatment of CoIIPPIX, prepared by stirring commercially 
available CoIII(PPIX)Cl with Zn amalgam, showed no change in the UV-Vis spectrum 
when treated with NBu4SH, H2S gas, or S8. 
Conclusion 
We have investigated the chemical reactivity of hydrogen sulfide with a series of 
metal protoporphyrin complexes by UV-Vis, NMR, and EPR spectroscopies. We found 
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that MgIIPPIX, CuIIPPIX, and CoIIPPIX to not react with H2S(g), HS–, or S8. In contrast, 
ZnIIPPIX, CrIII(PPIX)Cl, and SnIVPPIX simply bind HS–, with SnIVPPIX also showing 
binding of H2S(g). We also found that HS– binding to the ZnPPIX and CrIIIPPIX systems 
is chemically reversible by addition of acid or exposure to atmospheric oxygen, whereas 
SnIVPPIX reacts with H2S/HS– irreversibly to generate [SnIV(PPIX)(S)]–. Finally, addition 
of HS– to MnIII(PPIX)Cl resulted in reduction to MnII followed by HS– binding, similar to 
the observed reactivity of synthetic Fe porphyrins. Taken together, these results provide a 
consistent platform to understand the reaction and coordination chemistry of H2S/HS– 
with different bioinorganic targets. 
Bridge 
Having established the various reactive pathways with non-iron protoporphyrin 
complexes, we shifted our focus to explore iron porphyrins in more depth. While H. 
Sapien hemoglobin and myoglobin are covalently modified at the periphery of the 
porphyrin ring when exposed to H2S, the bivalve L. Pectinata, a resident of sulfide-rich 
swamps, is capable of transporting H2S with hemoglobin 1 (Hb1). There are several 
possible mechanisms by which H2S is stabilized within the binding pocket of Hb1, 
including hydrogen bonding from a proximal glutamate residue, a hydrophobic and 
protected pocket, or other more complex interactions working in tandem. We choose to 
isolate and study the protected pocket aspect by using Collman’s “Picket-Fence” 
porphyrin as described in Chapter V. 
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Experimental 
Materials and Methods. 
All manipulations were performed under an inert atmosphere using standard 
Schlenk techniques or an Innovative Atmospheres N2-filled glove box unless otherwise 
noted. All chemicals used as received unless otherwise noted. Hydrogen sulfide gas was 
purchased from Praxair and transferred through a custom-built stainless steel transfer 
line. Stock solutions of each protoporphyrin (Frontier Scientific) were prepared in dry 
DMSO and stored in an inert atmosphere glove box until immediately before use. Sulfur 
(S8) purchased from Fischer Scientific. Tetrabutylammonium acetate (NBu4OAc) and 
dicyclohexylamine purchased from TCI chemicals. 1,8-Diazabicyclo[5.4.0]undec-7-ene 
(DBU), HgCl2, zinc powder, and AgPF6 purchased from Sigma-Aldrich. Acetic acid and 
hydrochloric acid were purchased from EMD Chemicals. p-Toluenesulfonic acid 
purchased from STREM. Tetrabutylammonium hydrosulfide (NBu4SH) was synthesized 
as previously reported.44 Note: hydrogen sulfide and its salts are highly toxic and should 
be handled carefully to avoid exposure. Spectroscopic grade MeCN and THF degassed 
by sparging with argon followed by passage through a Pure Process Technologies solvent 
purification system to remove water and stored over 4 Å molecular sieves in an inert 
atmosphere glove box. DMSO-d6, CD2Cl2, and CD3CN were purchased from Cambridge 
Isotopes, dried with CaH2, distilled or vacuum transferred, exposed to three freeze-pump-
thaw cycles, and stored over 4 Å molecular sieves in an inert atmosphere glove box. 
Spectroscopic methods. 
UV-Vis measurements were acquired on an Agilent Cary 100 UV-Vis 
spectrophotometer equipped with a QNW dual cuvette temperature controller at 25.00 ± 
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0.05 °C. All spectroscopic samples prepared under an inert atmosphere in septum-sealed 
cuvettes obtained from Starna Scientific. NMR spectra were acquired on a Brüker 
Avance-III-HD 600 spectrometer with a Prodigy multinuclear broadband cryoProbe at 
25.0 °C. X-band continuous wave (cw) electron paramagnetic resonance (EPR) 
measurements were carried out on a Brüker Elexsys E500 EPR spectrometer equipped 
with an ER049X bridge at a microwave frequency of 9.46 GHz using a liquid nitrogen 
cooling system. The EPR spectra were measured at 77 K with a modulation amplitude of 
5 Gauss, a modulation frequency of 100 kHz, and a microwave power of 21.4 mW. The 
EPR spectra were simulated using the EasySpin package.152 
General procedure for UV-vis spectroscopic studies. 
Protoporphyrin (PPIX) stock solutions diluted to the desired concentration by 
addition of 3.0 mL of THF in a septum-sealed cuvette. Non-porphyrin reagents were 
prepared approximately 103 times more concentrated than the porphyrin to provide 
minimal dilution during addition. NBu4SH and other reagents added to the septum-sealed 
cuvettes by gas-tight syringe. H2S(g) bubbled via a custom-built stainless steel transfer 
line. Binding constants (Ka) were determined from UV-Vis titration data and fit a 1:1 
model using the Thordarson program.139 
General procedure for NMR studies. 
A 1 mM stock solution of the desired porphyrin prepared in a 50/50 DMSO-
d6/CD3CN mixture in a septum-capped NMR tube. A stock solution of NBu4SH (1 M in 
CD3CN) was prepared, and five equiv. were added to the NMR tube using a gas-tight 
syringe. 
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General Procedure for H2S gas studies. 
Protoporphyrin stock solutions were diluted to the desired concentration by 
addition of 3.0 mL of THF in a septum-sealed cuvette and removed from the glove box. 
H2S gas bubbled through the cuvette for one minute. Reversibility of H2S addition 
evaluated by bubbling the cuvette with N2 for 1 minute. 
General procedure for EPR studies: 
A 5 mM stock solution of protoporphyrin in 1:3 DMSO:CH2Cl2 was prepared. 
Stock solutions of NBu4SH (1 M in CH3CN) were prepared, and 30 equiv. added to the 
EPR tube using a gas-tight syringe. All tubes were placed under an argon atmosphere to 
prevent oxygen exposure. 
Preparation and use of Zinc Amalgam. 
HgCl2 (0.2 g, 0.8 mmol) was dissolved in a dilute 0.1M aqueous solution of HCl. 
Powdered zinc (1g, 15 mmol), freshly washed with concentrated HCl, was quickly added 
while stirring for 10 to 15 minutes while crushing clumps. The mixture was filtered and 
washed with H2O, EtOH, and Et2O before being transferred to a glove box. For metal 
reductions, 2.5 equiv. of the 5% zinc amalgam added to MnIIIPPIX, 1.5 mL of DMSO 
added, and the reaction mixture stirred for 15 minutes. The resultant precipitate was 
filtered to afford the MnIIPPIX stock solution. 
Removal of SnIV(PPIX)Cl2 chlorides. 
AgPF6 (2.5 equiv.) was added to Sn(PPIX)Cl2 in the absence of light, after which 
three mL of DMSO added, and the reaction mixture stirred for 15 minutes. The resultant 
solution was filtered to afford the stock solution of chloride-free SnIVPPIX. 
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CHAPTER V  
SPECTROSCOPIC INVESTIGATIONS INTO THE BINDING OF HYDROGEN 
SULFIDE TO SYNTHETIC PICKET-FENCE PORPHYRINS 
Published as Hartle M. D., James S. Prell, and Michael D. Pluth. “Spectroscopic 
investigations into the binding of hydrogen sulfide to synthetic picket-fence porphyrins” 
Dalton Transactions 2016 45(11) 4843-4853. The experimental work was performed by 
me and J. S. Prell collected mass spectrometry data. The majority of the manuscript is 
written by me, with editorial assistance from M. D. Pluth. Associated content can be 
found in Appendix D. 
Preface 
The reversible binding of hydrogen sulfide (H2S) to hemeprotein sites has been 
attributed to several factors, likely working in concert, including the protected binding 
pocket environment, proximal hydrogen bond interactions, and iron ligation environment. 
To investigate the importance of a sterically-constrained, low-polarity environment on 
sulfide reactivity with heme centers, we report here the reactivity of H2S and HS– with 
the picket-fence porphyrin system. Our results indicate that the picket-fence porphyrin 
does not bind H2S in the ferric or ferrous state. By contrast, reaction of the ferric scaffold 
with HS– results in reduction to the ferrous species, followed by ligation of one 
equivalent of HS–, as evidenced by UV-vis, NMR spectroscopy and mass spectrometry 
studies. Measurement of the HS– binding affinities in the picket-fence or tetraphenyl 
porphyrin systems revealed identical binding. Taken together, these results suggest that 
the low-polarity, sterically-constrained environment alone is not the primary contributor 
for stabilization of ferric H2S/HS– species in model systems, but that other interactions, 
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such as hydrogen bonding, must play a critical role in facilitation of reversible 
interactions in ferric hemes. 
Introduction 
Interactions between heme-containing metalloproteins and gas molecules play 
important roles in biological systems. For example, dioxygen (O2) ligation to Myoglobin 
(Mb) and Hemoglobin (Hb) constitutes a critical mechanism of oxygen transport 
associated with aerobic respiration.156 Consistent with the importance of a protected 
binding pocket, not only to provide protection for the bound O2 but also to prevent 
unwanted µ-oxo bridged dimer formation, preparation and use of the all-cis-tetra-
pivaloylamide-ortho-substituted phenyl porphyrin (“picket-fence porphyrin”) by Collman 
and co-workers provided the first example of reversible O2 binding to a synthetic heme 
model almost 40 years ago.157-158  
In addition to O2, the last few decades have witnessed the acceptance of other 
small molecule gases, namely carbon monoxide (CO), nitric oxide (NO), and hydrogen 
sulfide (H2S), as important endogenously-produced gaseous signaling molecules involved 
in physiological functions including smooth muscle relaxation, neurotransmission, and 
vasoregulation.26,61 Extending the use of the picket-fence porphyrin model beyond O2-
binding investigations, treatment with CO leads to irreversible heme-CO formation and 
inhibition of O2 binding, both of which are consistent with the effects of CO poisoning.158 
Similarly, the reaction of NO and related oxidized species including nitrite (NO2–) has 
also been investigated in the picket-fence porphyrin, leading to an greater understanding 
of steric interactions involved in the heme-mediated oxidation of NO to NO2–.159-162 For 
example, reaction of atmospheric oxygen in pyridine with heme-nitrosyl produces a 
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stable bis-ligated NO2– adduct in which the pocket-bound NO2– is stabilized by a weak 
hydrogen bond to one of the amides in the porphyrin scaffold.118,162 Despite the important 
insights gained from use of the picket-fence porphyrin model to investigate O2, CO, and 
NO interactions with heme centers, analogous investigations with H2S remain absent. 
Hydrogen sulfide is the most recently discovered endogenously produced 
gasotransmitter, with identified roles in diverse aspects of biological signaling and human 
health.1-2 Adding to the challenges of unravelling this important biomolecule, H2S 
exhibits more complex reactivity than that of NO or CO. In addition to being a good 
reductant, highly metallophilic, and oxygen sensitive, H2S exists in various protonation 
states at biological pH, thus complicating whether H2S or HS– is the active species when 
reacting with bioinorganic centers.62,134,163 One of the first recognized reactions of sulfide 
with heme iron was sulfheme formation, in which the periphery of the porphyrin is 
irreversibly modified by sulfide in the presence of an oxidant, such as H2O2, iron 
hydroperoxo, or iron(IV) oxo species.121,128,164-166 The resulting compound is 
characterized by a green color and dominant absorption band near 620 nm in ferrous 
Mb.165,167-168 Sulfheme formation reduces the affinity for other gasses at the heme center, 
as evidenced by a 2500- and 1500-fold reduction in O2 and CO affinity, respectively.164-
166 By contrast to the detrimental effects of sulfheme formation, H2S/HS– binds reversibly 
to heme centers in many organisms that live in sulfide-rich environments, such as the HbI 
center of the Lucina Pectinata clam found in sulfide-rich mangrove swamps.169-170 The 
reversible binding of sulfur to hemeprotein sites has been attributed to several factors, 
likely working in concert, including the protected binding pocket environment and 
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proximal glutamate residue forming a hydrogen bond with bound sulfide, and iron 
ligation environment.128,169-170 
As a whole, investigations of sulfide with synthetic hemes have focused on 
relatively simple porphyrin platforms. In one of the first such studies, Scheidt and co-
workers reported the structure of an iron hydrosulfido complex from a 
tetra(methoxyphenyl)porphyrin system in 1984.70 Studies by Collman and co-workers 
aimed at reactions of sulfide with a cytochrome c oxidase model renewed the field in 
2012.63,78 Recent investigations into heme/sulfide interactions have included work on the 
binding of HS– to open-faced ferrous porphyrin complexes75 and use of silyl-protected 
sulfur species to overcome Fe-SH instabilities.77 The importance of distal 
histidine/pyridine coordination has also been investigated using a microperoxidase and a 
cyclodextrin-functionalized porphyrin system; both of which suggest that distal ligation is 
important for stable ferric hydrosulfido formation.94,135 As a whole, these investigations 
have focused on open-faced synthetic porphyrins, which do not probe effects such as a 
protected binding site or the importance of proximal hydrogen bonding interactions. 
Motivated by the utility of the picket-fence porphyrin in investigating and understanding 
O2,158 CO,158,171-172 and NO162,173-175 reactivity with synthetic heme systems, we sought to 
extend the utility of this model compound to investigate whether the presence of a 
protected binding pocket alone would be sufficient to bind H2S or HS–. In addition, we 
hypothesized that the low-polarity pocket in the picket fence porphyrin system could 
provide useful insight into the different factors impacting bound sulfide stability in 
synthetic heme centers. 
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Results and Discussion 
To investigate the chemistry of H2S with synthetic heme platforms and to 
determine whether protected axial binding environments affect H2S/HS– binding, we 
chose to use the “picket-fence porphyrin” (PFP) model because of its protected axial 
cavity. Furthermore, the PFP model allows for direct sulfide binding comparison in both 
low and high polarity solvents, as well as with the parent tetraphenyl porphyrin (TPP) 
complexes, which lack the axial pocket. 
We prepared the picket-fence porphyrin as described in the literature using minor 
modifications (see Experimental Section) to afford isomerically-pure all-cis ligand 
(Figure V-1). To compare the charge and the importance of axial ligands, we prepared 
FeIII(TPivPP)Br (1), imidazole-free FeII(TPivPP) (2), and FeII(TPivPP)(N-MeIm)2 
(3).158,176-177 To compare the results of these protected systems, we also used the parent 
TPP complexes FeIII(TPP)Cl (4), FeII(TPP) (5), and FeII(TPP)(N-MeIm)2 (6). Although 
such model compounds are only soluble in organic solvents, the broad solubility in 
solvents ranging from toluene to DMF provides the unique opportunity to investigate the 
role of solvent polarity in concert with the protected PFP pocket. Additionally, the ability 
to isolate different protonation states of sulfide using H2S gas or organic-soluble NBu4SH 
allows for differentiation of H2S versus HS– reactivity, which is otherwise not possible in 
aqueous systems.*44,178-179 
                                                
* Although most protein-based H2S/heme investigations have assumed that HS– is the active sulfide species 
at physiological pH, sulfide binding in Mb decreases in alkaline solution. This observation suggests that 
H2S may be the active species or that pH changes significantly influence the protonation state of important 
residues that stabilize sulfide binding interactions. (Kraus, D. W.; Wittenberg, J. B. J. Biol. Chem. 1990, 
265, 16043-16053 and Brittain, T.; Yosaatmadja, Y.; Henty, K. IUBMB Life 2008, 60, 135-138.) 
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Figure V-1. Model Fe(II) and Fe(III) scaffolds used to study sulfide binding. The 
hydrophobic pocket in picket-fence porphyrin systems (1-3) provides a distinct ligand 
environment from the parent tetraphenyl porphyrin systems (4-6). 
Reaction of FeII(TPivPP)(N-MeIm)2 with sulfide. 
To determine the reactivity of different sulfide sources with Fe(II) picket-fence 
systems, we first treated toluene solutions of 3 with stoichiometric as well as saturated 
solutions of H2S gas. In all experiments, excess N-methylimidazole (N-MeIm) was 
present to ensure blockage of the bottom face of 3. No changes in the UV-Vis or NMR 
spectra of 3 were observed upon treatment with H2S, suggesting that H2S does not bind to 
the ferrous system. Similarly, treatment with elemental sulfur (S8) failed to change the 
UV-Vis spectrum of 3. Treatment of 3 in toluene (Figure V-2a) with 
tetrabutylammonium hydrosulfide (NBu4SH), an organic-soluble source of HS–,44 results 
in clean formation of [FeII(TPivPP)(SH)]– (7), as evidenced by a bathochromic shift of 
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the Soret band from 429 to 419 nm with a concomitant reduction in intensity and 
appearance of a shoulder at 455 nm. Additionally, the principle Q-band absorbance of 3 
at 534 nm decreased in intensity with the associated formation of new bands at 534, 578, 
and 620 nm (Figure V-2a, inset). Similar spectroscopic changes in the Soret band, 
including the shoulder near 450 nm, have been observed previously in the binding of HS– 
to FeII(octaethylporphyrinate) (FeII(OEP)), FeII(tetra-p-methoxyphenylporphyrinate) 
(FeII(p-MeOPP)), and FeII(tetramesitylpophyrinate) (FeII(TMP)).75 
Because both the binding pocket of 3 and toluene (2.38) have low dielectric 
constants we also investigated whether a solvent with a higher dielectric, such as DMF 
(38.25), would lead to similar observed reactivity with HS–. Much like in toluene, 
treatment of a DMF solution of 3 with H2S gas or S8 failed to produce spectral changes, 
however treatment with NBu4SH resulted in a bathochromic shift of the Soret band from 
443 to 419 nm, with concurrent appearance of a shoulder at 455 nm (Figure V-2b). The 
Q-band region of the spectrum also parallels the observed reactivity in toluene with new 
absorbances at 538, 575, and 621 nm corresponding to 7. As observed in toluene, 
conversion of 3 to 7 proceeds cleanly, with well-anchored isosbestic points at 428 and 
457 nm. The identical reactivity between NBu4SH in toluene and DMF suggests that the 
sulfide bound in the PFP cavity of 3 is unaffected by changes to bulk solvent polarity. 
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Figure V-2. (a) Titration of 3 (black) with 0.25 equiv. increments of NBu4SH leads to 
clean conversion to [Fe(TPivPP)(SH)]–, 7, (red). Conditions: MePh solution of 10.8 µM 3 
with 367 µM N-methylimidazole titrated with 10 equiv. of NBu4SH in 1:9 MeCN:MePh. 
(b) Titration of 3 (black) with 0.25 equiv. increments of NBu4SH leads to clean 
conversion to 7 (red). Conditions: DMF solution of 5.2 µM 3 with 36.5 µM N-
methylimidazole titrated with 10 equiv. of NBu4SH in DMF. All titrations were 
performed under anaerobic conditions with sufficient time to allow for complete reaction 
between aliquot additions. 
To confirm that excess imidazole was not impacting HS– binding, we prepared 
imidazole-free FeII(TPivPP) (2). Addition of 0.25 equiv. of NBu4SH to 2 in toluene in the 
absence of N-methylimidazole resulted in splitting of the Soret band from 414 nm to new 
peaks at 445 and 419 nm (Figure V-3), which is consistent with disaggregation of the 
porphyrin.† Further addition of HS– cleanly converts the split Soret band to a final 
                                                
† An alternative possibility is that two porphyrins are coming together to form a µ-sulfido bridged complex 
through initial sulfide binding to the bottom face of the porphyrin. Although we are unaware of µ-sulfido 
species in similar systems, the µ-oxo bridged Fe(III) PFP exhibits a single, well-resolved band at 408 nm. 
(J. P. Collman, R. R. Gagne, T. R. Halbert, J. C. Marchon and C. A. Reed, J. Am. Chem. Soc., 1973, 95, 
7868-7870.) In addition, the parent Fe(II)(TPP) (Cheng, L.; Powell, D. R.; Khan, M. A.; Richter-Addo, G. 
B. Chem. Commun. 2000, 2301-2302.) exhibits a split Soret band at 418 and 443 nm for the unligated 
species, and single absorbance at 409 nm is associated with the µ-oxo bridged species. (Conradie, J.; 
Ghosh, A. Inorg. Chem. 2006, 45, 4902-4909.) 
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absorbance at 419 nm and results in three Q-bands at 534, 577, and 621 nm, all of which 
match the spectrum generated from reaction of 3 with NBu4SH (Figure V-2a), suggesting 
that the imidazole is not bound in the final product. Formation of a five-coordinate, SH-
ligated product is also consistent with previous work with FeII(OEP), FeII(p-MeOPP), and 
FeII(TMP).75 In addition, no reaction was observed when N-methylimidazole-free 2 was 
treated with H2S and S8, suggesting that N-methylimidazole does not out-compete sulfide 
binding. When taken together with the previous experiments using 3, as well as the 
observation that addition of N-methylimidazole at the end of the titration does not 
significantly alter the spectrum, these results suggest that the presence of N-
methylimidazole does not interfere with sulfide binding to the iron center.158,180 
 
Figure V-3. Titration of 2 (black) with 0.25 equiv. increments of NBu4SH leads to 
conversion to 7 (red) after disaggregation of the porphyrin (blue). Conditions: MePh 
solution of 5.7 µM 2 titrated with 5 equiv. of NBu4SH in a 1:9 MeCN:MePh solution. All 
titrations were performed under anaerobic conditions with sufficient time to allow for 
complete reaction between aliquot additions. 
Reactivity of FeIII(TPivPP)Br with sulfide. 
Based on our results with 2 and 3, we expected that treatment of ferric 1 with HS– 
would result in initial reduction from FeIII to FeII producing various oxidized polysulfide 
species, followed by HS– binding to form 7. As expected, titration of 1 in toluene with 
300 400 500 600 700 800
Wavelength (nm)
0.0
0.2
0.4
0.6
0.8
1.0
A
bs
or
ba
nc
e
419
450
445
414
500 550 600 650 700
Wavelength (nm)
X5
534 567 577
621
610
661
571
  72 
NBu4SH initially produces a spectrum similar to that of 3 with an increase in intensity of 
the Soret band and a bathochromic shift from 419 nm to 429 nm, and also a shift in the 
Q-band from 510 to 534 nm (Figure V-4a). Further addition of NBu4SH produces a 
spectrum identical to that of 7, consistent with initial reduction of FeIII to FeII, followed 
by binding of HS– to form [FeII(TPivPP)(SH)]–. Identical reactivity was observed in DMF 
solution, which upon titration of 1 with NBu4SH (Figure V-4b) produced a spectrum 
similar to that of 3 with Q-band peaks at 536, 567, and 609 nm. Further addition of 
NBu4SH produces an identical spectrum to 7 with a Soret band at 419 nm, a prominent 
shoulder at 455 nm, and Q-band peaks at 538, 575, and 621 nm. Similar to the ferrous 
system, treatment of 1 in MePh or DMF, in the presence or absence of N-
methylimidazole, with S8 failed to produce any changes in the UV-Vis spectrum. In 
addition to reactivity with HS–, we reasoned that the protected binding pocket in the PFP 
could potentially allow for observation of bound H2S to the ferric scaffold; however, 
addition of stoichiometric H2S or a saturated H2S solution to 1 in the presence or absence 
of N-methylimidazole failed to produce any changes in the UV-vis spectrum in either 
toluene or DMF. 
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Figure V-4. (a) Titration of 1 (black) with 0.25 equiv. increments of NBu4SH leads to 
reduction of Fe(III) to Fe(II) (blue trace shows 0.75 equiv. NBu4SH) followed by binding 
of HS– to form 7 (red). Conditions: MePh solution of 20 µM 1 with 69 µM N-
methylimidazole titrated with 3 equiv. of NBu4SH in 1:9 MeCN:MePh. (b) Titration of 1 
(black) with 0.25 equiv. increments of NBu4SH leads to reduction of Fe(III) to Fe(II) 
(blue trace shows 0.5 equiv. NBu4SH) followed by binding of HS– to form 7 (red). 
Conditions: DMF solution of 12 µM 1 with 80 µM N-methylimidazole titrated with 5 
equiv. of NBu4SH. 
Oxygen sensitivity of [FeII(TPivPP)(SH)]–. 
Unlike the TPP systems, the FeII(TPivPP)(N-MeIm)2 scaffolds can bind O2 
reversibly, thus providing a unique opportunity to directly investigate the interaction of 
HS– and O2 at the heme center. Compound 3 readily binds O2, either by exposure of 3 to 
the atmosphere or by direct injection of O2, and the presence of Fe(TPivPP)(O2)(N-
MeIm) (9) is characterized by a decrease in intensity and hypsochromic shift of the Soret 
band from 429 to 427 nm with a concomitant attenuation and bathochromic shift of the 
Q-band from 534 to 540 nm (Figure V-5).158 To remove any excess O2, the headspace of 
the cuvette was purged with dry N2 prior to NBu4SH addition. Upon treatment of 9 with 
NBu4SH in toluene, the intensity of the porphyrin absorbances are attenuated with an 
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increased baseline absorbance, suggesting the formation of particulates in the solution. 
Additionally, an increase in absorbance at 320 nm is observed, which is consistent with 
formation of sulfur oxidation and polysulfide formation.181-184 Treatment of 3 with 
NBu4SH to form 7, followed by exposure to the atmosphere afforded the same reactivity. 
These data suggest that the porphyrin ring is irreversibly oxidized in the presence of 
oxygen and HS–, matching earlier observations of irreversible oxidation O2-bound PFP 
compounds in the presence of acids.158 Mass spectrometric data of the oxidized product 
showed a peak at 1160.4010 m/z, which matches the exact mass (1160.4097 m/z) and 
isotope pattern of addition of three O2 molecules to the PFP system, consistent with 
porphyrin oxidation.‡ 
 
Figure V-5. Exposure of 3 to atmospheric oxygen leads to conversion to 7. Titration of 7 
(blue) with 0.25 equiv. increments of NBu4SH leads to irreversible oxidation (red, 20 
equiv. and green, 220 equiv.). Conditions: MePh solution of 5.6 µM 3 and 192 µM N-
methylimidazole, exposed to atmosphere for 5 minutes, followed by purging headspace 
for 10 minutes with N2, and titrated with NBu4SH in a 1:39 acetonitrile-MePh solution. 
                                                
‡ This mass increase also suggests against the formation of verdoheme derivatives, which are another form 
of oxidized porphryins in which the meso position of the porphyrin ring is oxidized. (Y. Du, G. Liu, Y. 
Yan, D. Huang, W. Luo, M. Martinkova, P. Man and T. Shimizu, BioMetals, 2013, 26, 839-852. F. Yan, V. 
Fojtikova, P. Man, M. Stranava, M. Martinkova, Y. Du, D. Huang and T. Shimizu, BioMetals, 2015, 28, 
637-652.) 
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NMR Reactivity of Picket-fence Complexes with sulfide. 
To complement the UV-Vis spectroscopic studies, and to determine any changes 
in the iron spin state upon HS– binding, we used 1H NMR spectroscopy to probe the 
reaction of 3 with NBu4SH. The 1H NMR spectrum of 3 in toluene-d8 exhibits sharp 
features consistent with an FeII complex and allow for its reactivity to be monitored by 
NMR spectroscopy.185-186 Treatment of 3 in toluene-d8 with 5 equiv. of NBu4SH in 
CD3CN results in a clean downfield shift of the pyrrole protons to 63 ppm, consistent 
with formation of a five-coordinate high-spin FeII complex ligated by a sulfur (Figure 
V-6).187 The loss of the resonance at -14 ppm is consistent with dissociation of N-
methylimidazole from the complex (Figures D-26 and D-33).187-188  These spectral 
changes, as well as the upfield shift of the phenyl protons to the 7-12 ppm region are all 
consistent with formation of 7. Similarly, 1H NMR spectroscopy of 1 with NBu4SH also 
confirmed the reduction to 2, followed by binding of HS– to form 7. The 80 ppm pyrrole 
resonance, indicative of a high spin FeIII complex,188 shifts upon treatment of 1 with 5 
equiv. of NBu4SH, consistent with reduction to FeII followed by formation of 7.187 
 
Figure V-6. 1H NMR (600 MHz, toluene-d8) spectra of 1 (4 mM, black), 3 (4 mM, blue) 
and 7 (red) in CD3CN. The spectrum of 7 was recorded after addition of 5 equiv. of 
NBu4SH to either 1 or 3. 
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To confirm the spin and charge change from 1 to 7, we measured the magnetic 
susceptibility of both complexes using the Evan’s method.189-190 The magnetic 
susceptibility of 1 was measured to be µeff = 5.6 µB, supporting a high-spin (S = 5/2) FeIII 
complex, which is consistent with solid state measurements.176 Upon treatment of 1 with 
NBu4SH, the magnetic susceptibility changes to µeff = 5.0 µB, supporting the formation of 
a high-spin (S = 2) FeII complex, matching previously reported Fe-SH bound 
structures.155,187,191 Taken together, the NMR data supports the reaction sequence in 
which HS– initially reduces FeIII to FeII, after which an additional equivalent of HS– can 
bind to the metal center forming a ferrous hydrosulfide product. 
Reaction of Fe(TPP) with sulfide. 
Based on the identical reactivity of 1 and 3 in toluene and DMF, we reasoned that 
the protected axial binding pocket of the PFP compounds does not provide additional 
thermodynamic stability or protection from solvent over the un-protected systems. To 
provide a direct comparison for the experimental sulfide reactivity reactions of the picket-
fence heme analogues, we performed analogous experiments with the parent 
tetraphenylporphyrin (FeII(TPP)(N-MeIm)2, 6). Upon treatment of 6 with NBu4SH 
(Figure V-7a), similar spectral changes to those observed with 3 were observed, which 
are consistent with formation of [FeII(TPP)(SH)]– (8). The Soret band decreases in 
intensity and shifts to 418 nm with concomitant formation of a prominent shoulder at 463 
nm with a well-anchored isosbestic point at 444 nm. The Q-band shows characteristic 
change from a prominent peak at 532 nm to three peaks at 532, 573, and 622 nm. 
Similarly, Treatment of FeIII(TPP)Cl (4) with NBu4SH (Figure V-7b) in DMF shows an 
initial change in the spectrum consistent with the formation of 6 with features at 432 and 
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563 nm. Further addition of NBu4SH results in clean conversion to 8 with an associated 
Soret band shift from 432 nm to 418 nm and shoulder at 463 nm. The Q-bands adopt 
characteristic peaks at 532, 573, and 622 nm, decreasing in intensity with lower energy 
(Figure V-7b, inset). Similar to 1, 2, and 3, treatment of 4, 5, or 6 in either DMF or 
toluene, in the presence or absence of N-methylimidazole, with S8 or H2S fails to perturb 
the UV-vis spectrum of the iron complexes. 
 
Figure V-7. (a) Titration of 6 (black) with 0.25 equivalent increments of NBu4SH to 
form 8 (red). Conditions: MePh solution of 3.8 µM 6 with 35 µM N-methylimidazole 
titrated with 10 equivalents of NBu4SH.  (b) Titration of 4 (black) with 0.25 increments 
of NBu4SH leads to reduction of FeIII to FeII (6) (blue trace shows 0.75 equiv. NBu4SH) 
followed by binding of HS– to form 8 (red). Conditions: DMF solution of 4.5 µM 4 with 
30 µM N-methylimidazole titrated with 10 equivalents NBu4SH. 
Sulfide Binding Affinities. 
To confirm a 1:1 Fe:SH binding stoichiometry, we constructed a competitive 
continuous variation (CCV) plot of 3 and NBu4SH by varying the molar ratios of 3 and 
HS– while keeping the N-methylimidazole concentration constant. These experiments 
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resulted in a plot with a clean break centered at 0.5, which is consistent with a 1:1 
binding stoichiometry (Figure V-8).192-194 Based on this binding stoichiometry, we 
titrated solutions of 2 and 3 with NBu4SH to determine the apparent association constants 
of sulfide and fit all titration data to a 1:1 Fe:SH model using the Thordarson 
method.139,153 The magnitude of these measurements matches binding constants 
associated with Lucina Pectinata HbI, and several synthetic porphyrin compounds 
including a cyclodextrin pyridine coordinated porphyrin, Fe(OEP), Fe(p-MeOPP), and 
Fe(TMP) (  
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Table V-1).75,94,178 Furthermore, the observed Ka values show that the binding 
affinity of HS– for the porphyrin complexes are similar in DMF and toluene, and that the 
presence or absence of N-methylimidazole does not appreciably impact the observed 
sulfide binding affinity. Comparison of the picket-fence 3 with the parent 6 reveals that 
the presence of the protected binding pocket does not provide a significant 
thermodynamic stabilization of sulfide binding. 
 
Figure V-8. A competitive continuous variation plot of 3 and NBu4SH supports 1:1 
binding. Conditions: Total concentration: 11.1 µM in 1:9 MePh:MeCN solution with 0.33 
mM N-methylimidazole. The molar ratio of Fe was varied from 0.1 to 1 and the 
absorbance was corrected for the concentration of N-methylimidazole. 
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Table V-1. Comparison of HS– binding constants for Fe-porphyrin systems. 
Species Solvent log(Ka) Source 
Fe(TPivPP)(N-MeIm)2 MePh 4.5 ± 0.1 This work 
Fe(TPivPP)(N-MeIm)2 DMF 5.0 ± 0.1 This work 
Fe(TPivPP) MePh 4.2 ± 0.1 This work 
Fe(TPP)(N-MeIm)2 MePh 4.8 ± 0.2 This work 
L. Pectinata HbI Water 4.7 94,178 
Fe(OEP) PhCl 5.0 ± 0.2 75 
Fe(p-MeOPP) PhCl 4.7 ± 0.4 75 
Fe(TMP) PhCl 4.6 ± 0.7 75 
Met-hemoCD3 Buffer  4.9 94 
 
Mass Spectrometry. 
To gain further insight into sulfide binding, and to determine whether the picket-
fence system provides a kinetic barrier to sulfide dissociation, we used HRMS to 
investigate HS– binding and dissociation in the gas phase. Based on the 1:1 Fe:SH 
stoichiometry determined from the CCV plot, we expected to only observe ligation of one 
HS– ligated to the metal center. Mass spectrometric analysis of ferrous 3 treated with 15 
equiv. of NBu4SH confirmed this expectation with the appearance of a parent ion peak at 
1097.4294 m/z, which matches the expected mass (1097.4122 m/z) and isotope pattern of 
anionic 7 (Figure V-9a). We also observed a mass peak at 1063.4426 m/z corresponding 
to [2 – H+]– (calculated 1063.4402 m/z), which we attribute to the loss of HS– as well as 
H+ (likely from the amide NH in the PFP scaffold) from 7. No peaks corresponding to 
ligation of two HS– ligands were observed (Figure D-34). Consistent with the results 
obtained from 3, treatment of ferric 1 with 15 equiv. of NBu4SH in THF produces an 
identical mass spectrum as experiments with the ferrous species, which supports initial 
reduction followed by HS– ligation (Figure V-9b). Taken with the CCV plot, this is 
consistent with a 1:1 binding ratio of Fe:SH. 
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Figure V-9. (a) Mass spectrum of 3 with 15 equiv. of NBu4SH added in THF results in 
formation of 2 (blue) and 7 (red), [FeII(TPivPP) – H+]– and [Fe(TPivPP)(SH)]– 
respectively. (b) Mass spectrum of 1 with 15 equiv. of NBu4SH added in THF results in 
the formation of 2 (blue) and 7 (red), [FeII(TPivPP) – H+]– and [Fe(TPivPP)(SH)]– 
respectively. (c) Mass spectrum of 6 with 15 equiv. of NBu4SH added in THF results in 
formation of 5 (blue) and 8 (red), which ionize as [FeII(TPP) – H+]– and [FeII(TPP)(SH) – 
H•]– respectively. (d) Mass spectrum of 4 with 15 equiv. of NBu4SH added in THF results 
in formation of 5 (blue) and 8 (red), which ionize as [FeII(TPP) – H+]– and 
[FeII(TPP)(SH) – H•]– respectively. Conditions: electrospray in negative ion mode with 
[Fe] = 1 mM in THF with 15 equiv. NBu4SH added in 1:1 THF-acetonitrile. 
Similar to 1 and 3, treatment of ferrous 6 in THF with 15 equiv. of NBu4SH 
resulted in formation of mono-sulfur ligated 8 at 700.1522 m/z (ionized as [8 – H•]–, 
calculated 700.1385 m/z) (Figure V-9c). As observed in the PFP system, the second 
major peak at 668.1656 m/z corresponds with unligated 5 (calculated m/z 668.1664). 
Treatment of ferric 4 under identical conditions affords an identical spectrum as the 
reaction of the ferrous TPP 6 with NBu4SH (Figure V-9d). Interestingly, the [M – H2S]– 
peak observed in the PFP system was not observed in the TPP system ([M – SH•]– was 
observed), suggesting that the proximity of the acidic N-H groups on the PFP ligand were 
involved in the H2S ionization. A second notable difference between the PFP and parent 
(a)
(b)
(c)
(d)
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TPP system is the relative intensity of the HS– ligated and unligated species. With both 
mass spectrometric experiments measured under identical instrumental conditions, these 
relative stabilities suggest that the protective pocket in the PFP system provides 
additional stability to the bound hydrosulfide ligand. Based on the similar binding 
thermodynamics measured in solution, this increased stability is likely due to an 
increased kinetic barrier for sulfide dissociation from the protected pocket in the PFP 
system rather than a thermodynamic ground state stabilization of bound sulfide. Variation 
of the collisional energy and comparison to the Fe(TPP) scaffold showed kinetic 
stabilization of the bound sulfide, suggesting it is bound inside the porphyrin pocket (See 
Appendix D).195-196 
Conclusion 
Motivated to extend the utility of synthetic heme structures we used the picket-
fence porphyrin, which contains a protected axial binding pocket, as a model to 
investigate sulfide binding. Our spectroscopic investigations revealed that the FeIII or FeII 
PFP scaffolds do not react with H2S, but rather with HS–. Upon treatment with HS–, 
FeIII(TPivPP)Br is reduced to its FeII form (Scheme V-1), after which a single HS– ligand 
binds to the heme iron. This binding stoichiometry was confirmed by UV-Vis and NMR 
spectroscopic studies as well as mass spectrometric investigations. Comparison of the 
sulfide binding affinity to FeII in the PFP system to that observed in the less hindered TPP 
system revealed similar sulfide association constants, suggesting that the protected axial 
pocket of the PFP system did not provide significant thermodynamic stabilization of the 
bound sulfide. Mass spectrometric studies using variable collisional energy experiments 
established that sulfide dissociation from the PFP system had a larger kinetic barrier than 
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ionization of sulfide from the TPP system, which is consistent with a kinetic, rather than 
thermodynamic, stabilization of bound sulfide within sterically constrained PFP scaffold. 
Taken together, these results suggest that the sterically-constraining low-polarity 
environment alone is not the primary contributor for stabilization of ferric H2S/HS– 
species in model systems, but that other interactions, such as hydrogen bonding or the 
interplay between hydrogen-bonding and a low-polarity binding pocket must play a 
critical role. We are currently investigating other systems that probe these different 
interactions, which will be reported in due course. 
 
Scheme V-1. Overall reactivity of the FeIII/II(TPivPP) scaffold with H2S, HS–, and O2. 
Bridge 
Having established the sterically constrained, low-polarity pocket of Hb1 in L. 
Pectinata alone does not stabilize the binding of H2S/HS–, we next turned our attention to 
understanding how other factors may contribute to the thermodynamic stability of sulfide 
transport. The binding pocket of Hb1 contains a proximal glutamate residue that acts as a 
hydrogen bond accepting moiety that contributes to the stabilization of H2S. This 
structure is similar to the binding of O2 in H. Sapiens, where a proximal histidine acts as 
a hydrogen bond donor to stabilize the binding of O2. To explore the role of hydrogen 
FeII(TPivPP)(O2)(Im)
N2
O2
FeIII(TPivPP)Br HS FeII(TPivPP)(Im)2
HS
[FeII(TPivPP)(SH)]
HS
decomp
O2
H2S
no reaction
decomp
H2S
no reaction
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bond accepting moieties in the secondary coordination sphere, we collaborated with the 
Gilbertson group at Western Washington University. The Gilbertson group developed a 
zinc pyridinediimine ligand with an H-bond accepting amine in the secondary 
coordination sphere, which we used to bind and stabilized HS– in Chapter VI.  
Experimental 
Materials and Methods. 
All manipulations were performed under an inert atmosphere using standard 
Schlenk techniques or an Innovative Atmospheres N2-filled glove box unless otherwise 
noted. All chemicals were used as received unless otherwise noted. Pyrrole, 2-
nitrobenzaldehyde, and N-methylimidazole were purchased from TCI Chemicals. 
Pivaloyl chloride, 1,2-dimethoxyethane, tetrabutylammonium chloride, and 1,3,5-
trimethoxybenzene were purchased from Sigma-Aldrich. SnCl2•2H2O was purchased 
from Strem chemicals. FeBr2 (anhydrous) and NaSH (anhydrous) were purchased from 
Strem chemicals and handled under nitrogen. Hydrogen sulfide gas was purchased from 
Sigma Aldrich and transferred through a custom-built stainless steel transfer line into a 
glass storage bulb prior to use. Tetrabutylammonium hydrosulfide (NBu4SH) was 
synthesized as previously reported.44 Note: Hydrogen sulfide and its salts are highly toxic 
and should be handled carefully to avoid exposure. Spectroscopic grade toluene, 
acetonitrile, and tetrahydrofuran were degassed by sparging with argon followed by 
passage through a Pure Process Technologies solvent purification system to remove 
water and stored over 4Å molecular sieves in an inert atmosphere glove box. Heptane 
was passed through an alumina column, dried and distilled over calcium hydride then 
deoxygenated by three freeze-pump-thaw cycles and stored in an inert atmosphere glove 
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box over 4Å molecular sieves. Spectroscopic grade N,N-dimethylformamide was dried 
and distilled over calcium hydride, deoxygenated by three freeze-pump-thaw cycles, and 
stored in an inert atmosphere glove box over 4Å molecular sieves. Toluene-d8 and 
acetonitrile-d3 were purchased from Cambridge Isotope laboratories and distilled from 
calcium hydride, deoxygenated by three freeze-pump-thaw cycles, and stored in an inert 
atmosphere glove box. Porphyrin stock solutions were prepared in dry toluene or DMF 
and stored in an inert atmosphere glove box until immediately prior to use. 
Spectroscopic Methods. 
UV-Vis measurements were acquired on an Agilent Cary 100 UV-Vis 
spectrophotometer equipped with a QNW dual cuvette temperature controller at 25.00 ± 
0.05 °C. All spectroscopic samples were prepared under an inert atmosphere in septum-
sealed cuvettes obtained from Starna Scientific. NMR spectra were acquired on a Brüker 
Avance-III-HD 600 spectrometer with a Prodigy multinuclear broadband cryoProbe at 
25.0 °C. Chemical shifts are reported in parts per million (d) and are referenced to 
residual solvent resonances. IR spectra were acquired on a Thermo Scientific Nicolet 
6700 spectrometer equipped with a diamond crystal Smart ATR Attachment. Mass 
spectra were acquired on a Synapt G2-Si from Waters Corporation and introduced by 
nanoelectrospray using a platinum wire at 0.4 kV potential. All data were acquired with 
an ESI voltage of 500 V using “resolution” mode. 
General procedure for UV-Vis spectroscopic studies. 
In a glove box, the porphyrin stock solutions were diluted to the desired 
concentration by addition to 3.0 mL of solvent in a septum-sealed cuvette and removed 
from the glove box. Non-porphyrin reagents were prepared approximately 105 times more 
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concentrate than the porphyrin to provide minimal dilution during addition. NBu4SH, 
H2S, and other reagents were added to the septum-sealed cuvettes by gas-tight syringe. 
Titration studies were performed using 0.25 equiv. increments unless otherwise noted. 
Binding constants (Kassoc) were determined from UV-Vis titration data and fit to a 1:1 
model.139,153 
General procedure for NMR studies. 
In a glove box, 1.6 µmol of the different Fe(TPivPP) species were added to ~0.4 
mL of toluene-d8 in a septum-capped NMR tube. Stock solution of NBu4SH (0.688 M in 
acetonitrile-d3) was prepared, and ~5 equiv. was added to the NMR tube using a gas-tight 
syringe. 
General procedure for mass spectrometry studies. 
Solutions of Fe species (1 mM) containing 1.5 mM N-methylimidazole were 
prepared in THF. To this solution, 15 equiv. of NBu4SH in 1:1 THF-acetonitrile were 
added, and negative ion mode nano-electrospray mass spectra were acquired with a 
Synapt G2-Si quadrupole time-of-flight mass spectrometer (under identical conditions for 
each species). 
General procedure for Evans’ Method magnetic susceptibility measurements. 
A stock solution containing 1,3,5-trimethoxybenzene (20.2 mg, 120 µmol) in 500 
µL of toluene-d8 and 100 µL of CD3CN was prepared. Fe(TPivPP)Br (2.7 mg, 2.3 µmol) 
was added to 450 µL of the 1,3,5-trimethoxybenzene stock solution. NBu4SH (36.5 mg, 
132 µmol) was added to 100 µL of the stock solution and an additional 100 µL of 
CD3CN was added to ensure complete solubility. The remaining 50 µL of 1,3,5-
trimethoxybenzene stock solution was added to a capillary tube. A septum-sealed NMR 
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tube was charged with 400 µL of the Fe(TPivPP)Br stock solution and the capillary tube 
containing the 1,3,5-trimethoxybenzene standard. The 1H NMR spectrum was recorded, 
after which 16 µL (5 equiv.) of the NBu4SH stock solution was added. The NMR tube 
was sonication for 20 minutes to ensure complete mixing, after which another 1H NMR 
spectrum was recorded. The chemical shift difference between the 1,3,5-
trimethoxybenzene resonances in the capillary tube and the Fe(TPivPP)Br solution were 
measured and corrected using standard diamagnetic corrections.189 
Synthesis of Cr(OAc)2 and Cr(acac)2. 
A 20 mL scintillation vial equipped with a stir bar was charged with K2Cr2O7 (2.0 
g, 6.8 mmol), powdered zinc (5 g, 76 mmol), and 5 mL of water under nitrogen. 
Concentrated hydrochloric acid (20 mL) was then added drop wise to the stirred reaction 
mixture for approximately 20 minutes, and the solution was stirred until the color of the 
reaction mixture changed from yellow to green and finally to blue. The supernatant was 
transferred by filter cannula to a 100 mL flask containing 20 mL of a saturated NaOAc 
solution, which resulted in formation of a red precipitate. The solid product was filtered, 
washed with EtOH and Et2O, and then dried under vacuum overnight to yield the desired 
product (1.06 g, 41%). Cr(acac)2 was prepared from the crude Cr(OAc)2 product in a 
glove box as described in the literature.197 Note: Cr(acac)2 is a pyrophoric powder and 
should be handled carefully under an inert atmosphere. 
Synthesis of iron porphyrin complexes. 
The synthesis of the iron porphyrin complexes was conducted according to 
published procedures using the modifications noted below.158,176-177 Spectroscopic 
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properties of the isolated product are provided to aid future preparations of these 
complexes. 
5,10,15,20-tetrakis(2-nitrophenyl)porphyrin (H2TNPP). 
2-Nitrobenzaldehyde (25.0 g, 165 mmol) was dissolved in 500 mL of glacial 
acetic acid in a 3-neck 1-L round bottom flask fitted with a reflux condenser and a 
syringe pump inlet. The solution was then heated to reflux and stirred vigorously. Pyrrole 
(12 mL, 170 mmol) was added drop-wise via the syringe pump over 30 minutes. (Note: 
This is a highly exothermic reaction and care is needed to keep the reaction under control. 
We have found that uniform addition of pyrrole using a syringe pump facilitates 
maintaining a vigorous, but controllable, reaction and increases the reproducibility). After 
the addition of pyrrole was completed, the solution had turned black and was refluxed for 
30 minutes. The oil bath was then allowed to cool to 35 °C and CHCl3 (65 mL) was 
added to prevent tar formation. (Note: Fast cooling or cooling below 35 °C can lead to 
intractable tar formation, as noted previously.)176 After stirring for 1 h, the reaction 
mixture was filtered through an extra course frit, and the collected solid was washed with 
5 x 100 mL of CHCl3. Additional product can be obtained by pouring the filtrate through 
a medium porosity frit and washing the collected solid with 5 x 50 mL of CHCl3. The 
purple solids obtained by filtration were combined and dried overnight at 100 °C under 
vacuum to yield the desired product (2.89 g, 8.7%). FTIR (ATR, neat) cm-1: 3316 (w, C-
H), 1518 (s, NO2), 1341 (s, NO2); 1H NMR (300 MHz, DMSO-d6) d: 8.98-7.95 (m, 24H), 
-2.80 (s, 2H); lmax (DMF): 420, 516, 550, 593, 650 nm. 
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5,10,15,20-tetrakis(2-aminophenyl)porphyrin (H2TAPP). 
A 1-L round bottom flask was charged with H2TNPP (2.5 g, 3.14 mmol) and 125 
mL of concentrated HCl. Reagent grade SnCl2•2H2O (10.6 g, 47.0 mmol, 15 equiv.) 
dissolved in 10 mL of HCl was added to the H2TNPP solution and stirred for 1 h at room 
temperature, after which the flask was transferred to an oil bath that had been preheated 
to 65 °C. (Note: The activity of the SnCl2 can be tested by mixing 1 g of SnCl2•2H2O in 
1.5 mL of HCl with 0.25 g of 3-nitrobenzaldehyde. The mixture should become warm 
and turn red-orange within 10 minutes.)176 After heating with vigorous stirring for 25 
min, the flask was removed from the oil bath and cooled to room temperature in an ice 
bath. The reaction mixture was then neutralized carefully with 250 mL concentrated 
NH4OH over 25 minutes. After the pH was adjusted to > 10 with NH4OH, 200 mL of 
CHCl3 was added and the biphasic solution was stirred for at least 12 hours, after which 
the organic layer was separated. The aqueous layer was transferred to a 1-L separatory 
funnel, diluted with water, and extracted with CHCl3 (3 x 150 mL). The combined 
organic layers were washed with 400 mL of 10% NH4OH and concentrated to ~50 mL 
and filtered through celite to remove any remaining tin compounds. The celite was 
washed with CHCl3 until the filtrate had faded in color, and the combined filtrates were 
concentrated to ~50 mL. EtOH (34 mL) and NH4OH (2 mL) were added, and the solution 
was further concentrated to ~40 mL, after which an additional 20 mL of EtOH was added 
and the solution was concentrated to ~16 mL. The resultant solution was filtered through 
a medium porosity frit and the purple-black crystals were rinsed with small amounts of 
ethanol and dried in a 140 °C oven for 1 h to afford 1.65 g (78%) of the desired product. 
FTIR (ATR, neat) cm-1: 3350 (w, N-H), 3312 (w, N-H), 3023 (w); 1H NMR (600 MHz, 
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CDCl3) δ 8.91 (s, 8H), 7.91-7.81 (m, 4H), 7.59 (t, J = 7.9 Hz, 4H), 7.16 (q, J = 6.4 Hz, 
4H), 7.09 (d, J = 8.0 Hz, 4H), 3.51 (d, J = 17.3 Hz, 8H), -2.67 (s, 2H); 13C{1H} NMR 
(151 MHz, CDCl3) d: 146.9, 134.9, 131.4, 129.8, 127.0, 117.7, 116.0, 115.4; lmax 
(CHCl3): 420, 515, 550, 590, 650 nm. 
Separation of all-cis-H2TAPP. 
The separation was carried out in a one-column procedure that enriches the 
desired all-cis isomer as described in the literature.177 To separate the mixture, 45 g of 
silica, 100 mL of benzene, and a stir bar were added to a 250 mL 3-neck round bottom 
flask equipped with a reflux condenser and a benzene-saturated nitrogen stream. After 
heating at 75 °C for 2 h, 1.25 g of H2TAPP in 6 mL of benzene was added via syringe 
and the resultant mixture was stirred at 75 °C for 20 h. The resultant dark slurry was 
cooled to room temperature and poured into a 50 mm OD column. The undesired isomers 
were eluted with 1:1 C6H6:Et2O until the eluent became a pale red color (~400 mL). The 
solvent was then switched to 1:1 Et2O:acetone and the desired isomer was eluted. The 
collected fractions were checked for purity by TLC (SiO2, 4:1 CHCl3:Et2O, Rf = 0.57) 
and stored at 4 °C for no longer than 12 hours prior to use. Isolated fractions were not 
reduced in volume in order to minimize isomerization. 
(all-cis)-5,10,15,20-tetrakis[2-(2,2-dimethylpropionamido)phenyl]porphyrin 
(H2TPivPP). 
All of the pure collected fractions of the all-cis isomer were placed in a 1-L round 
bottom flask under N2. Pyridine (3 mL) and pivaloyl chloride (3 mL) were added and the 
reaction mixture was stirred for 2.5 h, after which 5 mL of MeOH was added to quench 
any residual acid chloride. The reaction mixture was evaporated to dryness, dissolved in 
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125 mL CHCl3, and washed with 80 mL of 10% NH4OH and 2 x 80 mL of water. The 
combined aqueous washes were combined and extracted with 2 x 30 mL of CHCl3. The 
combined organic layers were dried with Na2SO4, filtered, and evaporated to dryness 
under reduced pressure. The crude residue was purified by column chromatograph (SiO2, 
4:1 CHCl3:Et2O). Further purification was achieved by dissolving the product in CHCl3, 
adding EtOH and heptane, reducing the volume under reduced pressure, and filtering the 
purple crystalline product. The crystals were dried overnight under vacuum to yield 0.72 
g (39%) of the desired isomerically-pure product. FTIR (ATR, neat) cm-1: 3430 (m, N-
H), 3315 (m, N-H), 3060 (w, C-H), 2956 (m, C-H), 2867 (m, C-H), 1686 (s, C=O); 1H 
NMR (600 MHz, CDCl3) d: 8.83 (s, 8H), 8.73 (d, J = 8.45 Hz, 4H), 7.90 (d, J = 6.43 Hz, 
4H), 7.85 (t, J = 8.59 Hz, 4H), 7.50 (t, J = 7.84, 4H), 7.21 (s, 4H), 0.07 (s, 36H), -2.59 (s, 
2H); 13C{1H} NMR (151 MHz, CDCl3) d: 175.6, 138.6, 134.4, 131.0, 130.3, 123.2, 
121.0, 115.0, 39.1, 26.6; lmax (CHCl3): 418, 512, 545, 588, 641 nm. 
Bromo{(all-cis)-5,10,15,20-tetrakis-[2-(2,2-
dimethylpropionamido)phenyl]porphyrinato(2-)}-iron(III), (Fe(TPivPP)Br) 
In an inert atmosphere glove box, H2TPivPP (0.54 g, 0.53 mmol), anhydrous 
FeBr2 (0.54 g, 2.5 mmol) 1,2-dimethoxyethane (35 mL), pyridine (0.25 mL) and a stir bar 
were added to a 250 mL round bottom flask equipped with a reflux condenser. The 
apparatus was then removed from the glove box, placed under positive pressure of N2, 
and refluxed at a bath temperature of 100 °C for 1 h. The progress of the reaction was 
monitored by UV-Vis spectroscopy by removing small aliquots, exposing them to the 
atmosphere and acidifying the solution with a few drops of concentrated HBr. Any 
remaining free base porphyrin is readily detected by its characteristic absorption at 450 
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nm (Figure D-19). When no remaining free porphyrin was detected, the reaction mixture 
was cooled to room temperature, exposed to the atmosphere, and brought to dryness 
under reduced pressure. The crude residue was dissolved in 16 mL of CHCl3 and purified 
by column chromatograph (basic Al2O3, CHCl3). The black residue obtained after 
removing the solvent from the combined fractions was suspended in 10 mL of MeOH and 
0.1 mL of HBr. The resultant reaction mixture was heated to 70 °C for 5 minutes and 
cooled to room temperature. CH2Cl2 (5 mL) was added to dissolve any remaining solid 
while warm, and the flask was placed in a 20 °C refrigerator overnight to afford a 
crystalline product. The crystals were filtered, washed with MeOH, and dried at 70 °C 
under vacuum overnight. A second crop of crystals was obtained from the filtrate, total: 
0.15 g (24%). FTIR (ATR, neat) cm-1: 3430 (m, N-H), 3315 (m, N-H), 3060 (w, C-H), 
2956 (m, C-H), 2867 (m, C-H), 1686 (s, C=O); 1H NMR (600 MHz, toluene-d8) d: 80.09, 
16.45, 12.13, 8.68, 1.35, 0.93, 0.28, -0.16; lmax (CHCl3): 359(sh), 391(sh), 419, 509, 584, 
655, 685 nm. 
Bis(N-methylimidazole)[all-cis)-5,10,15,20-tetrakis-[2-(2,2-
dimethylpropionamido)phenyl]porphyrinato(2-)]-iron(II) (Fe(TPivPP)(N-MeIm)2). 
In a glove box, a 20 mL scintillation vial was charged with Fe(TPivPP)Br (30 mg, 
26 µmol), Cr(acac)2 (19.7 mg, 110 µmol), THF (10 mL), N-methylimidazole (21 µL, 260 
µmol), and a stir bar. The stirred reaction mixture was heated to boiling for 5 minutes, 
filtered hot, then cooled to room temperature, while layering with heptane, and cooled to 
-25 °C overnight. The resultant microcrystalline solution was filtered through a glass 
wool filter, washed with heptane, extracted from the filter with THF, and evaporated to 
dryness under vacuum to yield the desired product (7.1 mg, 54%). FTIR (ATR, neat) cm-
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1: 3425 (m, N-H), 2658 (m, C-H), 2868 (m, C-H), 1686 (s, C=O); 1H NMR (600 MHz, 
toluene-d8) d: 19.60, 18.75, 14.40, 12.94, 12.04, 3.35, 1.35, 0.29, -14.01; lmax (toluene): 
333, 429, 535, 564, 606 nm. 
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CHAPTER VI  
STABILIZATION OF A ZINC(II) HYDROSULFIDO COMPLEX UTILIZING A 
HYDROGEN-BOND ACCEPTING LIGAND 
Published as Hartle, M. D.; Delgado, M; Gilbertson, J. D; Pluth, M. D. 
“Stabilization of a Zn(ii) hydrosulfido complex utilizing a hydrogen-bond accepting 
ligand” Chemical Communications 2016, 52(49) 7680-7682. Experimental work was 
completed by me. Ligand synthesis was performed by M. Delgado. Editorial assistance 
was provided by J. D. Gilbertson and M. D. Pluth. Associated content can be found in 
Appendix E. 
Preface 
Hydrogen sulfide (H2S) has gained recent attention as an important biological 
analyte that interacts with bioinorganic targets. Despite this importance, stable H2S or 
HS– adducts of bioinorganic metal complexes remain rare due to the redox activity of 
sulfide and its propensity to form insoluble metal sulfides. We report here reversible 
coordination of HS– to Zn(didpa)Cl2, which is enabled by an intramolecular hydrogen 
bond between the zinc hydrosulfido product and the pendant tertiary amine of the didpa 
ligand. 
Introduction 
Although historically known for its malodor and toxicity, hydrogen sulfide (H2S) 
has joined nitric oxide (NO) and carbon monoxide (CO) as a physiologically important 
gasotransmitter.1 Complicating its reactivity with different bioinorganic targets, H2S has 
multiple protonation states, participates in complex redox chemistry, and is highly 
metallophilic.62,163 For example, the high affinity between zinc and sulfide (DGf° = -48.11 
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kcal/mol, sphalerite)198 limits generation of stable sulfide-ligated products, but has also 
been leveraged as a sulfide sequestration strategy in quantification and detection 
methods.199-200 Consequently, stable zinc hydrosulfido complexes remain rare,201-205 with 
reported examples including (tris)pyrazolylborate zinc hydrosulfide (TpZnSH) 
complexes, supported by the steric protection from the Tp ligand.201-202 Complementing 
the use of steric protection, secondary-coordination sphere interactions have also been 
used to stabilize metal-sulfide species with other metals, such as iron.71 Additionally, 
these stabilizing forces are hypothesized to be important in the mechanism of carbonyl 
sulfide fixation by carbonic anhydrase.206-207 
Toward increasing our understanding of the solution state stabilization of metal 
hydrosulfido complexes, we viewed that a ligand scaffold with a pendant hydrogen-bond 
(H-bond) acceptor would provide a viable scaffold for Zn-SH stabilization. We noted that 
the pyridinediimine (PDI) ligand scaffold didpa ([(2,6-
iPrC6H3)N=CMe)(N(iPr)2C2H4)N=CMe)C5H3N]) has been demonstrated to function as an 
H-bond donor when the pendant diisopropylamine is protonated and used to stabilize 
metal halogen hydrogen bonds (MHHBs), with calculated MHHB strengths of ~6 
kcal/mol for [Zn(Hdidpa)Cl2][PF6].208 Additionally, the protonated form of the ligand can 
also function as an H-bond donor to stabilize rare Fe-OH species.209 Although ligands 
displaying hydrogen-bond donors in the secondary coordination sphere are now 
frequently used in bioinorganic model complexes,210-211 hydrogen-bond accepting ligands 
are rare.212-216 On the basis of these properties, we reasoned that the didpa ligand could 
function as an H-bond acceptor in its neutral form to provide a suitable ligation 
environment for metal hydrosulfido stabilization. 
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Scheme VI-1. Reaction of Zn(didpa)Cl2 (1) with NBu4SH to generate hydrosulfide 
adduct 2. 
Results and Discussion 
Treatment of Zn(didpa)Cl2 (1) with H2S gas failed to produce any reaction, 
however treatment of 1 with NBu4SH44 in either CH2Cl2 (Figure VI-1) or MeCN (Figure 
E-1) resulted in a significant change in the UV-Vis spectrum. In CH2Cl2 the shoulder at 
313 nm decreased in intensity with a concomitant increase in absorbance at 280 nm and a 
well-anchored isosbestic point at 296 nm upon addition of HS–. A Job plot was consistent 
with 1:1 binding of HS– to 1 (Figure VI-1, inset). In addition, titration with HO– resulted 
in 1:1 binding (Figure E-13). Based on these results, and because chloride abstraction 
was not required for HS– binding, we propose that HS– binds to 1 to generate six-
coordinate [Zn(didpa)Cl2SH]– (2, Scheme VI-1). All attempts to grow single crystals 
suitable for X-ray structural determination of 2 resulted in precipitation of a white 
amorphous powder after prolonged standing. Supporting the associative formation of a 
six-coordinate product, titration of 1 with excess Cl– showed similar spectral changes by 
UV-Vis spectroscopy (Figures E-3 and E-4), and the Job plot was consistent with 1:1 Cl– 
binding (Figure E-12). Attempts to isolate and crystallize the six-coordinate 1:1 adduct of 
Cl– and 1 with a range of different Cl– sources (Bu4NCl, Ph4PCl, PPNCl) resulted in 
simple recrystallization of the starting chloride salt and 1, presumably due to the 
reversibility of the process. 
N
N N
N
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Cl Cl NBu4SH
1
N
N NZn
Cl
Cl S
N H
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2
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Figure VI-1. Titration of Zn(didpa)Cl2 (87.3 µM, CH2Cl2, black) with NBu4SH (0.1 
equiv. increments up to 6 equiv., red). The inset shows the Job plot of 1 with NBu4SH in 
MeCN at a total concentration of 420 µM. The observed break is consistent with 1:1 
binding. 
To gain further insights into the HS– binding, we used 1H NMR spectroscopy to 
investigate the stability of 2 and the role of hydrogen-bonding in the complex. Treatment 
of 1 with 1.5 equiv. of NBu4SH in CD3CN resulted in significant changes in the 1H NMR 
spectrum. The resultant spectrum did not match that of the free ligand,208 suggesting that 
addition of HS– does not remove Zn from the didpa ligand (Figure VI-2). Upon HS– 
addition, the pyridine and other aryl resonances of 1 shifted significantly in a pattern 
consistent with loss of free rotation of the 2,6-diispropylphenyl group of the ligand. 
Similarly, the isopropyl resonance at 1.00 ppm, corresponding to the isopropyl methyl 
groups of the pendant amine, shifts downfield and bifurcates. Each of these spectral 
changes indicated a significant change in the primary coordination sphere of the zinc and 
are consistent with formation of a six-coordinate complex in which the Zn-SH moiety is 
hydrogen bonded to the pendant diisopropylamine (Scheme VI-1). 
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Figure VI-2. 1H NMR spectra of 1 (11.8 mM in CD3CN) before (top, black) and after 
(bottom, red) addition of 1.5 equiv. of NBu4SH. Peaks denoted with a (*) correspond to 
the NBu4+ counterion. 
Low temperature 1H NMR investigations provided additional information about 
the structural flexibility of the scaffold and the presence of the coordinated hydrosulfide. 
Although we were unable to observe an appreciable signal corresponding to the 
coordinated HS– at room temperature, we expected that lowering the temperature would 
not only enable HS– observation, but also lock the conformation of the ethylene backbone 
of the ligand. Consistent with these expectations, cooling to -35 °C in CD3CN resulted in 
the appearance of a new resonance at 11.05 ppm, matching the general chemical shift 
expected for partial protonation of the nitrogen as an H-bond acceptor (Figure VI-3).217 
For comparison, the 1H NMR spectrum of the previously reported [Zn(Hdidpa)Cl2][PF6] 
displays an N-H resonance at 8.50 ppm in CD2Cl2 due to the protonated diisopropylamine 
of the didpa ligand acting as an H-bond donor and forming an intramolecular MHHB 
with a chloride ligand.208 The downfield shift observed for 2 is consistent with the 
diisopropylamine acting as an H-bond acceptor, likely accepting a hydrogen bond from 
the Zn-ligated SH moiety.218 
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Additionally, we observed that the broad peak centered at 3.6 ppm corresponding 
to the ethylene bridge decoalesced upon cooling. The presence of the internal hydrogen 
bond between the sulfhydryl group and the tertiary amine significantly limits the 
flexibility of the secondary coordination sphere, resulting in a sharpening in the signal 
produced by the ethylene linker, methine protons, and methyl groups (Figure E-8). 
Supporting the presence of an intramolecular SH hydrogen bond, a 1H NOESY 
experiment at -35 °C revealed cross peaks between the SH and the ethylene, methine, and 
methyl signals of the tertiary amine linker (Figure E-5). 
 
Figure VI-3. Variable temperature 1H NMR spectra of 11.4 mM Zn(didpa)Cl2, and 1.5 
equiv. NBu4SH in CD3CN. Cooling to -35 °C results in sharpening and an upfield shift of 
the broad SH peak to 11.05 ppm. See Figure E-9 for an expanded spectrum of the SH 
peak. 
Although the N---HS interaction was not observed by solution state FTIR, we 
note that the N-H stretch involved in hydrogen bonding in the [Zn(Hdidpa)Cl2][PF6] 
system is also absent in solution FTIR spectra.208 The N-H stretch in the N---HS moiety 
is likely severely broadened or obscured, which is common in many hydrogen bonding 
systems.217  
To demonstrate the reversibility of 2, and to provide evidence for the formation of 
a six-coordinate complex, we performed a displacement experiment by 1H NMR 
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spectroscopy. Treatment of 1 with 1.5 equiv. of NBu4SH resulted in the formation of 2 
with characteristic shifts in the aryl peaks, and broad resonance at 3.6 ppm (Figure VI-4). 
Upon addition of 20 equiv. of NBu4Cl, the aryl protons maintained the same 
configuration; however, the broad resonance at 3.6 ppm resolved, characteristic of the Cl– 
adduct of 1 (Figure E-6).* 
 
Figure VI-4. 1H NMR spectrum of 10.3 mM 1(black), upon addition of 1.5 equiv. of 
NBu4SH (red) is characteristic for 2. Addition of 20 equiv. of NBu4Cl produces the 
spectrum characteristic of the Cl– adduct. 
To further determine whether the internal hydrogen-bond was necessary for 
stabilization of the zinc-sulfido product, we also titrated a Zn-pyridinediimine compound 
which does not possess the pendant amine hydrogen-bond acceptor (Scheme VI-2). Upon 
addition of 0.5 equiv. of HS– to a solution of Zn(iPrPDI)Cl2 (3) (iPrPDI = 2,6-(2,6-
iPr2C6H3N=CMe)2C5H3N) a white precipitate (ZnS) was immediately observed, along 
with a significant change in the NMR spectrum. The shifts in the NMR spectrum and 
formation of precipitate continued until 1 equiv. of HS– was added, after which no more 
changes were observed (Figure E-11). The resultant solid was isolated, washed with 
acetonitrile to remove any excess free sulfide, then acidified and subjected to the 
                                                
* Given the number of equivalents required for the displacement of hydrosulfide by chloride, we estimate 
the binding constant of hydrosulfide to be of a similar magnitude, and no larger than 10 times greater than 
that of chloride. See Figure E-3. 
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methylene blue assay, which provided a positive response for acid-labile sulfur and was 
consistent with ZnS formation.219 These data illustrate the importance of the hydrogen-
bond acceptor in the stabilization of the zinc-sulfido complex, as the pendant amine in 1 
is vital in this system. 
 
Scheme VI-2. Reaction of 3 with NBu4SH shows decomposition, demonstrating the 
importance of the H-bond acceptor in 2. 
Conclusion 
In conclusion, we have shown the stabilization of a rare synthetic zinc 
hydrosulfide complex stabilized by a hydrogen bond accepting ligand. Removal of the 
hydrogen bonding ability of the ligand resulted in decomposition and ZnS precipitation, 
highlighting the importance of the second coordination sphere in stabilizing the zinc 
hydrosulfido adduct. 
Bridge 
In this chapter, we established the necessity of hydrogen bonding in the 
stabilization of metal-sulfido complexes. Given the high importance of hydrogen bonds 
in metal complexes, we began to think of how other systems in which the stabilization of 
H2S or HS– via hydrogen bonding would be beneficial. This investigation lead to 
supramolecular anion binding, or the non-covalent interaction of anions with synthetic 
scaffolds in solution. Supramolecular scaffolds help researchers understand anion-
binding environments in biology, while also providing new real-time detection methods 
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that do not consume the target analyte. To explore the supramolecular chemistry of H2S 
and HS–, we describe a collaboration with the Johnson and Haley groups at the 
University of Oregon using their bis(ethynylaniline) anion-binding receptors in Chapter 
VII. 
Experimental 
General considerations. 
All manipulations were performed under an inert atmosphere using standard 
Schlenk techniques or an Innovative Atmospheres N2-filled glove box unless otherwise 
noted. Tetrabutylammonium chloride and butane thiol were purchased from TCI 
Chemicals and used without purification. 1,3,5-Trimethoxybenzene was purchased from 
Sigma Aldrich and used without further purification. Sodium hydride was purchased 
from TCI chemicals, taken into a dry glove box and washed several times with hexanes 
before use. Tetrabutylammonium hydrosulfide (NBu4SH) was prepared as described in 
the literature.44 Note: Hydrogen sulfide and its salts are highly toxic and should be 
handled carefully to avoid exposure. Zn(didpa)Cl2 and Zn(iPrPDI)Cl2 were prepared 
according to reported methods.208,220 Spectroscopic grade acetonitrile and 
dichloromethane were degassed by sparging with argon followed by passage through a 
Pure Process Technologies solvent purification system to remove water and stored over 4 
Å molecular sieves in an inert atmosphere glove box. Acetonitrile-d3 and 
dichloromethane-d2 were purchased from Cambridge Isotope laboratories and distilled 
from calcium hydride, deoxygenated by three freeze-pump-thaw cycles, and stored in an 
inert atmosphere glove box. Zn(didpa)Cl2 and NBu4SH stock solutions were prepared in 
dry acetonitrile and stored in an inert atmosphere glove box until immediately prior to 
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use. Concentrations of Zn(didpa)Cl2 were corrected to account for uncoordinated Zn(II) 
as determined by titration with N,N,N’,N’-tetrakis(2-pyridylmethyl)ethylenediamine 
(TPEN), vide infra. Dichloromethane stock solutions of NBu4SH were always prepared 
immediately prior to use. 
Spectroscopic Methods. 
UV-Vis measurements were acquired on an Agilent Cary 100 UV-Vis 
spectrophotometer equipped with a QNW dual cuvette temperature controller at 25.00 ± 
0.05°C. All spectroscopic samples were prepared under an inert atmosphere in septum-
sealed cuvettes obtained from Starna Scientific. NMR spectra were acquired on a Brüker 
Avance-III-HD 600 spectrometer with a Prodigy multinuclear broadband cryoProbe or 
Varian INOVA 500 MHz spectrometer at 25.0°C unless otherwise indicated. Chemical 
shifts are reported in parts per million (d) and are referenced to the residual solvent 
resonances. 
UV-Vis Titrations. 
In a glove box, Zn(didpa)Cl2 stock solutions were diluted to the desired 
concentration by addition to a 3.0 mL of solvent in a septum-sealed cuvette and removed 
from the glove box. NBu4SH stock solutions were prepared approximately 105 times 
more concentrated than the Zn solution to provide minimal dilution during addition, and 
were added to the septum-sealed cuvettes by gas-tight syringe. Sodium butane thiolate 
solutions were prepared immediately prior to use by injecting butane thiol into a 
suspension of sodium hydride in acetonitrile. After shaking and a cessation of bubbling, 
the suspension was allowed to settle before aliquots were removed from the supernatant. 
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Control experiments of sodium hydride suspensions and butane thiol solutions were 
conducted as well, and showed no reactivity. 
NMR experiments. 
In a glove box, a 10 mM Zn(didpa)Cl2 solution was prepared in either 
acetonitrile-d3 or dichloromethane-d2 and added to a septum-capped NMR tube. Stock 
solutions of NBu4SH (~0.5 M in acetonitrile-d3) were prepared. Aliquots of the NBu4SH 
stock solutions were added to the NMR tube by gas-tight syringe. 
Determination of excess Zinc in Zn(didpa)Cl2. 
Stock solutions of N,N,N’,N’-tetrakis(2-pyridylmethyl)ethylenediamine (TPEN) 
and Zn(didpa)Cl2 were prepared in CD3CN, with each stock solution containing 50.5 mM 
1,3,5-trimethoxybenzene as an internal standard. Two equivalents of TPEN from the 
stock solution were added to the Zn(didpa)Cl2 solution, and the spectrum was measured. 
Integration of the signals corresponding to free TPEN and Zn(TPEN) against the internal 
standard established that 6.0% free zinc was present, which is due to small excess of zinc 
being present regardless of purification method. 
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CHAPTER VII  
A SYNTHETIC SUPRAMOLECULAR RECEPTOR FOR HYDROSULFIDE ANION 
Published as Hartle, M. D; Hansen R. J; Tresca, B. W; Prakel, S. S; Zakharov, L. 
N; Haley, M. M; Pluth, M. D; Johnson, D. W. “A Synthetic Supramolecular Receptor for 
Hydrosulfide Anion” Angewandte Chemie International Edition 2016 55(38) 11480-
11484. Experimental work completed by either me, S. S. Prakel under my direction, or R. 
J. Hansen. Computational work completed by B. W. Tresca. Crystallographic data 
provided by L. N. Zakharov. Written primarily by me and R. J. Hansen with editorial 
assistance from B. W. Tresca, M. M. Haley, M. D. Pluth, and D. W. Johnson. Associated 
content can be found in Appendix F. 
Preface 
Hydrogen sulfide (H2S) has emerged as a crucial biomolecule in physiology and 
cellular signaling. Key challenges associated with developing new chemical tools for 
understanding the biological roles of H2S include developing platforms that enable 
reversible binding of this important biomolecule. Here we report the first synthetic small 
molecule receptor for hydrosulfide anion, HS–, solely utilizing reversible, hydrogen-
bonding interactions in a series of bis(ethynylaniline) derivatives. Binding constants up to 
90,300 ± 8700 M–1 were obtained. The fundamental science of reversible sulfide 
binding—in this case featuring a key CH···S hydrogen bond—will expand the possibility 
for discovery of sulfide protein targets and molecular recognition agents. 
Introduction 
Supramolecular hosts have been developed to selectively bind a variety of anionic 
species in solution, ranging from inorganic phosphates and phosphorylated biomolecules, 
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to halides, to other anions of environmental and/or biological relevance.221-226 These 
synthetic supramolecular receptors use reversible, mostly non-covalent interactions to 
select anions based on factors such as their basicity, shape/charge, softness/hardness, 
position on the Hofmeister series, hydrophobic/solvophobic effects, among others. 
Notably lacking in the anion binding literature are efforts to target hydrosulfide (HS–), the 
smallest monoanionic sulfur species, which has recently gained interest as an important 
biomolecule. We report here the first examples of synthetic receptors that reversibly bind 
HS– using solely hydrogen bonding interactions. Importantly, a critical CH···S hydrogen 
bond is key to the strong binding of hydrosulfide, lending support to the hypothesis that 
appropriately polarized CH hydrogen bond donors106,226-231 can target softer anions.225,232 
Hydrogen sulfide (H2S) plays diverse roles in the global sulfur cycle and has 
recently been implicated as an important biologically-relevant signaling molecule.1 In the 
last decade, H2S (and its more prevalent HS– conjugate base form under biological 
conditions) has emerged as the third endogenously produced gasotransmitter, along with 
CO and NO. H2S is now implicated in diverse (patho)physiological functions in the 
cardiovascular, immune, gastrointestinal, as well as other systems, making its absence in 
the supramolecular chemistry of anions even more surprising.3,17,233-235 In parallel to the 
biological advances in H2S research, chemical tools for detecting and imaging H2S are 
rapidly emerging and form a cornerstone of the investigative approaches used to study 
this critical biomolecule.3,236 Despite this importance, current detection methods are 
plagued by irreversibility, which presents a significant problem in developing chemical 
tools that provide real-time information on biological processes, suggesting a 
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supramolecular (i.e., reversible) approach to HS– binding would represent an important 
contribution. 
 
Figure VII-1. (a) Protein structure of HSC (PDB:3TDX) showing five individual 
channels with the bound anion represented as a yellow sphere. (b) Enlargement of the 
binding pocket showing short contacts to His (2.980 Å), Thr (3.010 Å), Leu (3.725 Å) 
and Val (3.619 and 4.610 Å). Non-interacting helices are excluded for clarity. (c) 
Synthetic receptors 1-3. 
Complicating biological H2S investigations, the pKa of H2S (7.0) ensures that both 
the neutral (H2S) and monoanionic (HS–) forms are present under physiological 
conditions, leading to significant and unresolved questions on the specific chemistry and 
recognition events associated with the individual protonation states. Heightening this 
dichotomy, HS– was recently identified to be a viable substrate for Cl–/HCO3– anion 
exchange proteins,237 and a bacterial ion channel for HS– transport was recently identified 
(Figure VII-1a-b).64 Importantly, the recognition events in sulfide transport in these 
systems rely on non-covalent, reversible interactions with HS– rather than metal 
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coordination or interaction with the sulfane-sulfur pool. Taken together, these examples 
suggest that HS–, which has until now been almost entirely overlooked, needs to be 
included in the complex landscape of biologically-relevant anions, such as Cl–, HCO3–, I–, 
and NO2–. Despite the emerging importance of sulfide, HS– has only appeared in anion 
screening sporadically, and we are unaware of any synthetic receptors able to bind H2S or 
HS– reversibly through well-defined non-covalent interactions.103,222,238-240 Systems that 
could bind H2S or HS– selectively through reversible interactions would not only provide 
significant insights into potential HS– binding environments in biological contexts, but 
also provide new strategies for developing reversible and real-time H2S detection 
methods. 
To approach this challenge, we reasoned that synthetic anion receptors could 
provide a viable platform to develop reversible HS– binding systems. To optimize 
selective binding for hydrosulfide, we initially assumed the ideal receptor should feature 
hydrogen bond donors to target the anionic portion of hydrosulfide and a hydrogen bond 
acceptor (or suitable pocket of electron density) to accommodate the slightly acidic 
hydrogen atom. Aligned with these requirements, sulfide has a similar ionic radius to Cl– 
(S2– = 1.84 Å, Cl– = 1.81 Å) and biological examples reveal that HS– can fill similar roles 
as Cl–.241 This similarity has not yet been exploited in the synthetic supramolecular 
community to target HS–, perhaps because of a prevailing assumption that Cl– and HS– 
should have quite different binding properties based on their different protonation states, 
nucleophilicities, hardness/softness, shape, pKb (-8 vs 7, respectively) and resulting 
hydrogen bond accepting ability. 
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In this light we reinvestigated the bis(ethynylaniline) anion-binding receptors we 
have developed for Cl– as a viable platform for non-covalent HS– binding.242-243 These 
modular scaffolds bind anions through tunable urea NH hydrogen bonds, and the central 
core can be easily modified to incorporate an additional hydrogen bond donating arene 
(1) or a hydrogen bond accepting pyridine group (2-3).232 The semi-preorganized binding 
pocket significantly reduces the entropic penalty for anion encapsulation, while 
maintaining flexibility to accommodate different anions. The ability to tune the urea 
hydrogen bond donors as well as the central core binding motif has resulted in a family of 
receptors that can selectively target a diverse range of analytes.233,244 In addition, recent 
work has suggested that CH hydrogen bond donors polarized by inductive electron 
withdrawing groups (e.g., the electronegative sp-hybridized alkyne carbon atoms in 1) 
should exhibit selectivity for softer anions.232 Although the place of HS– on the 
Hofmeister series and HSAB theory tables is not clear, intuition suggests that 
hydrosulfide should be a softer anion than chloride. Motivated by these challenges, we 
report here the first examples of synthetic receptors that reversibly bind HS– using solely 
supramolecular interactions (Figure VII-1c). 
Results and Discussion 
To investigate whether HS– is a suitable guest for hosts 1-3, we titrated NBu4SH44 
into 0.5-1.0 mM solution of each host in 10% DMSO-d6/CD3CN and monitored the 
titrations by 1H NMR spectroscopy (Figure F-1). In each case, we observed that the urea 
NH resonances shifted significantly downfield upon HS– addition, consistent with anion 
binding (Figure VII-2). For example, upon addition of HS– to a solution of 1, the aryl 
CHa shifted from 7.99 to 9.24 ppm, and the NHb and NHc urea protons shifted downfield 
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from 7.94 and 8.92 to 8.63 and 11.18 ppm, respectively. Highlighting the preference of 
each receptor 1-3 for HS– rather than H2S, addition of H2S gas to any of the receptors 
failed to change the UV-Vis or NMR spectra of the hosts. We also confirmed that the 
observed changes in the NMR spectra upon HS– addition were not due to deprotonation 
of the urea NH groups. Addition of the strong base 1,8-diazabicyclo[5.4.0]undec-7-ene 
(DBU) produced significantly different UV-Vis and NMR spectra than those observed 
upon HS– addition (Figure F-14). On the basis of the high nucleophilicity of HS–, we also 
confirmed that the anion did not irreversibly modify the alkyne moieties of the host 
scaffolds by monitoring the 13C{1H} NMR spectrum of 1 before and after addition of 10 
equivalents of HS– (Figure F-13). Additionally, titration data of HS– with the host fit to 
simple 1:1 binding isotherm models. Taken together, these results support the hypothesis 
that HS– binds within the host pocket and does not covalently modify the host scaffold. 
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Figure VII-2. (a) Scheme showing HS– host-guest equilibrium. (b) Representative UV-
Vis difference titration of NBu4SH with 10 µM 2 in CH3CN and fit to a 1:1 binding 
isotherm (inset). (c) 1H NMR spectra of a titration of 0.988 mM 1 with NBu4SH in 10% 
DMSO-d6/CD3CN. 
To determine whether receptors 1-3 exhibited selectivity for HS– over similar 
anions, we performed comparison titrations with NBu4Cl under identical conditions. We 
initially expected that pyridine-based hosts 2 and 3 would exhibit higher binding 
affinities for HS– because of the hydrogen bond accepting pyridine core; however, 
titration data established hosts 2 and 3 had significantly lower binding constants for both 
anions than did phenyl core host 1. This difference suggests that the extra CH hydrogen 
bond donated from the phenyl core is a key component in establishing the binding 
magnitude and selectivity. This result was contrary to our initial hypothesis that HS– 
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should also act as a weak hydrogen bond donor to an acceptor on the host receptor (e.g., 
the pyridine nitrogen of 2 and 3).245 Despite the lower binding affinities, the pyridine-
based hosts 2 and 3 exhibited 6-fold selectivity for HS– over Cl–, whereas host 1 
exhibited 2.8-fold selectivity. The higher selectivity could be due to the putative N···HS– 
hydrogen bond from the pyridine lone pair acting as a hydrogen bond acceptor, which 
provides an additional stabilizing interaction for HS– and a destabilizing interaction for 
Cl–. The phenyl core of host 1 donates a hydrogen bond to both anionic guests, resulting 
in decreased selectivity for hydrosulfide, even if this CH hydrogen bond is an important 
component to the higher overall binding energy. 
To further investigate the difference in anion selectivity, binding constants were 
also measured by UV-Vis spectroscopy in CH3CN (Table VII-1). We expected that 
removal of the DMSO co-solvent would increase the observed binding affinities since 
acetonitrile is a slightly less competitive solvent (especially as a hydrogen bond 
acceptor). Addition of NBu4SH to 10 µM solutions of 1, 2, or 3 resulted in attenuation of 
the 330 nm absorbance with concomitant increase at 360 nm, while proceeding through a 
well-anchored isosbestic point near 350 nm. As expected, removal of DMSO produced 
significantly higher binding affinities, with host 1 having a binding constant of 90,300 M–
1 and hosts 2 and 3 providing binding constants of ~25,000 M–1. For 1, the selectivity for 
HS– over Cl– remained similar to the 10% DMSO-d6/CD3CN system, whereas in the case 
of the pyridine core, a significant increase in selectivity is observed (~18.5:1 HS–:Cl–). 
The difference between the binding energy of HS– with 1 and 2 is the same in both 
solvents (∆∆G = 0.90 kcal mol–1), whereas the Cl– binding energy exhibits a larger 
solvent dependence (∆∆G = 1.24 (DMSO/CH3CN) vs. 1.83 (CH3CN) kcal mol–1). For 
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HS–, the ∆∆G is the difference between two stabilizing hydrogen bond motifs and leads 
to an estimate that a C–H···S hydrogen bond is up to 0.90 kcal mol–1 stronger than an S–
H···N hydrogen bond. The ∆∆G of Cl– binding is larger because this represents the 
difference between a small repulsive N:···Cl contact and an attractive C–H···Cl hydrogen 
bond. 
Table VII-1. HS– and Cl– Binding Parameters in Hosts 1-3. 
Host Solvent HS– (log(Ka)) 
∆G (kcal mol–1) 
Cl– (log(Ka)) 
∆G (kcal mol-1) 
1 10% DMSO-d6/CD3CN 3.70 ± 0.07[a] 
-5.05 
3.25 ± 0.03[a] 
-4.43 
 CH3CN 4.96 ± 0.04[b] 
-6.76 
4.53 ± 0.07[b] 
-6.18 
2 10% DMSO-d6/CD3CN 3.04 ± 0.06[a] 
-4.15 
2.34 ± 0.07[a] 
-3.19 
 CH3CN 4.30 ± 0.07[b] 
-5.86 
3.19 ± 0.07[b] 
-4.35 
3 10% DMSO-d6/CD3CN 3.12 ± 0.07[a] 
-4.25 
2.34 ± 0.02[a] 
-3.19 
 CH3CN 4.45 ± 0.07[b] 
-6.07 
3.08 ± 0.06[b] 
-4.20 
[a] Fitting NMR spectroscopic data. [b] Fitting UV-Vis spectroscopic data. 
 
To further establish the reversibility of HS– binding, we treated a solution of 1 in 
10% DMSO-d6/CD3CN (Figure VII-3a) with two equivalents of NBu4SH to form the HS– 
bound adduct (Figure VII-3b), after which four equivalents of Zn(OAc)2 were added. 
Addition of Zn(OAc)2 rapidly resulted in precipitation of ZnS and regenerated the NMR 
spectrum corresponding to free 1 (Figure VII-3c). Further addition of five equivalents of 
NBu4SH regenerated the HS– host-guest complex, confirming reversible binding. 
Importantly, the 13C{1H} resonances of the alkyne carbons did not shift significantly 
(Figure VII-3b, d), confirming that there was no covalent modification of the receptor 
scaffold. 
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Figure VII-3. (a) Reversibility reaction scheme. (b) 1H NMR spectrum of a 1.0 mM 
solution of 1 in 10% DMSO-d6/CD3CN. (c) Treatment with 2 equiv. of NBu4SH. (d) 
Addition of 4 equiv. Zn(OAc)2. Each inset shows the 13C{1H} resonances corresponding 
to the alkyne region of 1. 
Single crystals of [1•HS–][NBu4+] were grown by layering n-hexanes onto an 
equimolar solution of 1 and NBu4SH in THF in a glovebox. [1•HS–][NBu4+] crystallizes 
in the space group Pna21 with one molecule of THF per unit cell. Consistent with the 
solution NMR data, the HS– occupies the binding pocket created by an aryl proton and 
four urea protons with the NBu4+ cation sitting just above the sulfide – phenyl core plane 
(Figure F-15). The structure shows five hydrogen bonds from the host to the bound 
sulfide guest. The C–H···S hydrogen bond (3.711 Å) is longer than those formed 
between the distal bis(urea) protons (3.277, 3.281 Å) (Figure VII-4a). The average of all 
five hydrogen bond distances from the host to the guest is 3.56 Å, and all fall within 
previously defined criteria for hydrogen bonds.228,246-248 The host conformation in [1•HS–
] is remarkably similar to the previously published chloride-bound structure, with an 
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RMS distance between the two structures of only 0.184 Å (Figure F-16).245 These data 
demonstrate the similar recognition geometries required for Cl– and HS– binding, again 
highlighting the potential for HS– to be a substrate for classical Cl– binding domains in 
both native and synthetic systems. 
 
Figure VII-4. ORTEP representation showing selected hydrogen bond distances. Atoms 
are drawn at the 50% probability level.  Hydrogens not interacting with the bound HS– 
are removed for clarity. 
Conclusion 
In conclusion, we report a series of bis(ethynylaniline) derivatives capable of 
binding hydrosulfide anion with association constants as high as 90,300 ± 8700 M–1, 
representing the first reversible binding of the hydrosulfide anion in a synthetic receptor. 
1H NMR and UV-Vis spectroscopy both indicate stronger binding of hydrosulfide by the 
phenyl core receptor 1; however, a greater selectivity for HS– is observed in the pyridine 
cores (2 and 3). The preference for the phenyl core highlights the unexpected conclusion 
that a C–H···S contact is favored over an N:···H–S contact by up to 0.9 kcal mol–1. This 
difference may be related to the mechanisms that underlie anion binding selectivities 
beyond shape, size, and charge. Importantly, these results indicate that hydrogen bond 
polarizability and other aspects of hard/soft acid base theory are relevant to the 
characterization of anion selective host-guest systems. Additionally, these data suggest 
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that CH hydrogen bond donors are important components in targeting hydrosulfide 
reversibly. Taken in total, these experiments establish the reversible binding of HS– to 
synthetic host molecules, and highlight that HS– is an important, and thus far overlooked, 
biologically-important anion that can be targeted by synthetic molecular architectures. 
These studies also begin to establish the design rules for targeting hydrosulfide anion 
using such synthetic receptors. Moreover, we anticipate that the basic science of non-
covalent sulfide binding to synthetic targets will help to identify new target proteins for 
sulfide binding, while also informing on new potential sulfide detection strategies that do 
not rely on the irreversible covalent modification of sensing platforms. 
Summary 
This final chapter culminates the entire work of the dissertation. After an 
overview of the currently available tools to study H2S at the interface of chemistry and 
biology, chapter II began with an identification of the differential reactivity of HS– and 
H2S with metal centers. This lead to chapter III, which reported a simple method to 
prepare tetrabutylammonium hydrosulfide (NBu4SH) as an organic soluble salt for 
studies in organic aprotic solutions. With NBu4SH in hand, chapter IV expanded the 
reaction of H2S with metal centers in the protoporphyrin scaffold, showing three reaction 
pathways: no reaction, reduction, or binding. Chapter V expanded upon this by 
investigating the protected pocket stabilization hypothesis for sulfide transport in L. 
Pectinata by using the picket fence porphyrin. The picket fence identified that a protected 
binding pocket alone is insufficient for stabilizing binding. Chapter VI built upon the 
conclusion of chapter V by exploring the thermodynamic stabilization provided by 
hydrogen bond accepting motifs in the secondary coordination sphere of a zinc complex. 
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Chapter VII removed the metal center, and showed stabilization of HS– by a completely 
synthetic organic receptor, modeling the hydrogen bonding interactions of a bacterial 
hydrosulfide transport protein. 
Experimental 
Materials and Methods. 
All manipulations were performed under an inert atmosphere using standard 
Schlenk techniques or an Innovative Atmospheres N2-filled glove box unless otherwise 
noted. Tetrabutylammonium chloride (NBu4Cl) was purchased from Sigma-Aldrich, and 
tetrabutylammonium hydrosulfide (NBu4SH) was prepared as described in the 
literature.44 Spectroscopic grade MeCN was degassed by sparging with argon followed 
by passage through a Pure Process Technologies solvent purification system to remove 
water and stored over 4Å molecular sieves in an inert atmosphere glove box. CD3CN and 
DMSO-d6 were purchased from Cambridge Isotope laboratories, distilled from CaH2, 
deoxygenated by three freeze-pump-thaw cycles, and stored in an inert atmosphere glove 
box. 
Spectroscopic Methods. 
UV-Vis measurements were acquired on an Agilent Cary 100 UV-Vis 
spectrophotometer equipped with a QNW dual cuvette temperature controller at 25.00 ± 
0.05 °C. All spectroscopic samples were prepared under an inert atmosphere in septum-
sealed cuvettes obtained from Starna Scientific. NMR spectra were acquired on a Brüker 
Avance-III-HD 600 spectrometer with a Prodigy multinuclear broadband cryoProbe at 
25.0 °C or on a Varian 500 MHz spectrometer. Chemical shifts are reported in parts per 
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million (δ) and are referenced to residual solvent resonances (CD3CN 1H 1.94 ppm, 
13C{1H} 118.26 ppm and DMSO-d6 1H 2.50 ppm, 13C{1H} 39.52 ppm). 
General procedure for UV-Vis titrations. 
A septum-sealed cuvette was charged with a 10 µM solution of the desired host in 
MeCN. A second reference cuvette was also prepared with the same volume of MeCN, 
and a stock solution of NBu4SH was prepared in a septum-sealed vial. NBu4SH was 
added to both the reference and sample cuvette via gas-tight syringe, and the spectrum 
was recorded after each addition. All spectra were corrected for dilution and fit to a 1:1 
model using the Thordarson method.139,153  
General procedure for NMR titrations. 
In an N2-filled glove box, a stock solution of 1-3 in 10% DMSO-d6/CD3CN (3 ml) 
was prepared and used to prepare an NBu4SH stock solution (2.4 ml). The remaining host 
stock solution (0.6 ml) was added to a septum-sealed NMR tube using a Hamilton gas-
tight syringe. Spectra were recorded after each addition of NBu4SH, and the Δδ of urea 
proton Hc was used to follow the progress of the titration. Association constants were 
determined using a 1:1 model with the Thordarson method.139,153 
X-ray crystallography. 
Diffraction intensities for 1 were collected at 173 K on a Bruker Apex2 CCD 
diffractometer using CuKα radiation (λ = 1.54178 Å). The space group was determined 
based on systematic absences and the absorption correction was applied by SADABS.114 
The structure was solved by direct methods and Fourier techniques and refined on F2 
using full matrix least-squares procedures. All non-H atoms were refined with anisotropic 
thermal parameters. All H atoms were treated in calculated positions except five H atoms 
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at the C and N atoms involved in C–H···S and N–H···S hydrogen bonds, which were 
located from the residual density map and refined with isotropic thermal parameters. The 
hydrogen atom in the HS– anion was not located, but the residual density map contains a 
peak with orientation opposite to the C– H···S hydrogen bond, which appears to be the 
HS– hydrogen. Structural refinement without any restrictions on the S–H fragment did 
not provide a stable position for this hydrogen atom, suggesting that it may be disordered 
over several positions. The structure was determined in non- centrosymmetric space 
group symmetry, and the value of Flack parameter, 0.59(3), shows that the sample is a 
racemic twin. All calculations were performed by the Bruker SHELXL-2013 package.249  
CCDC 1472308 contains the supplementary crystallographic data. These data can 
be obtained free of charge from The Cambridge Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/data_request/cif.
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Titration of CoPc with [NBu4][BH4]. 
 
Figure A-1. UV-vis titration data of 3.0 mL of 10 µM CoPc with 2.8 mM [NBu4][BH4] 
in 5.9 µL aliquots in THF showing reduction of CoPc to [CoPc]–. The band at 320 nm 
observed in the [NBu4][BH4] titration is consistent with formation of borane-THF 
complex. 
Job Plots 
 
 
Figure A-2. Job plot of ZnPc and NaSH in 1:1 THF:DMSO following the absorbance at 
426 nm. 
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Table A-1. Parameters for ZnPc Job Plot in 1:1 THF:DMSO. 
Host (µL) 2700 2400 2100 1800 1500 1200 900 600 300 
Host Concentration 
(M) 
1.65E-
04 1.47E-04 1.28E-04 1.10E-04 9.17E-05 7.34E-05 5.50E-05 3.67E-05 1.83E-05 
Guest (µL) 300 600 900 1200 1500 1800 2100 2400 2700 
Guest Concentration 
(M) 
1.83E-
05 3.66E-05 5.49E-05 7.32E-05 9.16E-05 1.10E-04 1.28E-04 1.46E-04 1.65E-04 
Mol fraction of Host 0.90 0.80 0.70 0.60 0.50 0.40 0.30 0.20 0.10 
Total Concentration 
1.83E-
04 1.83E-04 1.83E-04 1.83E-04 1.83E-04 1.83E-04 1.83E-04 1.83E-04 1.83E-04 
 
Figure A-3. Job plot of CoPc and NaSH in 1:1 THF:DMSO following the absorbance at 
467 nm. 
Table A-2. Parameters for CoPc Job Plot in 1:1 THF:DMSO. 
Host (μL) 2700 2400 2100 1800 1500 1200 900 600 300 
Host Concentration 
(M) 
3.46E-
05 3.08E-05 2.69E-05 2.31E-05 1.92E-05 1.54E-05 1.15E-05 7.70E-06 3.85E-06 
Guest (μL) 300 600 900 1200 1500 1800 2100 2400 2700 
Guest Concentration 
(M) 
3.88E-
06 7.76E-06 1.16E-05 1.55E-05 1.94E-05 2.33E-05 2.72E-05 3.10E-05 3.49E-05 
Mol fraction of Host 0.90 0.80 0.70 0.60 0.50 0.40 0.30 0.20 0.10 
Total Concentration 
3.85E-
05 3.86E-05 3.86E-05 3.86E-05 3.86E-05 3.87E-05 3.87E-05 3.87E-05 3.88E-05 
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1H NMR spectra for ZnPc 
 
Figure A-4. 1H NMR spectrum of ZnPc in THF-d8. 
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Figure A-5. 1H NMR spectrum of ZnPc in THF-d8 with 2 equiv. of NaSH in DMSO-d6. 
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Figure A-6. 1H NMR spectrum of ZnPc in THF-d8 with 2 equiv. of KOH in DMSO-d6. 
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1H NMR spectra for CoPc 
 
Figure A-7. 1H NMR spectrum of 0.136 mM CoPc in 750 µL of THF-d8 with 40 µL of 
added DMSO-d6. 
0123456789101112131415
f1 (ppm)
1.
51
1.
00
0.
10
0.
89
1.
28
1.
73
1.
94
2.
05
2.
42
2.
42
2.
63
2.
82
2.
95
3.
58
 T
H
F
-d
8
10
.1
7
12
.6
6
12.012.212.412.612.813.013.213.4
f1 (ppm)
-1
.0
0
12
.6
6
10.0010.1010.2010.30
f1 (ppm)
1.
51
10
.1
7
  127 
 
Figure A-8. 1H NMR spectrum of 0.136 mM [Co(I)Pc]– in 750 µL of THF-d8 with 40 µL 
of 22.6 mM NaSH (8.8 equiv.) in DMSO-d6 added. The change in the Pc resonances 
from a broad singlet to well defined peaks is consistent with a change from paramagnetic 
Co(II) to diamagnetic Co(I).
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NMR Spectroscopic Data 
 
Figure B-1 1H (600 MHz, CD3CN) NMR spectrum of NBu4SH. 
 
Figure B-2. 13C{1H} (151 MHz, CD3CN) NMR spectrum of NBu4SH.  
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Figure B-3. 1H NMR spectra demonstrating that H2S is not sufficiently nucleophilic to 
react with BnCl. Only upon deprotonation to form HS– does nucleophilic attack on BnCl 
occur. a) A saturated solution of H2S gas in CD3CN. b) Addition of BnCl does not result 
in any reaction. c) Addition of NEt3 (TEA) to deprotonated H2S generates HS–, which is 
quickly trapped by BnCl to form Bn2S. 
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Figure B-4. 1H NMR spectrum of the reaction of NBu4SH with BnCl to form Bn2S and 
BnSH. Unlike in Figure B-3, no added base is required for this reaction to occur. Bottom: 
NBu4SH in CD3CN. Top: Addition of 3 equiv. of BnCl.  
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IR Spectroscopic Data 
 
Figure B-5. FTIR (ATR, neat) spectrum of NBu4SH. 
 
Figure B-6. FTIR (ATR, neat) spectrum of NaSH.  
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X-Ray crystallographic data 
Table B-1. Crystal data and structure refinement for NBu4SH. 
 NBu4SH 
Empirical formula C19.50H41NS 
[C16H36N]+[SH]–(C7H8)0.5 
Formula weight 321.59 
Wavelength (Å) 1.54178 
Crystal size (mm) 0.14 x 0.13 x 0.04 
Temperature (K) 173 K 
Crystal system, space group Monoclinic, C2/c 
Unit cell dimensions (Å) a = 22.043(10) 
 b = 14.9292(7) 
 c = 14.8080(6) 
 b = 118.618(3)° 
Volume (Å 3) 4277.7(3) 
Z 8 
Calculated density (Mg/m3) 0.999 
µ (mm-1) 1.295 
F(000) 1448 
2θmax 135.36° 
Reflections collected 14231 
Independent reflections 3729 
Rint 0.0489 
[I>2s(I)]  
     R1 0.0741 
     wR2 0.2044 
     GOF 1.053 
 3729 reflections 
 163 parameters 
R1 0.934 
wR2 0.2180 
GOF 1.053 
 All reflections 
Residual electron density (e/Å3) Max Max = 0.565 
 Min = -0.330 
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Summary of Results 
Table C-1. Summary of Results. 
 Sulfide Reversibility Control experiments 
Metal HS– Log(Ka) HS– S8 H2S AcOH O2 Dilute AcOH AcO– O2 Dilute DBUa DCHAb Cp2Co 
Zn Bind 4.24 ± 0.02 None None Yes Yes Yes None Bind None None Bind Bind None 
Cr Bind 3.92 ± 0.02 None None Yes Yes No None None None None None None None 
Sn Bind —c None None Yesd No No None Bind None None Bind Bind None 
MnII Bind 4.36 ± 0.04 None Bind Yes MnIII No None Bind MnIII None Bind Bind None 
a1,8-Diazabicylco[5.4.0]undec-7-ene bdicyclohexylamine cUnable to obtain. dReverts to the Sn-
SH2spectrum. 
 
Additional UV-Vis spectroscopy experiments of ZnIIPPIX 
 
Figure C-1. Titration of ZnPPIX (1.8 µM) with NBu4SH (30 equiv.) followed by 
titration with AcOH (30 equiv.) in THF. 
 
Figure C-2. Treatment of ZnPPIX (2.4 µM, black) with NBu4SH (80 equiv., blue) 
followed by exposure to the atmosphere for 15 minutes (purple) in THF. 
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Figure C-3. Treatment of ZnPPIX (2.3 µM) with NBu4OAc (20 equiv.) in THF. 
 
Figure C-4. Treatment of ZnPPIX (2.5 µM) with DBU (890 equiv.) followed by 
NBu4SH (30 equiv.) in THF. 
 
Figure C-5. Treatment of ZnPPIX (2.6 µM) with dicyclohexylamine (4.5 equiv.) in THF. 
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Figure C-6. ZnPPIX binding isotherm and associated fit for titration data shown in 
Figure 2b. Data points related to the deprotonation of carboxylic acid moieties removed 
(first equivalent), as they did not show significant spectral change. 
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Additional UV-Vis spectroscopy experiments of CrIII(PPIX)Cl 
 
Figure C-7. Treatment of CrIII(PPIX)Cl (2.4 µM, red) with NBu4SH (26 equiv., blue) in 
THF, followed by AcOH (50 equiv., orange). Note: The reverse reaction was kinetically 
slow. 
 
Figure C-8. Treatment of CrIII(PPIX)Cl (2.4 µM, black) with NBu4SH (25 equiv., blue) 
in THF followed by exposure to the atmosphere for 30 minutes (red). 
 
Figure C-9. CrIII(PPIX)Cl binding isotherm and associated fit for titration data shown in 
Figure 4b. Data points corresponding to deprotonation (1st equiv.) showed no spectral 
change and were removed before fitting. 
  139 
Additional UV-Vis spectroscopy experiments of SnIVPPIX 
 
Figure C-10. Treatment of SnIVPPIX (6 µM) with Cl– (25 equiv.) in THF.  
 
Figure C-11. Treatment of SnIVPPIX (3.9 µM, red) with NBu4SH (20 equiv., blue) 
followed by addition of triflic acid (1 µL, black) in THF. 
 
Figure C-12. Treatment of SnIVPPIX (5.5 µM, red) with NBu4OAc (20 equiv., blue) in 
THF. 
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Figure C-13. Treatment of SnIVPPIX (5.4 µM, red) with DBU (200 equiv., black) in 
THF. 
 
Figure C-14. Treatment of SnIVPPIX (6 µM, red) with dicyclohexylamine (11 equiv., 
black) in THF.  
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Additional UV-Vis spectroscopy experiments of MnII/IIIPPIX 
 
Figure C-15. Treatment of MnIIIPPIX (9.6 µM, red) with NBu4SH (15 equiv., blue) 
followed by AcOH (40 equiv., purple) in THF 
 
Figure C-16. Treatment of MnIIPPIX (7.7 µM, black) with NBu4SH (4 equiv., red) 
followed by AcOH (40 equiv., blue) in THF. 
 
Figure C-17. Treatment of MnIIPPIX (7.7 µM, black) with NBu4SH (4 equiv., red) 
followed by exposure to the atmosphere for 60 minutes (blue) in THF. 
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Figure C-18. Treatment of MnIIIPPIX (10 µM, black) with NBu4OAc (20 equiv., red) in 
THF. 
 
Figure C-19. Treatment of MnIIPPIX (6.4 µM, red) with DBU (1 µL, black) in THF. 
 
Figure C-20. Treatment of MnIIPPIX (10 µM, red) with dicyclohexylamine (50 equiv., 
blue), followed by addition of NBu4SH (30 equiv., black) in THF. 
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Figure C-21. Treatment of MnIIIPPIX (7.5 µM, red) with CoCp2 (1.5 equiv., black) in 
THF. 
 
Figure C-22. MnIIPPIX binding isotherm and associated fit for titration data shown in 
Figure 6b after complete conversion to MnII(PPIX). 
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Additional EPR Spectra and simulation parameters 
CrIIIPPIX 
In addition to UV-vis spectroscopy, we also used EPR spectroscopy to explore the 
electronic effects of binding HS– with CrIII(PPIX)Cl. A frozen solution (1:2 
DMSO:DCM, 7 K) of CrIII(PPIX)Cl provided the spectrum of a typical axial high-spin 
chromium porphyrin (Figure C-24a).250 Chromium porphyrins are notably difficult to 
simulate,251 and we were unable to produce a reasonable simulation of the porphyrin; 
however, visual comparison of this spectrum with those of known ZFS values indicate a 
D value of 0.23 cm-1 and isotropic g value of 1.98.252 Upon addition of excess NBu4SH, 
an axial EPR spectrum in which the axial components are reversed was produced (Figure 
C-24b). The exchange of axial g-values is unusual, but consistent with displacement of 
the Cl– ligand for HS–, which has a higher field-strength154 and the resultant spectrum is 
similar to other axial-ligated chalcogenide CrIII species, though not of other porphyrin 
species.154,252 
 
Figure C-23. Continuous wave EPR spectra (DMSO/CH2Cl2, 7 K) of (a) CrIII(PPIX) (2 
mM), (b) CrIII(PPIX)SH upon addition of 20.4 equiv. of NBu4SH. 
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Fitting parameters for MnIIIPPIX 
MnIII(PPIX)Cl+NBu4SH General Spectrum: S = 5/2, Nucs = Mn, gx = 6.154, gy = 5.724, 
gz = 1.975, Ax. = 672.05 MHz, Ay = 628.74 MHz, Az = 279.89 MHz D = 4.69 
MHz, E = 44.25 MHz, lwppGaussian = 0.70 MHz, lwppLorenzian = 1.96 MHz 
Fitting parameters for MnIIPPIX 
MnII(PPIX): S = 5/2, Nucs = Mn, gx = 6.203, gy = 5.706, gz = 1.968 Ax = 650.22 MHz, Ay 
= 619.40 MHz, gz = 263.00 MHz, D = 12.971 MHz, E = 13.62 MHz, lwppGaussian 
= 3.29 MHz, lwppLorenzian = 2.34 MHz. 
MnII(PPIX)+NBu4SH: S = 5/2, Nucs = Mn, gx = 6.154, gy = 5.735, gz = 1.974 Ax = 
674.79 MHz, Ay = 629.05 MHz, Az = 277.65 MHz, D = 4.86 MHz, E = 44.60 
MHz, lwppGaussian = 0.73 MHz, lwppLorenzian = 2.37 MHz. 
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Synthetic scheme for porphyrin materials 
 
Scheme D-1. Synthesis of Fe(TPivPP)(Im)2. 
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Spectroscopic characterization data 
5,10,15,20-tetrakis(2-nitrophenyl)porphyrin, (H2TNPP) 
 
Figure D-1. 1H (600 MHz, DMSO-d6) NMR spectrum of H2TNPP. 
 
Figure D-2. UV-Vis spectrum of H2TNPP in DMF. 
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Figure D-3. FTIR (ATR, neat) spectrum of H2TNPP. 
5,10,15,20-tetrakis(2-aminophenyl)porphyrin, (H2TAPP) 
 
Figure D-4. 1H (600 MHz, CDCl3) NMR spectrum of H2TAPP. 
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Figure D-5. 13C{1H} (151 MHz, CDCl3) NMR spectrum of H2TAPP. 
 
Figure D-6. UV-Vis spectrum of H2TAPP in CHCl3. 
 
Figure D-7. FTIR (ATR, neat) spectrum of H2TAPP. 
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(all-cis)-5,10,15,20-tetrakis[2-(2,2-dimethylpropionamido)phenyl]porphyrin, 
(H2TPivPP) 
 
Figure D-8. 1H (600 MHz, CDCl3) NMR spectrum of H2TPivPP. 
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Figure D-9. 13C{1H} (151 MHz, CDCl3) NMR spectrum of H2TPivPP. 
  153 
 
Figure D-10. 1H-1H COSY NMR spectrum of H2TPivPP. 
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Figure D-11. 1H-13C HMQC NMR spectrum of H2TPivPP. 
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Figure D-12. 1H-13C HMBC NMR spectrum of H2TPivPP. 
 
Figure D-13. UV-Vis spectrum of H2TPivPP in CHCl3. 
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Figure D-14. FTIR (ATR, neat) spectrum of H2TPivPP. 
Bromo{(all-cis)-5,10,15,20-tetrakis-[2-(2,2-
dimethylpropionamido)phenyl]porphyrinato(2-)}-iron(III), (Fe(TPivPP)Br) 
 
Figure D-15. 1H (600 MHz, toluene-d8) NMR spectrum of Fe(TPivPP)Br. 
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Figure D-16. UV-Vis spectrum of Fe(TPivPP)Br in CHCl3. 
 
Figure D-17. FTIR (ATR, neat) spectrum of Fe(TPivPP)Br. 
 
Figure D-18. Comparison of the UV-Vis spectra of different species in the metalation 
reaction for Fe(TPivPP)Br in CHCl3. 
  158 
 
Figure D-19. Full electrospray negative ion mode mass spectrum of Fe(TPivPP)Br. 
 
Figure D-20. Area of interest for negative ion mode mass spectrum of Fe(TPivPP)Br 
including the isotopic distribution of the observed and calculated peaks. 
 
Figure D-21. Area of interest for negative ion mode mass spectrum of Fe(TPivPP)Br 
including the isotopic distribution of the observed and calculated peaks. 
  159 
Bis(N-methylimidazole)[(all-cis)-5,10,15,20-tetrakis-[2-(2,2-
dimethylpropionamido)phenyl]porphyrinato(2-)]-iron(II), (Fe(TPivPP)(Im)2) 
 
Figure D-22. 1H (600 MHz, toluene-d8) NMR spectrum of Fe(TPivPP). 
 
Figure D-23. UV-Vis spectrum of Fe(TPivPP)(Im)2 (10.8 µM) in toluene with 33-fold 
excess of N-methyl imidazole. 
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Figure D-24. FTIR (ATR, neat) spectrum of Fe(TPivPP).  
 
Figure D-25. Full negative ion mode mass spectrum of Fe(TPivPP)(Im) 
 
Figure D-26. Area of interest for negative ion mode mass spectrum of Fe(TPivPP)(Im) 
including the isotopic distribution of the observed and calculated peaks. 
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Interactions of O2 with FeII(TPivPP) 
 
Figure D-27. UV-Vis spectrum of representative oxygen binding of Fe(TPivPP)(Im)2 (23 
µM) in toluene. 
Full 1H-NMR spectra of NBu4SH addition 
 
Figure D-28. 1H (600 MHz, toluene-d8) NMR Spectrum of Fe(TPivPP)(SH) after 
reaction with Fe(TPivPP)Br. 
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Figure D-29. 1H (600 MHz, toluene-d8) NMR spectrum of Fe(TPivPP)(SH) after 
reaction with Fe(TPivPP). 
 
Figure D-30. 1H (600 MHz, toluene-d8) NMR spectra of different Fe species and the 
reaction results with NBu4SH. 
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Figure D-31. UV-Vis of the starting and final product for NMR titrations. 
Binding characterization 
 
Figure D-32. Representative UV-Vis titration data (in toluene) and residual (inset). 
Negative ion mode mass spectra 
 
Figure D-33. Negative ion mode mass spectrum of Fe(TPivPP)(Im)2 with 15 equiv. of 
NBu4SH in THF. 
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Figure D-34. Negative ion mode mass spectrum of Fe(TPivPP)Br with 15 equiv. of 
NBu4SH. 
 
Figure D-35. Negative ion mode mass spectrum of Fe(TPP)(Im)2 with 15 equiv. of 
NBu4SH. 
 
Figure D-36. Negative ion mode mass spectrum of Fe(TPP)Cl with 15 equiv. of 
NBu4SH. 
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Figure D-37. Negative ion mode mass spectrum of the degradation product of 
Fe(TPivPP)(Im)2 treated with 15 equiv. of NBu4SH and exposed to the atmosphere. 
To test the hypothesis that the binding of HS– is kinetically stabilized by the PFP 
scaffold, solutions of ferrous 3 and 6 were treated with 15 equiv. of NBu4SH and their 
mass spectra were recorded at different collisional energies. Our expectation was that the 
kinetic stability of the bound sulfide in the PFP scaffold would require a higher 
collisional energy to dissociate sulfide than in the TPP system. To test this hypothesis, we 
isolated the sulfur-containing precursor ions (m/z 1097.4294 and 700.1522, respectively) 
and monitored the ratio of sulfur-ligated to unligated porphyrin species as a function of 
collisional energy using samples of 3 and 6 prepared under identical conditions (Figure 
S46). At the lowest collision energy (0.00 kV), the PFP exhibited a 33:1 sulfide-
ligated:unligated ratio, which was significantly larger than the 1.59:1 ratio observed in 
the TPP system. Increasing the collisional energy to 0.20 kV resulted in ratios of 1.25:1 
and 1.08:1 for the PFP and TPP systems, respectively. When taken together with the 
previous mass spectrometry studies, these data are consistent with an increased kinetic 
barrier for sulfide release from the PFP pocket by comparison to the TPP system.195-196 
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Figure D-38. (a) Mass spectrum of 3 after addition of 15 equiv. of NBu4SH in THF 
shows the formation of 2 (blue) and 7 (red).  (b) Mass spectrum of 6 after addition 15 
equiv. of NBu4SH in THF shows the formation of 5 (blue) and 8 (red). In both cases, 
increasing the collisional energy results in a decrease in the peak intensity corresponding 
to the SH-ligated iron complex with respect to the unligated porphyrin. The decrease in 
(b) is greater than that of (a), consistent with sulfur bound inside the pocket of the 
porphyrin. 
Absorption data for different Fe complexes 
Table D-1. Table of porphyrin compounds and absorbances. 
Species Compound # lmax (toluene) lmax (DMF) 
FeIII(TPivPP)Br 1 419, 510, 582, 655, 684 425, 570, 668 
FeII(TPivPP) 2 414, 571, 661 Not measured 
FeII(TPivPP)(Im)2 3 429, 534, 564 (sh), 610 419, 455, 538, 575, 621 
FeIII(TPP)Cl 4 Not measured 418, 566 
FeII(TPP) 5 Not measured Not measured 
FeII(TPP)(Im)2 6 427, 532, 566 Not measured 
[FeII(TPivPP)(SH)]– 7 419, 455 (sh), 534, 578, 620 419, 455 (sh), 534, 578, 620 
[FeII(TPP)(SH)]– 8 418, 463 (sh), 532, 573, 622 418, 463 (sh), 532, 573, 622 
FeII(TPivPP)(O2)(Im) 9 429, 540 Not measured 
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Additional UV-Vis experiments 
 
Figure E-1. Titration of a 88 µM solution of Zn(didpa)Cl2 in MeCN (black) with 
NBu4SH added in 0.1 equiv. increments up to 1.5 equiv. (red). The titration was 
continued up to 5 equiv. (blue) of NBu4SH, which results in a spectrum primarily 
dominated by the absorption of free HS–, which has an absorbance at 273 nm (inset) in 
MeCN. Attempts to fit this data to a 1:1 or 1:2 binding model were unsuccessful due to 
overlapping peaks. 
 
Figure E-2. Titration of a 87 µM solution of Zn(didpa)Cl2 in MeCN (black) with sodium  
butylthiolate added in 0.3 equiv. increments up to 6 equivalents (red). Further increase in 
the spectrum at 250 nm is due to sodium butane thiolate (blue). The spectrum of sodium 
butylthiolate is shown in the inset for comparison. Attempts to fit this data to a 1:1 or 1:2 
binding model were unsuccessful. 
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Figure E-3. Titration of a 88 µM solution of Zn(didpa)Cl2 in MeCN with NBu4Cl added 
in 0.1 equiv. increments of NBu4Cl up to 13.6 equivalents (red). Inset shows the binding 
isotherm at 282 nm with fit of 4,440 ± 15 M-1. Residuals are assigned to the right y-axis. 
 
Figure E-4. Titration of 175 µM solution of Zn(didpa)Cl2 in DCM with NBu4Cl added in 
0.1 equiv. increments of NBu4Cl up to 4.0 equivalents (red). Inset shows the binding 
isotherm at 263 nm and was unable to be fit due to its sinusoidal nature. The apparent 
induction behavior could be due to chloride binding free zinc (see methods); however, 
removal of these initial points does not provide reasonable fits to a 1:1 or 1:2 model. 
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Additional NMR experiments 
 
Figure E-5. NOESY spectrum of 11.6 mM Zn(didpa)Cl2, and 18.9 mM NBu4SH (1.6 
equiv.) in CD3CN recorded at -35 °C. The spectra were recorded with a 2.0 s relaxation 
delay and a 0.4 s mixing time. The largest observed peak is an exchange peak with 
residual water. 
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Figure E-6. 1H NMR spectra of Zn(didpa)Cl2 (5.8 mM in CD3CN) before (top, black 
spectrum) and after (bottom, red spectrum) addition of 5.7 equiv. of NBu4Cl. The (*) 
correspond to NBu4+. 
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Figure E-7. 1H NMR spectra of 1 (11.8 mM in CD3CN before (top, black) and after 
(bottom, red) addition of 1.5 equiv. of NBu4SH. Peaks denoted with (*) correspond to the 
NBu4+ counterion. (reprint of figure 2) 
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Figure E-8. Variable temperature 1H NMR spectra of 11.4 mM Zn(didpa)Cl2, and 1.5 
equiv. NBu4SH in CD3CN. Cooling to -35 °C results in sharpening and an upfield shift of 
the broad SH peak to 11.05 ppm. See Figure S6 for an expanded view of the SH peak. 
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Figure E-9. 1H NMR spectra of 11.4 mM Zn(didpa)Cl2, and 16.7 mM NBu4SH (1.5 
equiv.) in CD3CN showing the SH resonance upon cooling. All spectra were measured 
with a 5 second relaxation delay. 
 
Figure E-10. 1H NMR spectra of 10.3 mM 1 (black) at 25 °C. Addition of 1.5 
equivalents NBu4SH at 25 °C (red). Addition of 20 equiv. of NBu4Cl at 25 °C (blue). 
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Figure E-11. 1H NMR spectra of 2.63 mM Zn(iPrPDI)Cl2 and 4.85 mM NBu4SH in 
CD3CN. Formation of a white precipitate was observed during addition of the first two 
equivalents of sulfide. 
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Job Plot 
 
Figure E-12. Job plot of Zn(didpa)Cl2 with NBu4Cl in MeCN at an overall concentration 
of 412 µM. The break is consistent with a 1:1 binding event. The plot was corrected for 
6.0% excess zinc as determined by addition of TPEN by subtraction of that percentage 
from the mol ratio of zinc as described in the experimental details above. 
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Figure E-13. Titration of Zn(didpa)Cl2 (85.5 µM, CH2Cl2, black) with 
tetramethylammonium hydroxide pentahydrate (0.1 equiv. increments up to 3 
equivalents, red). The inset shows the Job plot of 1 with tetramethylammonium 
hydroxide pentahydrate in MeCN at a total concentration of 413 µM. The break is 
consistent with 1:1 binding. 
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NMR Titration Experiments 
Table F-1. Titration of 1 with HS–. (Stock [HS–] = 19.99 mM) 
Entry Guest (µL) [1] (M) [HS–] (M) Equiv. δ (ppm) 
0 0 9.88E-04 0.00E+00 0.00 8.922 
1 5 9.88E-04 1.49E-04 0.15 9.148 
2 10 9.88E-04 2.95E-04 0.30 9.429 
3 15 9.88E-04 4.39E-04 0.44 9.678 
4 20 9.88E-04 5.80E-04 0.59 9.913 
5 25 9.88E-04 7.20E-04 0.73 10.113 
6 30 9.88E-04 8.57E-04 0.87 10.318 
7 35 9.88E-04 9.91E-04 1.00 10.455 
8 40 9.88E-04 1.12E-03 1.14 10.550 
9 50 9.88E-04 1.38E-03 1.40 10.769 
10 60 9.88E-04 1.64E-03 1.66 10.872 
11 80 9.88E-04 2.12E-03 2.14 10.983 
12 100 9.88E-04 2.57E-03 2.60 11.074 
13 150 9.88E-04 3.60E-03 3.64 11.129 
14 200 9.88E-04 4.50E-03 4.55 11.171 
15 300 9.88E-04 6.00E-03 6.07 11.215 
16 500 9.88E-04 8.18E-03 8.28 11.237 
17 800 9.88E-04 1.03E-02 10.41 11.244 
18 1200 9.88E-04 1.20E-02 12.14 11.184 
19 1500 9.88E-04 1.28E-02 13.01 11.176 
 
Figure F-1. Binding isotherm for HS– titration of 1 in 10% DMSO-d6/CD3CN 
determined by 1H NMR spectroscopy.  1H NMR stacked plot of 1 (0.988 mM) titrated 
with NBu4SH (0-13 equiv., bottom to top) in 10% DMSO-d6/CD3CN. 
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Table F-2. Titration of 1 with Cl–. (Stock [Cl–] = 44.59 mM) 
Entry Guest (µL) [1] (M) [Cl-] (M) Equiv. δ (ppm) 
0 0 6.49E-04 0.00E+00 0.00 8.921 
1 5 6.49E-04 3.68E-04 0.57 9.306 
2 10 6.49E-04 7.31E-04 1.13 9.583 
3 15 6.49E-04 1.09E-03 1.68 9.771 
4 20 6.49E-04 1.44E-03 2.22 9.898 
5 25 6.49E-04 1.78E-03 2.75 9.986 
6 30 6.49E-04 2.12E-03 3.27 10.050 
7 35 6.49E-04 2.46E-03 3.79 10.102 
8 40 6.49E-04 2.79E-03 4.29 10.143 
9 50 6.49E-04 3.43E-03 5.28 10.197 
10 60 6.49E-04 4.05E-03 6.24 10.237 
11 80 6.49E-04 5.25E-03 8.08 10.285 
12 100 6.49E-04 6.37E-03 9.81 10.316 
13 150 6.49E-04 8.92E-03 13.74 10.364 
14 200 6.49E-04 1.11E-02 17.17 10.391 
15 300 6.49E-04 1.49E-02 22.89 10.423 
16 500 6.49E-04 2.03E-02 31.22 10.454 
17 800 6.49E-04 2.55E-02 39.25 10.470 
18 1200 6.49E-04 2.97E-02 45.79 10.472 
19 1500 6.49E-04 3.18E-02 49.06 10.472 
 
Figure F-2. Binding isotherm for Cl– titration of 1 in 10% DMSO-d6/CD3CN determined 
by 1H NMR spectroscopy.  1H NMR stacked plot of 1 (0.649mM) titrated with NBu4Cl 
(0-49 equiv., bottom to top) in 10% DMSO-d6/CD3CN.  
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Table F-3. Titration of 2 with HS–. (Stock [HS–] = 25.40 mM) 
Entry Guest (µL) [2] (M) [HS-] (M) Equiv. δ (ppm) 
0 0 6.81E-04 0.00E+00 0.00 8.920 
1 5 6.81E-04 2.10E-04 0.31 9.146 
2 10 6.81E-04 4.16E-04 0.61 9.409 
3 15 6.81E-04 6.20E-04 0.91 9.673 
4 20 6.81E-04 8.20E-04 1.20 9.901 
5 25 6.81E-04 1.02E-03 1.49 10.079 
6 30 6.81E-04 1.21E-03 1.78 10.222 
7 35 6.81E-04 1.40E-03 2.06 10.333 
8 40 6.81E-04 1.59E-03 2.33 10.442 
9 50 6.81E-04 1.95E-03 2.87 10.579 
10 60 6.81E-04 2.31E-03 3.39 10.674 
11 80 6.81E-04 2.99E-03 4.39 10.804 
12 100 6.81E-04 3.63E-03 5.33 10.883 
13 150 6.81E-04 5.08E-03 7.46 11.008 
14 200 6.81E-04 6.35E-03 9.33 11.088 
15 300 6.81E-04 8.47E-03 12.44 11.179 
16 500 6.81E-04 1.15E-02 16.96 11.283 
17 800 6.81E-04 1.45E-02 21.33 11.292 
18 1200 6.81E-04 1.69E-02 24.88 11.293 
19 1600 6.81E-04 1.85E-02 27.14 11.314 
 
Figure F-3. Binding isotherm for HS– titration of 2 in 10% DMSO-d6/CD3CN 
determined by 1H NMR spectroscopy.  1H NMR stacked plot of 2 (0.681 mM) titrated 
with NBu4SH (0-27 equiv., bottom to top) in 10% DMSO-d6/CD3CN.  
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Table F-4. Titration of 2 with Cl–. (Stock [Cl–] = 35.04 mM) 
Entry Guest (µL) [2] (M) [Cl-] (M) Equiv. δ (ppm) 
0 0 1.04E-03 0.00E+00 0.00 8.900 
1 5 1.04E-03 2.90E-04 0.28 8.994 
2 10 1.04E-03 5.74E-04 0.55 9.075 
3 15 1.04E-03 8.55E-04 0.82 9.147 
4 20 1.04E-03 1.13E-03 1.09 9.214 
5 25 1.04E-03 1.40E-03 1.35 9.275 
6 30 1.04E-03 1.67E-03 1.60 9.325 
7 35 1.04E-03 1.93E-03 1.85 9.370 
8 40 1.04E-03 2.19E-03 2.10 9.412 
9 50 1.04E-03 2.70E-03 2.59 9.482 
10 60 1.04E-03 3.19E-03 3.06 9.544 
11 80 1.04E-03 4.12E-03 3.96 9.638 
12 100 1.04E-03 5.01E-03 4.81 9.716 
13 150 1.04E-03 7.01E-03 6.73 9.854 
14 200 1.04E-03 8.76E-03 8.41 9.953 
15 300 1.04E-03 1.17E-02 11.21 10.091 
16 500 1.04E-03 1.59E-02 15.29 10.193 
17 800 1.04E-03 2.00E-02 19.22 10.197 
18 1200 1.04E-03 2.34E-02 22.42 10.233 
19 1500 1.04E-03 2.50E-02 24.03 10.236 
 
Figure F-4. Binding isotherm for Cl– titration of 2 in 10% DMSO-d6/CD3CN determined 
by 1H NMR spectroscopy.  1H NMR stacked plot of 2 (1.04 mM) titrated with NBu4Cl (0-
24 equiv., bottom to top) in 10% DMSO-d6/CD3CN.  
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Table F-5. Titration of 3 with HS–. (Stock [HS–] = 23.7 mM) 
Entry Guest (µL) [3] (M) [HS-] (M) Equiv. δ (ppm) 
0 0 8.64E-04 0.00E+00 0.00 9.165 
1 5 8.64E-04 1.96E-04 0.23 9.365 
2 10 8.64E-04 3.88E-04 0.45 9.590 
3 15 8.64E-04 5.77E-04 0.67 9.785 
4 20 8.64E-04 7.64E-04 0.88 9.959 
5 25 8.64E-04 9.47E-04 1.10 10.106 
6 30 8.64E-04 1.13E-03 1.30 10.234 
7 35 8.64E-04 1.30E-03 1.51 10.339 
8 40 8.64E-04 1.48E-03 1.71 10.432 
9 50 8.64E-04 1.82E-03 2.11 10.572 
10 60 8.64E-04 2.15E-03 2.49 10.681 
11 80 8.64E-04 2.78E-03 3.22 10.832 
12 100 8.64E-04 3.38E-03 3.91 10.937 
13 150 8.64E-04 4.73E-03 5.48 11.092 
14 200 8.64E-04 5.92E-03 6.85 11.183 
15 300 8.64E-04 7.89E-03 9.13 11.295 
16 500 8.64E-04 1.08E-02 12.45 11.385 
17 800 8.64E-04 1.35E-02 15.66 11.441 
18 1200 8.64E-04 1.58E-02 18.27 11.440 
19 1600 8.64E-04 1.72E-02 19.93 11.452 
 
Figure F-5. Binding isotherm for HS– titration of 3 in 10% DMSO-d6/CD3CN 
determined by 1H NMR spectroscopy.  1H NMR stacked plot of 3 (0.864 mM) titrated 
with NBu4SH (0-20 equiv., bottom to top) in 10% DMSO-d6/CD3CN.  
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Table F-6. Titration of 3 with Cl–. (Stock [Cl–] = 43.35 mM) 
Entry Guest (µL) [3] (M) [Cl-] (M) Equiv. δ (ppm) 
0 0 9.04E-04 0.00E+00 0.00 9.173 
1 5 9.04E-04 3.58E-04 0.40 9.291 
2 10 9.04E-04 7.11E-04 0.79 9.383 
3 15 9.04E-04 1.06E-03 1.17 9.468 
4 20 9.04E-04 1.40E-03 1.55 9.553 
5 25 9.04E-04 1.73E-03 1.92 9.612 
6 30 9.04E-04 2.06E-03 2.28 9.667 
7 35 9.04E-04 2.39E-03 2.64 9.715 
8 40 9.04E-04 2.71E-03 3.00 9.754 
9 50 9.04E-04 3.33E-03 3.69 9.822 
10 60 9.04E-04 3.94E-03 4.36 9.879 
11 80 9.04E-04 5.10E-03 5.64 9.970 
12 100 9.04E-04 6.19E-03 6.85 10.039 
13 150 9.04E-04 8.67E-03 9.59 10.167 
14 200 9.04E-04 1.08E-02 11.98 10.255 
15 300 9.04E-04 1.44E-02 15.98 10.367 
16 500 9.04E-04 1.97E-02 21.79 10.515 
17 800 9.04E-04 2.48E-02 27.39 10.562 
18 1200 9.04E-04 2.89E-02 31.96 10.544 
19 1500 9.04E-04 3.10E-02 34.24 10.544 
 
Figure F-6. Binding isotherm for Cl– titration of 3 in 10% DMSO-d6/CD3CN determined 
by 1H NMR spectroscopy.  1H NMR stacked plot of 3 (0.904 mM) titrated with NBu4Cl 
(0-34 equiv., bottom to top) in 10% DMSO-d6/CD3CN. 
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UV-Vis Titrations 
Table F-7. Titration of 1 with HS–. 
 Entry [1] (M) [SH-] (M) Equiv. Absorbance (310 nm) 
Absorbance 
(322 nm) 
Absorbance 
(330 nm) 
Absorbance 
(347 nm) 
0 1.03E-05 0.00E+00 0.00 0.189 0.215 0.203 0.095 
1 1.03E-05 3.30E-06 0.32 0.187 0.212 0.205 0.105 
2 1.03E-05 6.59E-06 0.64 0.183 0.211 0.206 0.110 
3 1.03E-05 9.89E-06 0.96 0.181 0.208 0.206 0.113 
4 1.03E-05 1.32E-05 1.28 0.180 0.208 0.206 0.117 
5 1.03E-05 1.65E-05 1.60 0.179 0.207 0.207 0.120 
6 1.03E-05 1.98E-05 1.92 0.176 0.205 0.207 0.122 
7 1.03E-05 2.30E-05 2.24 0.175 0.204 0.207 0.122 
8 1.03E-05 2.63E-05 2.56 0.175 0.204 0.208 0.125 
9 1.03E-05 2.96E-05 2.87 0.174 0.204 0.208 0.126 
10 1.03E-05 3.29E-05 3.19 0.175 0.205 0.209 0.128 
11 1.03E-05 3.94E-05 3.83 0.175 0.204 0.210 0.130 
12 1.03E-05 4.60E-05 4.46 0.174 0.203 0.210 0.131 
13 1.03E-05 5.25E-05 5.10 0.174 0.204 0.210 0.133 
14 1.03E-05 5.90E-05 5.73 0.172 0.203 0.209 0.134 
15 1.03E-05 6.56E-05 6.37 0.173 0.204 0.211 0.136 
16 1.03E-05 7.86E-05 7.63 0.174 0.205 0.213 0.137 
17 1.03E-05 9.15E-05 8.89 0.170 0.201 0.209 0.135 
18 1.03E-05 1.04E-04 10.14 0.173 0.204 0.214 0.140 
19 1.03E-05 1.17E-04 11.40 0.174 0.204 0.213 0.141 
20 1.03E-05 1.30E-04 12.65 0.173 0.204 0.213 0.140 
21 1.03E-05 1.56E-04 15.14 0.173 0.203 0.213 0.140 
22 1.03E-05 1.81E-04 17.62 0.174 0.205 0.213 0.141 
23 1.03E-05 2.07E-04 20.08 0.176 0.206 0.216 0.143 
24 1.03E-05 2.32E-04 22.54 0.173 0.204 0.213 0.141 
25 1.03E-05 2.57E-04 24.98 0.174 0.204 0.213 0.141 
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Figure F-7. UV-Vis titration of 1 with HS– in MeCN. HS– was incrementally added to a 
10.3 µM solution of 1. Inset: Representative curve at 333 nm: black dots are data 
collected, line is experimental fit, and red dots are residuals, corresponding to the right 
(red) axis. 
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Table F-8. Titration of 1 with Cl–. 
 Entry [1] (M) [Cl-] (M) Equiv. Absorbance (335 nm) 
Absorbance 
(338 nm) 
Absorbance 
(340 nm) 
Absorbance 
(343 nm) 
0 1.03E-05 0.00E+00 0.00 0.192 0.172 0.160 0.132 
1 1.03E-05 1.56E-06 0.15 0.193 0.174 0.161 0.133 
2 1.03E-05 3.12E-06 0.30 0.194 0.175 0.163 0.134 
3 1.03E-05 4.67E-06 0.45 0.195 0.176 0.164 0.136 
4 1.03E-05 6.23E-06 0.60 0.197 0.177 0.166 0.137 
5 1.03E-05 7.79E-06 0.75 0.196 0.177 0.165 0.137 
6 1.03E-05 1.09E-05 1.05 0.197 0.178 0.166 0.138 
7 1.03E-05 1.40E-05 1.35 0.200 0.181 0.169 0.141 
8 1.03E-05 1.71E-05 1.65 0.202 0.183 0.172 0.143 
9 1.03E-05 2.02E-05 1.95 0.204 0.185 0.174 0.146 
10 1.03E-05 2.33E-05 2.25 0.204 0.186 0.174 0.146 
11 1.03E-05 2.64E-05 2.55 0.206 0.187 0.176 0.149 
12 1.03E-05 3.25E-05 3.15 0.208 0.190 0.179 0.151 
13 1.03E-05 3.87E-05 3.74 0.210 0.192 0.181 0.154 
14 1.03E-05 4.48E-05 4.34 0.211 0.194 0.182 0.155 
15 1.03E-05 5.09E-05 4.93 0.213 0.196 0.185 0.158 
16 1.03E-05 5.70E-05 5.52 0.214 0.197 0.186 0.158 
17 1.03E-05 6.31E-05 6.11 0.214 0.198 0.187 0.160 
18 1.03E-05 6.92E-05 6.69 0.216 0.200 0.188 0.161 
19 1.03E-05 7.52E-05 7.28 0.216 0.200 0.189 0.162 
20 1.03E-05 8.73E-05 8.45 0.218 0.202 0.191 0.164 
21 1.03E-05 9.93E-05 9.61 0.219 0.203 0.192 0.166 
22 1.03E-05 1.11E-04 10.76 0.219 0.203 0.192 0.165 
23 1.03E-05 1.23E-04 11.91 0.221 0.205 0.195 0.168 
24 1.03E-05 1.35E-04 13.06 0.221 0.206 0.195 0.169 
25 1.03E-05 1.47E-04 14.19 0.221 0.205 0.195 0.168 
26 1.03E-05 1.58E-04 15.33 0.222 0.206 0.196 0.169 
27 1.03E-05 1.70E-04 16.45 0.221 0.206 0.195 0.168 
28 1.03E-05 1.82E-04 17.57 0.222 0.206 0.196 0.170 
29 1.03E-05 1.93E-04 18.69 0.222 0.207 0.196 0.170 
30 1.03E-05 2.05E-04 19.80 0.222 0.207 0.196 0.170 
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Figure F-8. UV-Vis titration of 1 with Cl– in MeCN. Cl– was incrementally added to a 
10.3 µM solution of 1. Inset: Representative curve at 343 nm: black dots are data 
collected, line is experimental fit, and red dots are residuals, corresponding to the right 
(red) axis. 
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Table F-9. Titration of 2 with HS–. 
 Entry [2] (M) [SH-] (M) Equiv. Absorbance (327 nm) 
Absorbance 
(333 nm) 
Absorbance 
(360 nm) 
Absorbance 
(375 nm) 
0 1.06E-05 0.00E+00 0.00 0.220 0.224 0.095 0.012 
1 1.06E-05 3.24E-06 0.31 0.219 0.223 0.097 0.013 
2 1.06E-05 6.47E-06 0.61 0.218 0.222 0.098 0.014 
3 1.06E-05 9.70E-06 0.92 0.218 0.221 0.099 0.015 
4 1.06E-05 1.29E-05 1.22 0.216 0.219 0.101 0.016 
5 1.06E-05 1.62E-05 1.53 0.215 0.219 0.102 0.016 
6 1.06E-05 1.94E-05 1.83 0.214 0.217 0.103 0.018 
7 1.06E-05 2.26E-05 2.14 0.214 0.217 0.105 0.020 
8 1.06E-05 2.59E-05 2.44 0.213 0.216 0.106 0.021 
9 1.06E-05 2.91E-05 2.75 0.212 0.215 0.107 0.021 
10 1.06E-05 3.23E-05 3.05 0.212 0.214 0.108 0.023 
11 1.06E-05 3.55E-05 3.36 0.211 0.213 0.109 0.023 
12 1.06E-05 3.88E-05 3.66 0.210 0.213 0.110 0.024 
13 1.06E-05 4.52E-05 4.27 0.208 0.210 0.111 0.026 
14 1.06E-05 5.16E-05 4.88 0.207 0.210 0.113 0.027 
15 1.06E-05 5.81E-05 5.48 0.207 0.210 0.115 0.029 
16 1.06E-05 6.45E-05 6.09 0.206 0.208 0.115 0.029 
17 1.06E-05 7.09E-05 6.70 0.205 0.207 0.116 0.030 
18 1.06E-05 7.74E-05 7.31 0.206 0.208 0.118 0.033 
19 1.06E-05 8.38E-05 7.91 0.204 0.206 0.117 0.031 
20 1.06E-05 9.02E-05 8.52 0.203 0.205 0.118 0.032 
21 1.06E-05 1.03E-04 9.73 0.200 0.203 0.120 0.035 
22 1.06E-05 1.16E-04 10.94 0.200 0.202 0.122 0.036 
23 1.06E-05 1.29E-04 12.15 0.200 0.203 0.123 0.036 
24 1.06E-05 1.41E-04 13.35 0.199 0.201 0.123 0.038 
25 1.06E-05 1.54E-04 14.56 0.198 0.201 0.123 0.037 
26 1.06E-05 1.80E-04 16.96 0.198 0.200 0.125 0.039 
27 1.06E-05 2.05E-04 19.36 0.197 0.200 0.125 0.040 
28 1.06E-05 2.30E-04 21.75 0.198 0.200 0.127 0.040 
29 1.06E-05 2.56E-04 24.14 0.197 0.199 0.127 0.041 
30 1.06E-05 2.81E-04 26.52 0.197 0.200 0.128 0.042 
31 1.06E-05 3.31E-04 31.26 0.197 0.200 0.130 0.042 
32 1.06E-05 3.81E-04 35.98 0.196 0.198 0.131 0.043 
33 1.06E-05 4.31E-04 40.68 0.196 0.198 0.131 0.044 
34 1.06E-05 4.80E-04 45.35 0.195 0.198 0.131 0.044 
35 1.06E-05 5.30E-04 50.00 0.195 0.197 0.132 0.044 
36 1.06E-05 5.79E-04 54.62 0.194 0.196 0.133 0.044 
37 1.06E-05 6.27E-04 59.23 0.194 0.197 0.133 0.044 
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Figure F-9. UV-Vis titration of 2 with HS– in MeCN. HS– was incrementally added to a 
10.6 µM solution of 2. Inset: Representative curve at 360 nm: black dots are data 
collected, line is experimental fit, and red dots are residuals, corresponding to the right 
(red) axis. 
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Table F-10. Titration of 2 with Cl–. 
 Entry [2] (M) [Cl-] (M) Equiv. Absorbance (352 nm) 
Absorbance 
(355 nm) 
Absorbance 
(357 nm) 
Absorbance 
(360 nm) 
0 1.06E-05 0.00E+00 0.00 0.169 0.150 0.137 0.115 
1 1.06E-05 3.59E-06 0.34 0.170 0.150 0.137 0.115 
2 1.06E-05 7.18E-06 0.68 0.170 0.150 0.137 0.116 
3 1.06E-05 1.43E-05 1.35 0.171 0.151 0.138 0.116 
4 1.06E-05 2.15E-05 2.03 0.170 0.151 0.138 0.116 
5 1.06E-05 2.87E-05 2.71 0.173 0.154 0.140 0.118 
6 1.06E-05 3.58E-05 3.38 0.172 0.152 0.139 0.117 
7 1.06E-05 4.29E-05 4.05 0.171 0.152 0.139 0.117 
8 1.06E-05 5.00E-05 4.73 0.173 0.153 0.140 0.118 
9 1.06E-05 5.72E-05 5.40 0.172 0.153 0.140 0.118 
10 1.06E-05 6.43E-05 6.07 0.173 0.154 0.141 0.119 
11 1.06E-05 7.14E-05 6.74 0.174 0.155 0.142 0.120 
12 1.06E-05 7.84E-05 7.41 0.174 0.154 0.141 0.119 
13 1.06E-05 9.26E-05 8.74 0.175 0.155 0.142 0.120 
14 1.06E-05 1.07E-04 10.07 0.175 0.156 0.143 0.121 
15 1.06E-05 1.21E-04 11.40 0.176 0.157 0.143 0.121 
16 1.06E-05 1.35E-04 12.73 0.176 0.157 0.144 0.121 
17 1.06E-05 1.49E-04 14.05 0.177 0.158 0.145 0.122 
18 1.06E-05 1.63E-04 15.37 0.178 0.159 0.146 0.123 
19 1.06E-05 1.77E-04 16.69 0.178 0.159 0.146 0.124 
20 1.06E-05 1.91E-04 18.00 0.178 0.159 0.146 0.124 
21 1.06E-05 2.18E-04 20.61 0.179 0.160 0.147 0.125 
22 1.06E-05 2.46E-04 23.21 0.180 0.162 0.149 0.126 
23 1.06E-05 2.73E-04 25.80 0.181 0.162 0.149 0.126 
24 1.06E-05 3.01E-04 28.38 0.182 0.163 0.150 0.127 
25 1.06E-05 3.28E-04 30.94 0.184 0.165 0.151 0.129 
26 1.06E-05 3.55E-04 33.49 0.183 0.165 0.152 0.129 
27 1.06E-05 3.82E-04 36.03 0.185 0.166 0.153 0.131 
28 1.06E-05 4.08E-04 38.56 0.185 0.166 0.153 0.130 
29 1.06E-05 4.35E-04 41.07 0.186 0.168 0.155 0.132 
30 1.06E-05 4.61E-04 43.57 0.186 0.168 0.155 0.132 
31 1.06E-05 4.88E-04 46.06 0.186 0.168 0.155 0.132 
32 1.06E-05 5.14E-04 48.53 0.186 0.168 0.155 0.132 
33 1.06E-05 5.40E-04 51.00 0.188 0.169 0.156 0.133 
34 1.06E-05 5.66E-04 53.45 0.188 0.169 0.156 0.133 
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Figure F-10. UV-Vis titration of 2 with Cl– in MeCN. Cl– was incrementally added to a 
10.6 µM solution of 2. Inset: Representative curve at 355 nm: black dots are data 
collected, line is experimental fit, and red dots are residuals, corresponding to the right 
(red) axis. 
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Table F-11. Titration of 3 with HS–. 
 Entry [3] (M) [HS-] (M) Equiv. Absorbance 
(324 nm) 
Absorbance 
(333 nm) 
0 1.07E-05 0.00E+00 0.00 0.2286 0.2370 
1 1.07E-05 1.44E-06 0.13 0.2285 0.2347 
2 1.07E-05 2.87E-06 0.27 0.2283 0.2350 
3 1.07E-05 4.31E-06 0.40 0.2279 0.2351 
4 1.07E-05 5.74E-06 0.54 0.2267 0.2337 
5 1.07E-05 7.17E-06 0.67 0.2254 0.2321 
6 1.07E-05 8.60E-06 0.80 0.2263 0.2326 
7 1.07E-05 1.00E-05 0.93 0.2260 0.2329 
8 1.07E-05 1.15E-05 1.07 0.2253 0.2312 
9 1.07E-05 1.29E-05 1.21 0.2255 0.2315 
10 1.07E-05 1.43E-05 1.34 0.2243 0.2301 
11 1.07E-05 1.57E-05 1.47 0.2238 0.2285 
12 1.07E-05 1.72E-05 1.61 0.2243 0.2294 
13 1.07E-05 1.86E-05 1.74 0.2243 0.2290 
14 1.07E-05 2.00E-05 1.87 0.2229 0.2277 
15 1.07E-05 2.14E-05 2.00 0.2232 0.2271 
16 1.07E-05 2.43E-05 2.27 0.2221 0.2259 
17 1.07E-05 2.71E-05 2.53 0.2212 0.2248 
18 1.07E-05 3.00E-05 2.80 0.2200 0.2237 
19 1.07E-05 3.28E-05 3.07 0.2188 0.2225 
20 1.07E-05 3.56E-05 3.33 0.2189 0.2219 
21 1.07E-05 3.85E-05 3.60 0.2200 0.2228 
22 1.07E-05 4.13E-05 3.86 0.2194 0.2222 
23 1.07E-05 4.69E-05 4.38 0.2190 0.2211 
24 1.07E-05 5.25E-05 4.91 0.2159 0.2171 
25 1.07E-05 5.82E-05 5.44 0.2191 0.2208 
26 1.07E-05 6.37E-05 5.95 0.2183 0.2194 
27 1.07E-05 6.93E-05 6.48 0.2179 0.2196 
28 1.07E-05 8.05E-05 7.52 0.2150 0.2167 
29 1.07E-05 9.15E-05 8.55 0.2159 0.2173 
30 1.07E-05 1.03E-04 9.58 0.2145 0.2149 
31 1.07E-05 1.13E-04 10.61 0.2127 0.2132 
32 1.07E-05 1.24E-04 11.63 0.2142 0.2150 
33 1.07E-05 1.35E-04 12.64 0.2113 0.2104 
34 1.07E-05 1.46E-04 13.65 0.2138 0.2143 
35 1.07E-05 1.57E-04 14.65 0.2130 0.2133 
36 1.07E-05 1.67E-04 15.65 0.2125 0.2126 
37 1.07E-05 1.78E-04 16.65 0.2142 0.2151 
38 1.07E-05 1.89E-04 17.64 0.2130 0.2135 
39 1.07E-05 1.99E-04 18.62 0.2116 0.2116 
40 1.07E-05 2.10E-04 19.60 0.2120 0.2122 
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Figure F-11. UV-Vis titration of 3 with HS– in MeCN. HS– was incrementally added to a 
10.7 µM solution of 3. Inset: Representative curve at 333 nm: black dots are data 
collected, line is experimental fit, and red dots are residuals, corresponding to the right 
(red) axis. 
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Table F-12. Titration of 3 with Cl–. 
 Entry [3] (M) [Cl-] (M) Equiv. Absorbance 
(350 nm) 
Absorbance 
(353 nm) 
Absorbance 
(355 nm) 
Absorbance 
(360 nm) 
0 1.08E-05 0.00E+00 0.00 0.180 0.145 0.128 0.081 
1 1.08E-05 2.03E-05 1.88 0.182 0.148 0.130 0.082 
2 1.08E-05 4.07E-05 3.77 0.178 0.149 0.133 0.083 
3 1.08E-05 6.10E-05 5.65 0.185 0.151 0.133 0.084 
4 1.08E-05 8.12E-05 7.52 0.181 0.152 0.136 0.087 
5 1.08E-05 1.01E-04 9.40 0.181 0.153 0.136 0.087 
6 1.08E-05 1.42E-04 13.14 0.184 0.155 0.139 0.089 
7 1.08E-05 1.82E-04 16.87 0.186 0.157 0.140 0.091 
8 1.08E-05 2.22E-04 20.60 0.193 0.159 0.141 0.091 
9 1.08E-05 2.63E-04 24.31 0.187 0.159 0.143 0.092 
10 1.08E-05 3.03E-04 28.02 0.189 0.161 0.145 0.094 
11 1.08E-05 3.82E-04 35.40 0.198 0.163 0.145 0.094 
12 1.08E-05 4.62E-04 42.75 0.195 0.166 0.150 0.098 
13 1.08E-05 5.41E-04 50.06 0.196 0.168 0.152 0.100 
14 1.08E-05 6.19E-04 57.33 0.200 0.172 0.155 0.102 
15 1.08E-05 6.97E-04 64.57 0.200 0.172 0.155 0.103 
16 1.08E-05 7.75E-04 71.78 0.201 0.173 0.157 0.103 
17 1.08E-05 8.52E-04 78.95 0.202 0.173 0.157 0.104 
18 1.08E-05 9.30E-04 86.08 0.207 0.174 0.156 0.103 
19 1.08E-05 1.01E-03 93.18 0.205 0.176 0.160 0.106 
20 1.08E-05 1.10E-03 102.01 0.205 0.178 0.161 0.107 
21 1.08E-05 1.20E-03 110.78 0.209 0.180 0.164 0.109 
22 1.08E-05 1.29E-03 119.50 0.207 0.180 0.163 0.109 
23 1.08E-05 1.38E-03 128.17 0.208 0.181 0.165 0.110 
24 1.08E-05 1.48E-03 136.79 0.209 0.182 0.165 0.110 
25 1.08E-05 1.57E-03 145.35 0.214 0.186 0.170 0.115 
26 1.08E-05 1.66E-03 153.87 0.212 0.185 0.168 0.114 
27 1.08E-05 1.75E-03 162.33 0.212 0.184 0.168 0.113 
28 1.08E-05 1.84E-03 170.75 0.214 0.187 0.170 0.115 
29 1.08E-05 1.93E-03 179.11 0.214 0.188 0.171 0.116 
30 1.08E-05 2.02E-03 187.43 0.216 0.189 0.171 0.116 
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Figure F-12. UV-Vis titration of 3 with Cl– in MeCN. Cl– was incrementally added to a 
10.8 µM solution of 3. Inset: Representative curve at 350 nm: black dots are data 
collected, line is experimental fit, and red dots are residuals, corresponding to the right 
(red) axis. 
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13C{1H} NMR Spectra of Non-covalent Host-Guest Complex 
 
Figure F-13. a, 13C{1H} NMR spectrum of a 2.318 mM solution of 1 with addition of 10 
equivalents of NBu4SH. 13C NMR (151 MHz, CD3CN) δ 154.97, 153.56, 144.98, 138.51, 
136.94, 133.28, 130.71, 128.86, 128.70, 126.68, 123.21, 121.14, 121.08, 113.72, 111.92, 
93.85, 86.89.  b, 13C{1H} NMR spectrum of a 2.318 mM solution of 1.  13C NMR (151 
MHz, CD3CN) δ 155.36, 153.07, 144.98, 138.39, 134.64, 132.68, 131.76, 129.06, 128.87, 
127.03, 123.48, 121.03, 119.81, 114.05, 111.26, 93.80, 86.60. 
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Deprotonation Control Experiment 
 
Figure F-14. a 1H NMR spectrum of a 1.5 mM solution of 3.  b 1H NMR spectrum of a 
1.5 mM solution of 3 with 150 mM solution of 1,8-diazabicyclo[5.4.0]undec-7-ene 
(DBU). This results in the disappearance of urea protons NHb and NHc, as well as upfield 
shifting of remaining aryl protons.  c 1.5 mM of 3 with 3.74 mM of NBu4SH.  Spectrum 
of the host-guest complex bears a marked difference to the deprotonated host. 
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X-Ray Crystallographic Data 
Table F-13. Crystal data and structure refinement for 1 + HS–. 
 1 + NBu4SH + THF 
Empirical formula C66H91N5O5S 
 [C46H46N4O4][C16H36N][C4H8O][S] 
Formula weight 1066.49 
Wavelength (Å) 1.54178 
Temperature (K) 173(2) 
Crystal System Orthorhombic 
Crystal system, space group P n a 21 
     Hall group P 2c -2n 
Unit cell dimensions (Å) a = 24.5943(5) 
 b = 9.7176(2) 
 c = 25.6717(4) 
 a = b = g = 90° 
Volume (Å3) 6135.5(2) 
Z 4 
r (mm-1) 1.155 
µ(Cu) (mm-1) 0.870 
F(000) 2312.0 
Crystal Size (mm x mm x mm) 0.18 x 0.16 x 0.03 
Limiting indices -29 ≤ h ≤ 29; -11 ≤ k ≤ 11; -30 ≤ l ≤ 30 
q range (°) 3.44 – 66.55 
2qmax (°)  
Completeness to q 99.7 
Total reflections 63889 
Independent reflections 10802 
Rint 0.0557 
data/restraints/param 10802/1/715 
max, min transmission 0.7528, 0.6436 
R1 (wR2) [I > 2s(I)] 0.0451 (0.1125) 
R1 (wR2) 0.0562 (0.1209) 
GOF (F2) 1.018 
Max, min peaks (e Å-3) 0.275, -0.294 
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Figure F-15. ORTEP representation of the crystal structure of 1 and NBu4SH, showing 
short contacts to the NBu4 counterion. Non-coordinating hydrogen atoms omitted for 
clarity. 
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Figure F-16. Overlay of the X-ray crystal structures of 1 bound to Cl– and HS–. Non-
coordinating hydrogen atoms omitted for clarity. In the images, the hydrosulfide structure 
is represented in red with a yellow anion, while the chloride structure is represented in 
blue with a green anion. The RMS distance between the two structures is 0.184 Å. A, top 
view of the two structures overlaid. B, side view looking toward the phenyl core through 
the anions. 
 
a
b
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